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ABSTRACT 
 
Tomasz J. Czernuszewicz: Atherosclerotic Plaque Characterization in 
 Humans with Acoustic Radiation Force Impulse (ARFI) Imaging. 
(Under the direction of Caterina M. Gallippi) 
 
Cardio- and cerebrovascular diseases (CVD) are among the leading causes of death and disability 
in the United States. It is estimated that every 43 seconds someone experiences a heart attack, and every 
four minutes someone dies of a stroke, resulting in an annual cost of $312.6 billion in health care 
expenditures and lost productivity. A vast majority of heart attacks and strokes are linked to 
atherosclerosis; a condition characterized by inflammation and plaque accumulation in the arterial wall 
that can rupture and propagate an acute thrombotic event. Identification of plaques that are vulnerable to 
rupture is paramount to the prevention of heart attacks and strokes, but a noninvasive plaque 
characterization imaging technology that is cost-effective, safe, and accurate has remained elusive. 
The goal of this dissertation is to evaluate whether acoustic radiation force impulse (ARFI) 
imaging, an ultrasound-based elastography technique, can noninvasively characterize plaque components 
and identify features that have been shown to correlate with plaque vulnerability. Data are presented from 
preclinical studies, done in a porcine model of atherosclerosis, and clinical studies, performed in patients 
undergoing carotid endarterectomy (CEA), to demonstrate the sensitivity and specificity of ARFI for 
various plaque components. Additionally, the ability of ARFI to measure fibrous cap thickness is assessed 
with finite element method (FEM) modelling, and the limits of ARFI fibrous cap resolution are analyzed. 
Lastly, advanced ARFI-based plaque imaging methods are explored, including intravascular ARFI for 
coronary plaque characterization. Overall, these studies demonstrate that ARFI can delineate features 
consistent with vulnerable plaque in a clinical imaging context and suggest that ARFI has the potential to 
improve the current state of the art in atherosclerosis diagnostics.  
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CHAPTER 1 
 Introduction 
1.1 Purpose  
 Cardiovascular disease (CVD) is the leading cause of death in the United States and globally [1]. 
Heart attacks and strokes represent the majority of CVD-related deaths and are predominantly caused by 
ischemia secondary to atherosclerotic disease of major arteries. Unsurprisingly, considerable research 
effort has gone into understanding the etiology of atherosclerosis and developing diagnostic tools that can 
identify the early onset of the disease prior to ischemic event. 
Atherosclerosis has often been dubbed the “silent killer” because it generally develops 
asymptomatically for decades before presenting as a heart attack or stroke. While atherosclerosis itself 
can narrow arteries over time and eventually cause ischemia, an acute-onset event such as a heart attack 
often occurs when a plaque is disrupted or ruptured. In the 1990s and early 2000s, numerous 
histopathology studies determined that certain morphological features made plaques more prone to 
rupture, leading to the development of the “vulnerable plaque” hypothesis. Namely, plaques that were 
composed of large lipid-rich necrotic cores and active inflammation covered with thin fibrous caps were 
highly associated with rupture and thrombosis [2]. Importantly, these and other studies revealed that 
ruptured plaques were not necessarily those with the highest degree of stenosis, suggesting that plaque 
composition may be a superior biomarker to stratify plaque risk. 
Ultrasound is currently the most widely applied diagnostic imaging modality for atherosclerosis 
due to its sensitivity to detect stenosis, widespread availability, and relatively low cost. Unfortunately, 
conventional ultrasound, which relies on the acoustic backscatter properties of tissue, has been shown to 
be unreliable for plaque characterization [3]. The purpose of this dissertation therefore, is to investigate 
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the application of a novel ultrasound modality – acoustic radiation force impulse (ARFI) imaging – for 
plaque characterization. Unlike conventional ultrasound, ARFI interrogates the mechanical properties of 
tissue, in a method akin to palpation. Therefore, the work presented herein proposes a new vulnerable 
plaque-imaging paradigm that has the potential to substantially improve the accuracy of ultrasonic plaque 
characterization and facilitate its use in the clinic. 
1.2 Hypothesis 
The underlying hypothesis driving this research is that by interrogating mechanical properties, 
ARFI imaging can noninvasively describe the composition and structure of atherosclerotic plaques. 
To test this hypothesis, a clinical study was designed in which ARFI images were taken in patients 
undergoing carotid endarterectomy. The ARFI images were then compared to histology from the 
corresponding endarterectomy samples in order to validate whether ARFI is capable of identifying 
vulnerable plaque features such as necrotic core, fibrous cap, and intraplaque hemorrhage. This dataset 
proved to be very rich and instigated further hypothesis-driven research, for example, testing the limits of 
ARFI resolution for measuring fibrous cap thickness. Throughout this dissertation, data from this clinical 
study will be referred to and analyzed. 
1.3 Overview 
As mentioned above, this dissertation primarily focuses on the clinical validation of ARFI 
imaging for plaque characterization compared against a histological gold standard. The organization of 
this work is the following.  
Chapter 2 begins by describing the natural history of atherosclerosis and introduces the concept of 
the vulnerable plaque. Chapter 3 reviews the current state-of-the-art atherosclerosis imaging techniques 
that are implemented either clinically or in development in research laboratories, and introduces elasticity 
imaging as a novel modality for plaque characterization. In Chapter 4, elasticity-imaging techniques that 
specifically utilize acoustic radiation force are described in detail, including ARFI imaging, which is the 
focus of this dissertation. A detailed description of the physics underlying acoustic radiation force 
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generation is also provided in this chapter. Chapter 5 presents a pre-clinical reader study done in ex vivo 
porcine arteries that demonstrates the sensitivity and specificity of ARFI for delineating various plaque 
compositional elements compared with matched histology. The methods of this pre-clinical study serve as 
a basis for the following chapters, which implement ARFI clinically in a human patient population. 
Chapter 6 presents preliminary results from four carotid plaques imaged in vivo in patients undergoing 
endarterectomy. In Chapter 7, the feasibility of ARFI for quantifying fibrous cap thickness is assessed 
with FEM modeling. Chapter 8 continues analysis of in vivo ARFI images from a greater number of 
endarterectomy patients and proposes improved methods for spatially aligning histology. Chapter 9 
concludes the evaluation of transcutaneous ARFI for in vivo carotid plaque characterization by reporting 
on the performance of ARFI for delineating plaque features as measured by a statistical reader study. 
Chapter 10 presents a novel intravascular ultrasound (IVUS) transducer that has potential for performing 
ARFI imaging in the coronary arteries. Finally, Chapter 11 presents the overall conclusions of this 
dissertation and discusses the future of ARFI plaque characterization. 
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CHAPTER 2 
 Clinical Background 
Atherosclerosis, originating from the Greek words athere meaning “gruel” and skleros meaning 
“hard”, is a chronic disease of the arterial vasculature. It is characterized by the development of 
atheromatous plaque in the walls of either elastic or muscular arteries that feed critical organs, such as the 
heart and brain, and without warning can result in a fatal heart attack or stroke.  
While the etiology of atherosclerosis is still not completely known, our understanding of the key 
mechanisms has grown substantially over the past few decades. This chapter will begin by discussing the 
basic anatomy of an artery and review the pathological changes that occur during atherosclerosis. Next, 
the concept of the “vulnerable plaque” will be introduced, which is a term used to describe plaques that 
are at highest risk for causing acute ischemic events. Finally, to conclude the chapter, various clinical 
therapies for treating atherosclerosis, as well as the animal models that drive atherosclerosis research, will 
be presented. 
2.1 Pathogenesis of Atherosclerosis 
The normal muscular artery in humans consists of three layers, each with its own unique 
structural characteristics and functions (Figure 2.1a). The inner layer, the tunica intima, consists of a 
single layer of endothelial cells supported by a small amount of sub-endothelial connective tissue. The 
tunica intima is in constant contact with luminal blood and it is in this layer that atherosclerosis first 
develops. The middle layer, which is typically the thickest of the three layers, is known as the tunica 
media and is comprised of smooth muscle cells (SMCs) embedded in a complex matrix of elastic 
lamellae. The SMCs in this layer give the artery the ability to vasoconstrict or vasodilate, while the elastic 
fibers help mitigate variations in pressure from pulsation. Finally, the outer layer, the tunica adventitia, is  
5 
mostly comprised of connective tissue (including collagen and free elastin fibers) and adipose tissue that 
serves to support the artery and it houses nutrient vessels, known as vasa vasorum, and nerves, known as 
nervi vasorum. The three layers are separated by two dense elastic membranes called the internal elastic 
lamina (IEL) and external elastic lamina (EEL), at the intima/media and media/adventitia borders, 
respectively.  
The first step in atherogenesis involves the sub-endothelial deposition and retention of 
apolipoprotein (apo) B–containing lipoproteins, more commonly known as very-low and low density 
lipoproteins (VLDL and LDL, respectively) [4]. Once inside the arterial wall, LDL can undergo oxidative 
 
Figure 2.1: Stages in the development of atherosclerosis. (a) Normal arterial wall depicting the three 
arterial layers: intima, media, and adventitia. (b) Initial stage of atherosclerosis, characterized by 
monocyte trafficking into the subintimal space, differentiation of monocytes into macrophages, and 
macrophage uptake of lipid yielding foam cells. (c) Lesion progression into a “fibroatheroma”, 
characterized by smooth muscle cell infiltration, heightened synthesis of collagen, apoptosis of foam cells 
that lead to formation of a necrotic core and calcification, and neovascularization of the vasa vasorum.  
(d) Thrombosis due to fibrous cap rupture, the ultimate complication of atherosclerosis. Reprinted with 
permission from [6] (Copyright © 2011 Macmillan Publishers Ltd.). 
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stress and be modified to oxidized-LDL (oxLDL), a process exacerbated by hypertension, diabetes, and 
smoking. The retained LDL and oxLDL particles ultimately trigger an inflammatory response in the 
arterial wall and initiate the cycle of atherosclerosis (Figure 2.1b). The presence of oxLDL in the intima, 
through activation of transcription factors such as NF-κB, leads to the expression of leukocyte adhesion 
molecules (e.g. VCAM and ICAM) on the surface of the endothelium and initiates monocyte recruitment 
into the intimal space. Monocytes go on to differentiate into macrophages and attempt to scavenge 
oxLDL, however they are incapable of clearing the cholesterol-laden proteins and become trapped in the 
intima (these lipid-filled macrophages are typically referred to as “foam cells”). While the foam cells 
remained trapped, they continue to produce inflammatory cytokines, such as IL-1β, IL-12, and TNF-α, 
that, not only amplify the inflammatory response, but also cause more lipoprotein movement into the 
intima by increasing transcription of LDL-receptor gene [5]. Thus the vicious cycle is propagated, 
including altered lipoprotein trafficking and oxidation, and chronic inflammation, which is maintained in 
the artery for decades and leads to the development of an “atheroma”. 
In addition to lipid accumulation and inflammation, atheroma formation also typically involves 
the activation and migration of vascular SMCs from the medial layer (Figure 2.1c). In response to 
inflammation, quiescent SMCs down-regulate expression of differentiation marker genes, including those 
for smooth muscle α-actin and smooth muscle myosin heavy chain, and switch to a remodeling phenotype 
that is characterized by SMC migration, proliferation, and an increase in the production of extracellular 
matrix [4]. This increase in extracellular matrix, which includes the production of collagen and elastin 
fibers, is one the major factors leading to the general stiffening of arteries for which atherosclerosis 
derives its name, and is responsible for the formation of a fibrous cap which covers the growing 
atheroma. While the SMCs are laying down collagen to try to isolate and protect the growing plaque, 
foam cells trapped within the atheroma can die from apoptosis, releasing lipids and cellular debris into the 
extracellular space. Over time, a substantial number of foam cells die forming a localized region of 
extracellular lipids and debris known as a lipid-rich pool or necrotic core [6].  
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An interesting phenomenon that occurs in the late stages of atherosclerosis development is the 
potential for intimal calcification. Calcification tends to occur in one of two forms, either as diffuse 
microcalcifications, or as large, focal punctate fragments or sheets. Diffuse microcalcifications tend to 
localize in areas of fibrosis, including the fibrous cap, whereas the larger fragments are typically found in 
the necrotic core where microcalcifications are able to coalesce. The general consensus is that 
calcifications originate from the cellular debris of apoptotic SMCs or macrophages [7]. Precipitation of 
calcium occurs when the local ionic concentration increases over the salt solubility product in the local 
microenvironment of the plaque. This is known as the “passive” hypothesis for atherosclerotic 
calcification [8]. Apoptotic macrophages in particular have been shown to release high concentrations of 
mitochondrial phosphate and phosphatidylserine-containing molecules that may tip the ionic balance and 
lead to precipitation [8]. Recent studies though, have shown that calcification may also be driven as an 
“active” process, whereby arterial cells in the atheroma can differentiate into osteoblast-like phenotypes 
and express potent osteogenic factors such as BMP-2 [8]. This suggests that calcification may occur in a 
manner similar to conventional bone formation. 
Finally, the most significant complication that can occur during late atherosclerosis is the 
development of a blood clot, a term referred to as thrombosis or hemorrhage (Figure 2.1d). Thrombosis 
arises when plaque material is exposed to the flowing blood within the vessel lumen. This scenario occurs 
most frequently when the fibrous cap ruptures or fissures develop, uncovering the thrombogenic 
lipid/necrotic core; an event known as plaque rupture [9]. In other cases, the endothelial layer that lines 
the plaque can deteriorate causing a clot to form on the surface, which is known as plaque erosion [10]. 
Arterial thrombosis and atherosclerosis have traditionally been considered separate entities with distinct 
pathogenic mechanisms, but new evidence has suggested that the two are more closely linked, with 
thrombosis being a significant promoter of the rapid progression of the underlying atherosclerotic lesion 
[11]. In many cases, plaque rupture and thrombosis can be a clinically silent event and the body is able to 
heal the site of rupture [12]. Indeed, plaques may undergo a number of rupture and healing cycles prior to 
the event that causes sudden death, and recent studies have shown that a unique constellation of 
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prothrombotic processes (e.g.  systemic suppression of fibrinolytic pathways, or increase inflammatory 
activity) may be necessary to facilitate the final catastrophic occlusion event [13]. 
2.2 Atherosclerosis Classification System 
In the mid-1990’s the American Heart Association (AHA) developed a numerical classification 
system for atherosclerotic plaques based on the natural history of the disease that has since been widely 
adopted in the field [14]–[16]. In this system, plaque progression was broken into six broad categories 
(Type I – VI) starting from the initial formation of foam cells all the way through plaque rupture and 
thrombosis. The details of each plaque category are presented in Table 2.1 and will be briefly summarized 
in this section. 
Type I plaques represent the earliest stage of atherosclerosis, where enough atherogenic 
lipoprotein has been deposited in the intima to elicit an accumulation of macrophages and scattered foam 
Table 2.1: American Heart Association plaque rating scale. 
Plaque 
Type Morphological Description 
0 Normal artery; no intimal thickening 
I Initial lesion; not grossly apparent plaque; foam cells. 
II Fatty streak; lesion grossly apparent; foam cells and smooth muscle cells (SMC) contain lipid droplets. 
III 
Preatheroma; raised fatty streak in gross morphology, multiple but small 
extracellular lipidic cores, foam cells contain lipid droplets, increasing number of 
SMCs. 
IV 
Atheroma; single and massive extracellular lipid pool (lipid core), grossly visible, 
well delimited, covered by a proteoglycan-rich layer infiltrated with foam cells and 
smooth muscle cells with and without lipid droplet inclusion. 
Va Fibroatheroma; type IV with a cap rich in fibrosis (collagen), possible small calcification. 
Vb Calcified plaque; lesion with a lipid core or fibrotic tissue, with large calcifications. 
Vc Fibrotic plaque; fibrous connective tissue, no lipid core. 
VI Intraplaque hemorrhage, thrombosis, ulceration.  
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cells. Type II plaques consist primarily of layers of foam cells that are grossly visible as “fatty streaks” 
and include the infiltration of SMCs that initiate adaptive intimal thickening. Type III plaques are an 
intermediate stage of plaque, where the fatty streaks of a Type II plaque begin to coalesce in scattered 
collections of extracellular lipid droplets which are the precursor to the large, confluent, and more 
disruptive core of extracellular lipid that characterizes Type IV lesion (known as an atheroma). Over time, 
Type IV lesions can develop thick layers of fibrous connective tissue (i.e. fibrous caps), that marks the 
transition to a Type Va lesion (known as the fibroatheroma). Alternatively, Type IV lesions can progress 
into Type Vb or Vc lesions, which represent highly calcified or highly fibrotic lesions, respectively. 
Finally, Type VI lesions are Type V lesions that have experienced a thrombogenic event (such as a plaque 
rupture or erosion). In this system, Type VI lesions can further be subdivided into Type VIa, VIb, and VIc 
plaques, which indicate plaques with ulcerations, hemorrhage/hematoma, and surface thrombus, 
respectively.  
In the year 2000, the classification system was updated to better reflect the dynamic nature of 
atherosclerotic plaques, and allow for non-linear progression and regression through the various plaque 
types [17]. In the updated classification, Type Vb and Vc plaques were renamed to Type VII and VIII, 
and various pathways were added to allow for plaque type switching. The updated scale was developed in 
direct response to pathological studies done by Virmani et al. who suggested that the original 
classification system was inadequate [18].  
2.3 The “Vulnerable” Plaque 
As described previously, one of the most devastating features of atherosclerotic plaque is the 
ability to quickly transition from a silent, non-obstructive lesion to one that becomes obstructive and 
symptomatic. Lesions that are at the highest risk for this have classically been termed “vulnerable” 
plaques [19]. The transformation is most commonly precipitated by atherothrombosis, a process 
characterized either by the rupture of the fibrous cap or erosion of the endothelial layer followed by an 
acute clotting event that can occlude the vessel or embolize and obstruct downstream vessels.  
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The concept of the vulnerable plaque, by and large, was derived from post-mortem 
histopathological studies done on ruptured coronary plaques (Figure 2.2) [2], [18]. While erosion-prone 
plaques also fall under the definition of “vulnerable”, researchers have yet to identify features in precursor 
lesions that reliably predict erosion, representing a major limitation of the vulnerable plaque paradigm (it 
 
Figure 2.2: Histological examples of coronary plaques representing the spectrum of atherosclerotic 
lesions. Initial lesions, intimal thickening and intimal xanthoma, represent non-progressive lesions 
characterized by macrophage infiltration and fatty streak deposition (AHA type I and II). Pathologic 
intimal thickening (AHA type III) represents an intermediate lesion where extracellular lipids begin to 
coalesce into large lipid pools that can progress into a fibroatheroma (Type IV or Va). Thin-cap 
fibroatheroma, which is not explicitly captured in the AHA scale, is considered to be the precursor to 
plaque rupture. Finally, complicated plaques (AHA type VI), either via rupture or erosion, can occur with 
various amounts of hemorrhage and thrombosis. Reprinted with permission from [18] (Copyright © 2000 
Wolters Kluwer Health, Inc.). 
 
 
11 
is thought that 30-35% of SCD is caused by erosion, compared to 55-60% by rupture) [2]. Therefore, the 
following discussion on vulnerable plaque characteristics will be limited to the hallmarks of rupture-prone 
plaques, which include: (1) thin fibrous cap, (2) large necrotic core with increased free/esterified 
cholesterol ratio, (3) increased plaque inflammation, (4) positive vascular remodeling, (5) increased vasa 
vasorum neovascularization, and (6) intraplaque hemorrhage.  
2.3.1 Thin Fibrous Cap  
Fibrous cap thickness was one of the first plaque features to be associated with rupture potential. 
The fibrous cap is a layer of stiff collagenous tissue that protects the soft underlying necrotic core. In the 
coronary arteries, autopsy studies in men who died suddenly from SCD showed that 95% of plaques with 
ruptured caps (and consequently, atherothrombosis) had a thickness of <65 µm [20]. In the carotid 
arteries, the critical value is substantially higher, and has been reported as <200 µm (minimum thickness) 
and <500 µm (average thickness) [21]. Numerous finite element method (FEM) studies have shown that 
as the fibrous cap thickness decreases, the circumferential stress experienced by the plaque increases 
exponentially, which can lead to rupture if the ultimate stress (i.e. maximum stress at failure)  is exceeded 
[22], [23].  
In addition to thickness, there are a number of additional factors that can weaken the fibrous cap 
and make it susceptible to rupture. First, in caps with substantial inflammation, macrophage apoptosis can 
result in the continuous release of MMPs that can degrade collagen in the cap [24], [25]. Second, loss of 
SMCs, which produce collagen, can lead to the thinning of the fibrous cap. Finally, high resolution µCT 
and 3D FEM studies have demonstrated that microcalcifications in the fibrous cap can act as local stress 
concentrators and cause rupture either though cavitation or interfacial debonding [26].  
2.3.2 Enlarged Necrotic Core 
The necrotic core is one of the main destabilizing features of the atherosclerotic plaque. It is 
characterized by a lack of supporting collagen and cells, as well as the accumulation of free/esterified 
cholesterol. Following plaque rupture, the necrotic core is the most thrombogenic component of an 
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atherosclerotic plaque, estimated to be six-fold greater than collagen due to the high concentration of 
tissue factor (TF) [27]. Initial pathology studies identified a wide range of necrotic core areas that were 
associated with vulnerability; on the low end, necrotic core areas of 24% and 34% were considered 
vulnerable [28], while on the high end the values were above 50% [19]. Subsequent FEM modelling 
studies demonstrated that necrotic core thickness is a better indicator of plaque vulnerability compared to 
necrotic core area, and that no single value can reliably confer vulnerability without considering the 
thickness of the fibrous cap as well [29].  
2.3.3 Increased Plaque Inflammation 
Plaques with active inflammation, characterized by an abundance of macrophages and T-cells, 
have been shown to be more vulnerable to rupture than plaques in more quiescent states [19]. 
Macrophages increase the vulnerability of the plaque by producing proteolytic enzymes (e.g. plasminogen 
activators and MMPs) that are capable of degrading extracellular matrix and weakening/thinning the 
fibrous cap. Additionally, activated T-cells have been shown to secrete interferon-γ, which can impair the 
ability of SMCs to express interstitial collagen genes, further weakening the protective layers of fibrosis 
that stabilize the plaque from rupturing [2]. Clinical studies have demonstrated that macrophage content is 
increased in plaques from patients experiencing ACS when compared with plaques from patients with 
stable angina [19]. 
2.3.4 Positive Arterial Remodeling Index 
As the atherosclerotic process begins to degrade the elastic lamellae and impact the medial layer, 
positive arterial remodeling can occur [30]. This phenomenon was demonstrated in human coronary 
arteries by Glagov et al. [31], and is characterized by a compensatory enlargement of the artery to 
maintain luminal diameter. Glagov estimated that luminal diameter in human coronary arteries could 
remain constant up until the percent stenosis exceeded 40%, meaning that lesions can incur a significant 
plaque burden without any restriction of flow. Positive remodeling has been shown to increase the 
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circumferential stress on eccentric plaques in FEM studies [29], and in clinical studies is found more 
frequently in patients experiencing ACS and less frequently in patients experiencing stable angina [32]. 
2.3.5 Neovascularization and Intraplaque Hemorrhage 
When the plaque continues to grow, oxygen diffusion to the cells within the plaque is impaired, 
instigating growth of the vasa vasorum, or neovascularization. The predominant form of 
neovascularization is angiogenesis, which is characterized by the sprouting of endothelial cells from 
existing vasa vasorum in the adventitia [33]. It has been demonstrated that neovascularization tends to 
occur when the tunica intima thickens to 500 µm, however there is evidence suggesting that it may occur 
earlier and can be mediated by hypoxia-independent pathways linked to inflammation [34]. A number of 
studies have suggested that neovascularization may serve as a substantial pathway for additional 
lipoprotein deposition and leukocyte recruitment in the plaque. In neovessels, leukocyte adhesion 
molecules, such as VCAM, ICAM, and E-selectin, are expressed 2- to 3-times higher than on the luminal 
endothelium, suggesting that plaques with increased neovascularization will also have increased 
inflammation. 
Exacerbating the situation further is the fact that neovessels tend to be leaky and extravasate 
erythrocytes into the plaque, a phenomenon commonly referred to as intraplaque hemorrhage.  The 
release of red blood cells into the sub-intimal space triggers the recruitment of additional macrophages for 
the purpose of erythrophagocytosis. This can activate pathways leading to macrophage production of 
matrix metalloproteinases (MMPs) that can not only degrade the IEL but also disrupt protective fibrosis 
through collagenolysis [33]. Furthermore, hemoglobin, which is released from lysing red blood cells, can 
act as a potent inflammatory agent [35].  
Intraplaque hemorrhage from leaky neovessels should not be confused with 
hemorrhage/hematoma secondary to plaque rupture and thrombosis, which was described in the previous 
sections. In addition to greater spatial extent, hemorrhage/hematoma is typically characterized on 
histology by the presence of fibrin and fibrin degeneration products [36]. Previous studies have shown 
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that the age of a hemorrhage secondary to rupture (acute, recent, or old) can be predicted by examining 
the color of the hemorrhage on trichrome staining as well as the level of inflammatory response around it 
[37].  
2.3.6 Comparing Vulnerable Plaque in Different Arterial Locations 
While the features of vulnerability described in the previous sections are mostly generalizable to 
all atherosclerotic plaques, substantial differences in plaque morphology have been noted in various 
arterial beds. This section will briefly summarize some of the key similarities and differences in plaque 
morphology and vulnerable characteristics across the coronary, carotid, and femoral vasculature. 
Vulnerable plaque in the coronary and carotid systems is typically considered to be very similar. 
In both cases, plaque rupture tends to be the dominant etiology of ischemic event, and vulnerable 
characteristics include thin fibrous cap, large necrotic core, intraplaque hemorrhage and dense 
macrophage infiltrate [38]. The first key difference in vulnerable characteristics is that critical fibrous cap 
thickness tends to be higher in carotid plaques (<200 µm minimum thickness, and <500 µm average 
thickness) as compared to coronary plaques (<65 µm minimum thickness), which is attributed to the 
larger gauge and increased hemodynamic forces of the carotid arteries [39]. Second, the level of stenosis 
at plaque rupture may be higher in carotid arteries [21] compared to coronary arteries [40]. Finally, there 
is some evidence that macrophages may play more of a role in coronary plaque rupture as compared to 
carotid plaque [39]. 
While the description of coronary and carotid vulnerable plaque may be similar, studies have 
shown the femoral plaques tend to be phenotypically different. In an interesting study by Dalager et al. 
[41], histological sections were compared between femoral, carotid, and coronary arteries from 100 
autopsies. Patients included in the study spanned the ages of 20-70+, allowing the authors to analyze the 
time course of plaque development as well. It was shown that plaques in the femoral arteries occurred 
later in life and were more prone to fibrotic phenotypes, rather than the foam cell/lipid core phenotypes of 
the carotid and coronary arteries. This data supported an earlier study [42] that also reported a heavily 
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fibrotic phenotype and relatively small amount of lipid in femoral plaques. In another 
immunohistochemistry study [43], it was shown that femoral plaques had reduced expression of MMP-9, 
a protein responsible for degrading collagen, compared to carotid plaques. Finally, in a study analyzing 
arterial remodeling across different vascular beds, it was shown that lower extremity arteries experienced 
significantly less remodeling compared to the carotid and coronary arteries [44]. Therefore, while plaque 
rupture is the dominant cause of thrombogenic events in the coronary/carotid arteries, it is likely that 
femoral artery plaques are much more prone to experience plaque erosion and surface thrombus.   
2.4 Treatment 
To date, there is no cure for atherosclerosis. Treatment typically includes a combination of 
pharmaceutical therapies and lifestyle changes that are intended to reduce risk factors and slow the 
buildup of plaque. Numerous surgical techniques exist as well including procedures to widen/bypass 
occluded arteries, or procedures to remove plaque that may precipitate a fatal ischemic event. In the 
following section, these techniques and their efficacy will be described briefly. 
2.4.1 Pharmaceutical 
Current pharmaceutical therapies for atherosclerosis are largely restricted to controlling major 
risk factors such as hyperlipidemia and hypertension, and/or controlling hemostasis to prevent 
thrombosis.  
Lipid-Lowering Therapy (Hyperlipidemia) 
Lipid lowering has mainly been achieved by a class of drugs known as statins (e.g. atorvastatin or 
rosuvastatin). Statins work by inhibiting an intermediate protein, 3-hydroxy-3-methylglutaryl-coenzyme 
A (HMG-CoA) reductase, that produces cholesterol in the liver, ultimately lowering both the total and 
LDL cholesterol circulating in the blood stream [45]. Statins not only have been shown to reduce plaque 
lipids and cause plaque regression [46], but also have been demonstrated to reduce major cardiovascular 
event rates in patients with ACS [47]. More recently, the FDA approved the use of a statin in combination 
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with ezetimibe, a drug that inhibits cholesterol absorption in the small intestine. The combination of 
simvastatin and ezetimibe has been shown to lower total and LDL cholesterol levels more than just a 
statin alone [48], and shows modest improvement of preventing vascular events compared to a statin 
alone [49]. Statins have also been used in combination with fibrates (e.g. fenofibrate or bezafibrate); 
broad-spectrum lipid lowering drugs that, in addition to lowering LDL, lower triglycerides and raise 
HDL. Fibrates are a peroxisome proliferator-activated receptor (PPAR)-α agonist, and have been 
demonstrated to both reduce plaque burden and reduce the number of cardiovascular events [50], [51].  
Anti-Hypertensives 
 Hypertension, or high blood pressure, is typically controlled using either β-adrenergic blockers 
(beta-blockers) or angiotensin-converting enzyme (ACE) inhibitors, both of which have been shown to 
have atheroprotective effects beyond simply reducing blood pressure [52]. Beta-blockers have been used 
to effectively reduce recurrent myocardial infarction and SCD since the 1980s, and primarily work by 
blocking the action of epinephrine and norepinephrine. ACE inhibitors, on the other hand, interfere with 
the renin-angiotensin system by blocking the conversion of angiotensin I to angiotensin II and lowering 
arteriolar resistance. In serial monitoring studies, patients on beta blockers showed a statistically 
significant decrease in atheroma volume, compared to patients who were not on beta blockade [53]. 
Likewise, ACE inhibitors have been shown to improve endothelial function and lower the rate of 
coronary events [54]. 
Anti-Platelet Therapy (Hemostasis) 
Finally, antithrombotic therapies have long been a staple of atherosclerosis management, with the 
most common being aspirin. Aspirin primarily interferes with platelet aggregation, and prevents the acute 
formation of an occlusive thrombi at the site of plaque rupture or erosion [55].  Other antithrombotic 
drugs such as clopidogrel, presugrel, or ticagrelor have also been shown to be efficacious for secondary 
prevention in patients with ACS [56].  
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Despite the significant improvement in patient outcomes when employing the modern 
atherosclerosis drug cocktail, some patients still experience cardiovascular events. As shown in the 
PROVEIT trial, patients on a combination of ACE inhibitors, beta blockers, aspirin, and high doses of 
atorvastatin showed a 22% recurrent event rate within 2 years [57]. These data suggest that, while we 
have come far, there is still a need for improved atherosclerosis therapies, particularly in high-risk 
patients. 
2.4.2 Surgical 
Percutaneous Coronary Intervention (PCI) 
Percutaneous coronary intervention (PCI) is an umbrella term for minimally invasive procedures 
that use a catheter to access and treat the coronary arteries. The most common PCI procedure to treat 
atherosclerosis is balloon angioplasty and stent deployment. The PCI catheter is typically inserted either 
in the femoral artery (located near the groin) or the radial artery (located near the wrist), and guided to the 
coronary arteries using contrast-enhanced X-ray angiography. Once the catheter is placed in the stenosed 
region of the artery, a balloon is expanded to widen the artery and a stent is placed to maintain the 
vascularized luminal diameter. Stents can come in many different forms including simple bare-metal 
stents, or drug-eluting stents that are doped with chemicals intended to prevent neointimal hyperplasia 
and restenosis. While drug-eluting stents have been shown to be less susceptible to restenosis, there is 
evidence that they may be more susceptible to thrombosis, suggesting that there is still work to be done in 
designing the ideal stent [58]. PCI is typically indicated by cardiovascular symptoms including: 
myocardial infarction, stable/unstable angina, anginal equivalent (dyspnea, arrhythmia, or dizziness), or 
high-risk stress-test findings.  
Coronary Artery Bypass Grafting (CABG) 
Coronary artery bypass grafting (CABG) surgery is one of the most common open-heart 
surgeries, and is an alternative to PCI. In CABG, a healthy artery or vein is connected to the blocked 
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coronary artery forming a bypass for blood to flow around the obstruction. There are several vessels that 
are commonly used as grafts: internal mammary arteries, saphenous veins, and the radial artery. CABG is 
typically utilized as an option when PCI is not possible or fails to revascularize the artery. Primary 
indications for CABG include: >50% stenosis of left main coronary artery, >70% stenosis of proximal left 
anterior descending (LAD) artery and circumflex, 3-vessel disease in asymptomatic patients or those with 
mild or stable angina, 3-vessel disease with proximal LAD stenosis in patients with poor left ventricular 
function,  1- or 2-vessel disease and a large area of viable myocardium in high-risk area in patients with 
stable angina, >70% proximal LAD stenosis with either ejection fraction <50% or demonstrable ischemia 
on noninvasive testing [59]. 
Carotid Endarterectomy (CEA) 
Carotid endarterectomy (CEA) is a surgical procedure used to remove atherosclerotic plaque from 
the carotid arteries in order to prevent stroke. In the procedure, the surgeon makes an incision along the 
front of the neck to expose the carotid artery, clamps the carotid on either side of the stenosis (typically 
located at the carotid bifurcation), and removes the inner lining of the artery through a single arteriotomy 
made on the top surface of the carotid. The plaque is typically removed en bloc, and most of the medial 
layer is stripped away during the procedure. To complete the surgery, a bovine patch is sutured to the 
damaged portion of the artery to avoid restenosis, and the arteriotomy is closed. As with the cardiac 
procedures mentioned previously, the primary indications for CEA are symptoms of ischemic event, 
including transient ischemic attack (TIA), stroke, contralateral weakness of the face, arm, and/or leg, 
paresthesia, facial droop, and amaurosis fugax. Severe carotid stenosis (>70%), in combination with 
neurological symptoms, has been shown to be a strong indicator of CEA efficacy for future stroke 
prevention with the number needed to treat (NNT) at 6 procedures to prevent one stroke  at 5 years[60]. 
When stenosis is reduced to 50-69% in symptomatic patients, NNT increases to 15 procedures at 5 years. 
Interestingly, in patients with asymptomatic carotid stenosis, CEA only provides a modest 
improvement in future stroke risk. In patients with 60-90% asymptomatic stenosis, the NNT is 25, and at 
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50-69% NNT increases so much that CEA is currently not indicated for these patients [61]. While CEA is 
still utilized in patients with high-grade asymptomatic stenosis, there has been a trend away from surgical 
management to medical management alone. The groups supporting this movement have cited the 
reduction in smoking rates and the great improvements in medical management of atherosclerosis (statins, 
etc.) that were not available during the time of the CEA randomized controlled trials [62], [63]. Current 
estimates suggest that only 5% of patients with asymptomatic carotid stenosis will benefit from 
prophylactic CEA [62]. Therefore, there is a great need for an improved method of predicting which 
patients are at high risk for stroke to enhance the benefit and cost-efficacy of CEA (as well as other 
interventions). 
2.5 Animal Models 
Animal models have proven crucial to our understanding of the pathogenesis of atherosclerosis as 
well as in the development of therapies to treat the disease. Two of the most commonly used models for 
atherosclerosis are the mouse and the pig.  
2.5.1 Murine 
The mouse is the most widely used animal for atherosclerosis research; the genetics are well 
understood, they grow and breed relatively quickly, and are inexpensive to maintain. Atherosclerotic 
mouse models are typically developed by generating non-HDL based hypercholesterolemia [64]. The two 
most common approaches to achieving this is through knockout of either apolipoprotein-E (ApoE) or 
LDL receptor (LDLR) genes, the latter of which occurs in humans that have familial 
hypercholesterolemia. One advantage of the ApoE mouse is that it develops complex atherosclerotic 
lesions when fed a regular diet, and the lesions can be exacerbated by feeding a high-fat diet. The LDLR 
mice, on the other hand, need to be fed an atherogenic diet and the progression of atherosclerosis is 
notably slower, most likely due to the specific role of LDL receptor in the lipoprotein uptake and 
clearance chain. In mice, atherosclerosis mainly develops in the aorta (aortic root, innominate artery, and 
other branches), as well as in the pulmonary and carotid arteries. One of the major limitations of the 
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mouse models is the notable lack of atherosclerosis in the coronary arteries. The lesions typically follow a 
similar pathogenesis as in humans, with foam cells appearing first, followed by SMC infiltration, and 
lastly the development of a necrotic core covered by a fibrous cap. However, these lesions do not undergo 
plaque rupture and atherothrombosis. Various authors have reported that more complicated genetic 
modifications can precipitate coronary atherosclerosis and myocardial infarction in mice, for example in a 
double-knockout of ApoE and LDLR [64]. Overall, the mouse has been incredibly useful to 
understanding the biology of atherosclerosis and, despite its limitations, will continue to be used heavily 
in future research. 
2.5.2 Porcine 
Unlike mice, pigs can spontaneously develop atherosclerosis in a manner more closely 
resembling the human condition [65], [66]. This process can be accelerated either by feeding a high-fat 
diet to induce dietary hypercholesterolemia (DH), or by genetic modification to induce familial 
hypercholesterolemia (FH). FH pigs spontaneously exhibit hypercholesterolemia in the range of 350-500 
mg/dl when eating low fat pig feed due to a missense mutation in the LDL receptor [67], [68]. DH and FH 
pigs grow large (weighing between 200 and 700 lbs.) and have arterial geometries and gauges similar to 
an equivalently sized human. Additionally, pigs exhibit a human-like lipoprotein profile (including LDL-
driven hypercholesterolemia), atherosclerosis development in the coronary arteries, and complex lesions 
that include thick fibrous caps, necrotic cores, calcification, and hemorrhage. While the main drawback of 
the porcine model is the expense to maintain the animal colony, the pig is an invaluable asset to 
translating medical device technologies that target atherosclerosis to humans.  
2.6 Summary 
Atherosclerosis is a complex, systemic, inflammatory disease that is influenced by many factors, 
including genetics, diet, and lifestyle. Left undiagnosed and untreated, atherosclerosis can have severe 
consequences including physical disability, pain, and death. We have made great strides in last few 
decades in understanding atherosclerosis, and developing strategies to fight it; however, it remains the 
21 
number one health epidemic facing the world. Continued improvements in early detection and diagnostic 
technologies, in addition to novel therapeutic strategies, will be crucial to combating atherosclerosis and 
reducing its impact on healthcare. Advancements in medical imaging technologies specifically are needed 
not only to diagnose the presence of atherosclerosis before it becomes symptomatic, but also to help 
clinicians determine if intervention strategies are being effective. In the next chapter, the state of the art of 
atherosclerosis imaging techniques will be comprehensively reviewed detailing how atherosclerosis is 
diagnosed in the clinic and highlighting areas where it needs to be improved.  
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CHAPTER 3 
 Atherosclerosis Imaging Techniques 
Diagnostic atherosclerosis imaging has classically been implemented with techniques that 
interrogate luminal diameter, a field of imaging termed “angiography”. These techniques work by 
imaging blood flow, typically with the use of a contrast agent, and infer the presence of atherosclerosis by 
identifying regions where the lumen narrows and becomes stenotic. While angiography has been largely 
successful in the clinic, as described in the previous chapter, stenosis only occurs in very late stages of 
atherosclerosis and is not the best indicator of plaque vulnerability due to vascular remodeling. This has 
driven researchers to develop techniques that can look past the lumen, and identify not only the 
percentage of stenosis, but also the composition and morphology of the plaque itself.  
In this chapter, the various techniques for imaging atherosclerosis will be described, including 
methods for stenosis visualization (i.e. angiography) and methods of vulnerable plaque characterization. 
The following sections are organized by imaging modality, with specific attention given to ultrasound 
imaging, which is the focus of this dissertation. Note that not all diagnostic medical imaging modalities 
will be described, only those pertaining to atherosclerosis imaging. 
3.1 X-ray Techniques  
X-ray imaging, also known as radiography, was pioneered by German physicist Wilhelm 
Roentgen in the late 1800’s and was the first technique used to visualize the inside of the human body. 
Roentgen discovered that X-rays, which are a form of electromagnetic radiation with wavelengths 
between 0.001 and 10 nm, are able to pass through soft tissue but are attenuated by dense material such as 
bone. By placing X-ray sensitive film on the other side of an imaging target, these subtle variations of X-
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ray attenuation could be captured and turned into a two-dimensional (2D) image, a process known as 
projection radiography. 
With the advent of digital electronics and computer technology, there was an explosion of novel 
X-ray modalities that went beyond static 2D projection images – namely, fluoroscopy and computed 
tomography (CT) – that have become clinical standards for atherosclerosis imaging. Fluoroscopy is a 
form of real-time X-ray imaging that continuously updates a 2D projection and is used to visualize 
moving targets such as a catheter or contrast agent travelling through the body. CT, on the other hand, is a 
form of X-ray imaging where multiple projection images are taken from various angles and reconstructed 
to form cross-sectional 3D volumes of the body. While noninvasive CT imaging is largely replacing 
fluoroscopy for diagnostic atherosclerosis imaging, both techniques continue to be important tools in the 
clinic and will be described in the following sections. 
3.1.1 Fluoroscopy 
The most common form of fluoroscopy that is used for atherosclerosis imaging is known as 
digital subtraction angiography (DSA) (Figure 3.1a) [69]. DSA is a real-time contrast-enhanced X-ray 
imaging technique that is used in conjunction with a catheter to produce images of blood vessels. The 
catheter is inserted into the femoral artery and guided with fluoroscopy to a site of atherosclerosis (e.g. 
the coronary arteries). Once positioned, a small amount of radio-opaque contrast is injected through the 
catheter, and two X-ray images, one pre-injection and the other post-injection, are captured. The pre-
injection image serves as a mask and is subtracted from the post-injection images to remove overlying 
tissue, resulting in a very clear image of the luminal pathway of blood vessels [70]. The presence of 
atherosclerosis can be inferred from DSA by the reduction or blockage of flow, which appears as an 
absence of contrast in the image. 
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DSA is strictly a luminal imaging technique, and consequently, is most efficacious in diagnosing 
percentage stenosis. However, DSA has been shown to be capable of identifying plaque ulceration, 
defined as a crater from the lumen into a stenotic plaque, which can be used to infer plaque rupture and 
vulnerability [71]. DSA is unable though, to detect plaque composition and non-occlusive atherosclerosis 
in vessels that have undergone positive remodeling, which has led some to conclude that it has little value 
in preventing future coronary events [70], [72]. Due to these limitations, DSA is quickly being supplanted 
by safer noninvasive imaging technologies that can determine both percent stenosis and plaque 
composition, but will continue to be an important modality for coronary interventions such as balloon 
angioplasty and stenting where real-time catheter imaging is required. 
 
Figure 3.1: Examples of three angiography techniques. (a) Digital subtraction angiography of the carotid 
bifurcation showing a 50-69% stenosis. (b) Contrast-enhanced magnetic resonance angiography. (c) 
Computed tomography angiography. Reprinted with permission from [69] (Copyright © 2003 American 
Society of Neuroradiology). 
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3.1.2 Computed Tomography 
In computed tomography (CT) imaging, an X-ray source and detector unit is synchronously 
rotated around the patient’s body capturing hundreds of projection images that are then fed into a 
tomographic reconstruction algorithm to produce cross-sectional X-ray images and 3D volumes. Modern 
CT scanners can acquire volumetric scans in seconds or fractions of a second, with isotropic spatial 
resolution of approximately 400 to 600 µm [73]. Like DSA, CT imaging can be paired with an injectable 
contrast agent (iodine-based) to interrogate stenotic vessels, in a technique known as CT angiography 
(CTA) (Figure 3.1c). CTA has been shown to have high correlation with DSA (0.892 to 0.922) [74], and 
good sensitivity and specificity (0.77 and 0.95) for detecting >70% stenosis [75].  
Identification of plaque composition with CT is mainly based on radiodensity measurements 
(Table 3.1), expressed in terms of Hounsfield units (HU), which are normalized to the density of water (0 
Table 3.1: Noninvasive imaging signal characteristics of plaque components. Table adapted from [3]. 
Histology Ultrasound CT MRI  T1-weighted 
MRI  
T2-weighted 
MRI  
PD-weighted 
Ulceration Irregular border  Irregular border Irregular border Irregular border  Irregular border 
Lipid Core Echolucent Homogenic Hypodense Very hyperintense Hypointense Hyperintense 
Intraplaque 
hemorrhage 
Echolucent 
Heterogenic Hypodense Age dependent Age dependent Age dependent 
Fibrous plaque Echogenic Homogenic Isodense Hyperintense Hyperintense Hyperintense 
Calcifications Echogenic Heterogenic Hyperdense Hypointense 
Very 
hypointense 
Very 
hypointense 
Thrombus Echolucent Hypodense Very hyperintense Isointense Hyperintense 
Inflammation Echolucent  SPIO signal loss SPIO signal loss 
SPIO signal 
loss 
Vasa vasorum Contrast enhancement  
MRI signal 
increase   
Abbreviations: CT, computed tomography; MRI, magnetic resonance imaging; PD, proton density; SPIO, super 
paramagnetic iron oxide.  
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HU). In general, dense plaque components, e.g. calcifications, appear as hyperintense regions in CT 
images, while loose plaque components, e.g. lipid/necrotic core or thrombus, appear as hypointense. Due 
to the substantial difference in density of calcium compared to other features, CT is highly accurate for 
detecting calcified plaque, with sensitivities of 100% and specificities of 93%-100% [3], [76], [77]. 
However,  because of substantial overlap in radiodensity values, accuracy for loose components (i.e. 
necrotic core) and fibrous plaque is only moderate with sensitivities ranging from 62% - 94% and 
specificities ranging from 74% - 100% [3], [76], [77]. 
The ability of CT to distinguish calcification has led to the development of the coronary artery 
calcification (CAC) scoring system, which is currently one of the only noninvasive coronary plaque 
characterization techniques routinely implemented in the clinic today [78], [79]. In this semi-automated 
system, the area of each calcified “speck” is weighted by the HU intensity, and summed together to derive 
a single CAC score (also known as an Agatston score). The severity of calcification is then determined 
using a five-point scale, which reflects the patient’s atherosclerotic burden and, consequently, risk of 
future ischemic event. A CAC of 0 indicates no evidence of atherosclerosis, 1 – 10 indicates “minimal”, 
11 – 100 indicates “mild”, 101 – 400 indicates “moderate”, and >400 indicates “severe”. In the Multi-
Ethnic Study of Atherosclerosis (MESA), it was demonstrated that high CAC score was statistically-
significantly associated with future coronary events, yielding hazard ratios ranging from 2.6 to 9.5 in 
patients without diabetes or metabolic syndrome [79]. In patients with diabetes or metabolic syndrome, 
the hazard ratios ranged from 2.9 to 6.2, and 3.9 to 11.9 [79], respectively, and doubling CAC score was 
associated with a 29% increased risk of cardiovascular event in patients with diabetes [80].  
While CAC has been shown to be effective at predicting patient risk, as described in the previous 
chapter, calcification represents a more advanced stage of atherosclerosis and may occur as a stabilizing 
force in the setting of high-risk atherosclerotic plaque [81]. Therefore, it remains to be seen whether high 
CAC will have different prognostic implications as compared to total plaque volume or the identification 
of thin-cap fibroatheroma.   
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3.1.3 Advantages and Disadvantages 
One of the greatest advantages of CT compared to other noninvasive imaging modalities is the 
ability to noninvasively image atherosclerosis of the coronary arteries. The coronary arteries are a 
particularly challenging imaging target due to their small size (which necessitates high resolution) and the 
substantial motion of the heart during the cardiac cycle (which necessitates high frame rate). Currently, 
CT is the only modality with adequate resolution and speed of acquisition that can reliably image 
coronary atherosclerosis noninvasively. Another advantage of CT is that it provides isotropic 3D volumes 
through the entire depth of the human body. This not only allows for a wide field of view and entire organ 
imaging, but also enables implementation of automated segmentation techniques.  
However, the main disadvantage to CT and other X-ray based imaging modalities is the ionizing 
nature of X-ray radiation. The term ionizing radiation refers to any kind of radiation that carries enough 
energy to free electrons from atoms, thereby forming ions. This process of ionization is generally harmful 
to living organisms; specifically, it can damage DNA and lead to the formation of cancer. Although it is 
difficult to predict what amount of radiation is necessary to cause cancer, modelling studies suggest that 
the lifetime risk after CTA is 1 in 284 for a 40-year-old woman and 1 in 1,007 for a 40-year-old man [82]. 
Table 3.2: Diagnostic performance, strengths, limitations, and pitfalls of CTA in the evaluation of 
stenosis, plaque morphology, and composition. Table adapted from [103].  
CTA Stenosis (>70%) Plaque Morphology Plaque Composition 
Diagnostic performance Sensitivity 77% Specificity 95% 
Sensitivity 100% 
Specificity 100% 
Moderate correlation 
with histopathology 
Strength points Higher spatial resolution as compared to MRA 
Higher spatial resolution as 
compared to MRA 
Direct visualization of 
calcium 
Limitations 
May be hampered by wall 
calcifications, needing longer 
post-processing 
May be hampered by wall 
calcifications, needing 
longer post-processing 
Reduced accuracy in 
differentiation of “soft” 
components 
Pitfalls 
Beam-hardening artifacts 
induced by heavily calcified 
plaques 
Beam-hardening artifacts 
induced by heavily calcified 
plaques 
Impossibility to detect 
hemorrhage 
Abbreviations: CTA, computed tomography angiography; MRA, magnetic resonance angiography  
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In addition to ionizing radiation, CT scanners are typically expensive, and require significant amount of 
hardware, which make them immobile. Given these limitations, CT imaging may be precluded from being 
used a screening modality.   
3.2 Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI) is an advanced noninvasive imaging technique that uses the 
magnetic resonance properties of hydrogen atoms in order to make images of the human body. When the 
hydrogen atoms in the body are subjected to a strong magnetic field, they align with the field in either 
high or low energy states (known as antiparallel and parallel states, respectively) and create a net body 
magnetization. The net magnetization is then flipped by introducing an RF pulse that is matched to the 
Larmor frequency of hydrogen atoms. As the hydrogen, atoms gradually return to the original 
magnetization direction, they release energy in the form of an RF signal that can be detected. Hydrogen 
molecules bound in different tissues (fat, muscle, etc.) will exhibit different relaxation times, which 
results in contrast in the MRI image. The signal intensity in an MRI image is determined by four basic 
parameters that are directly related to tissue composition: 1) proton density, 2) longitudinal relaxation 
time (T1), 3) transverse relaxation time (T2), and 4) flow. Each parameter can be imaged independently 
by designing specialized RF pulse sequences, in a process known as “multicontrast-weighted” MRI 
(Figure 3.2), and is used in conjunction with the other parameters to determine tissue composition (Table 
3.3).  
As with CT, MRI can be used with a contrast agent (gadolinium-based) for improved 
visualization of the lumen in a technique known as contrast-enhanced magnetic resonance angiography 
(CE-MRA) (Figure 3.1b). Alternatively, because the movement of protons in blood can alter the MR 
signal, pulse sequences can be designed for non-contrast MRA as well, these are known as Time-of-Flight 
(TOF) or phase-contrast (PC-MRA) sequences. CE-MRA has been shown to have slightly better 
sensitivity and specificity (94% and 93%) for detecting >70% stenosis compared to non-contrast MRA 
(88% and 84%) with DSA as a gold standard [75].  
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In the context of plaque characterization, multicontrast-weighted MRI has been shown to be very 
sensitive to the “soft” plaque components such as lipid/necrotic core, fibrosis, and hemorrhage [83]–[98]. 
An example of a plaque with large lipid/necrotic core and thin intact fibrous cap is shown in Figure 3.2 
[98]. Using a standardized imaging protocol and classification criteria shown in Table 3.1, Watanabe et 
al. [96] reported a sensitivity of 96% and specificity of 93% to “soft” components when using both T1- 
and T2-weighted images; a substantial improvement compared to using T1 images alone (sensitivity 79%, 
specificity 84%) [97]. Cai et al. [89] reported similar results suggesting high sensitivity (range 80% - 
84%) and specificity (range 90% - 98%) for the detection of AHA plaque classes III-VII, however the  
 
 
Figure 3.2: MR images of a carotid artery plaque with a large lipid-rich necrotic-core (small arrow) with 
an intact fibrous cap (long arrow). Calcification is also visible at the base of the plaque (chevron). 
Asterisks represent the lumen. Abbreviations: TOF, time of flight; T1W, T1-weighted; CE-T1W, contrast-
enhanced T1-weighted; PDW, proton density weighted; T2W, T2-weighted. Reprinted under open access 
license from [98] (Copyright © 2009 BioMed Central Ltd.).  
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ability of MRI to detect calcifications by other groups have been shown to be more modest, with mean 
sensitivity of 77% and specificity of 88% [3].  
Prospective studies have demonstrated that MRI-derived plaque characteristics are associated 
with future ischemic events. In the PRIMARI study [99], it was shown that the presence of lipid-rich 
necrotic-core (HR: 4.4), intraplaque hemorrhage (HR: 5.2), or thin/ruptured fibrous cap (HR: 17.0) were 
all associated with future ischemic events. Results from MESA [100], a larger clinical trial, have shown 
similar trends, indicating that positive remodeling and the presence of lipid-rich necrotic-core on MRI are 
independent predictors of cardiovascular events.  
3.2.1 Advantages and Disadvantages 
In addition to high soft-tissue contrast, one of the greatest advantages of MRI for plaque 
characterization is the benefit of non-ionizing radiation. To date, there is no evidence of long-term 
adverse effects from the magnetic fields used in MRI, and short-term effects appear to be limited to 
mechanical risk associated with ferromagnetic devices or implants in the presence of a high powered 
magnet [101].  Therefore, from a patient safety standpoint, MRI is currently superior to CT. Other 
Table 3.3: Diagnostic performance, strengths, limitations, and pitfalls of MRA and CE-MRA in the 
evaluation of stenosis, plaque morphology, and composition. Table adapted from [103].  
MRA Stenosis (>70%) Plaque Morphology Plaque Composition 
Diagnostic performance 
(MRA and CE-MRA) 
Sensitivity 88-94% 
Specificity 84-93% 
Sensitivity 96% 
Specificity 97% 
Significant correlation 
with histopathology 
Strength points 
Not hampered by wall 
calcification, luminographic 
view 
Not hampered by wall 
calcification, luminographic 
view 
Differentiation between 
various “soft” plaque 
components 
Limitations 
Lower spatial and temporal 
resolution as compared to 
CTA. 
Lower spatial and temporal 
resolution as compared to 
CTA. 
Long acquisition, 
dedicated hardware 
Pitfalls Loss of signal at the site of extremely tight stenoses 
Susceptibility artifacts 
induced by heavily calcified 
plaques 
Partial signal overlap 
between fibrous core and 
hemorrhage 
Abbreviations: CTA, computed tomography angiography; MRA, magnetic resonance angiography;  
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benefits include the ability to measure flow without the need of contrast, the ability to produce 3D 
tomographic data for whole-organ imaging, and the relative insensitivity to heavy calcification that can be 
detrimental to both ultrasound and CT imaging.  
There are, however, a number of disadvantages to the modality (Table 3.3). First, MRI is one of 
the most expensive imaging systems on the market, which makes it difficult to implement broadly and 
precludes it from being used for general screening. Second, compared to CT, the spatial resolution is poor 
which prevents MRI from reliably imaging atherosclerosis in smaller arteries such as the coronary 
arteries. In current practice, MRI plaque characterization is limited to peripheral vessels, such as the 
carotid arteries, and requires specialized phase-array surface coils to achieve adequate spatial resolution 
[102]. Finally, the long acquisition time necessary to acquire MR images makes it susceptible to motion 
artifacts. 
3.3 Ultrasound Imaging 
Ultrasound (US) imaging (also known as sonography) is a technique that uses high-frequency 
acoustic waves (typically 3 MHz - 15 MHz) to make tomographic images of tissue structures. As 
ultrasound waves travel through the body, they encounter interfaces between tissues and are partially 
reflected back toward the ultrasound probe. The proportion of the wave that is reflected versus transmitted 
across the interface is related to the tissues’ acoustic impedance, Z, which is given by the product of the 
tissue density, ρ, and speed of sound, c.  
Images are made by recording the ultrasonic echoes and assigning grayscale values to their 
intensities. This mode of imaging is known as pulse/echo (P/E) ultrasound, and results in a one-
dimensional tomographic data set (amplitude vs. depth) referred to as a radiofrequency line (RF-line). RF 
data is then envelope-detected and log compressed to form an amplitude line (A-line), which encodes the 
intensity of the echo at a given depth position. To create two-dimensional images, successive A-lines are 
taken at various positions across the tissue of interest and stitched together to create a brightness mode 
(B-mode) image. A-lines can also be fired sequentially in the same location in a technique known as  
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motion mode (M-mode), which as the name suggests, is used to track motion such as blood flow. 
Variations on M-mode sequencing underlie the flow-mapping techniques of pulsed, color, and power 
Doppler that are utilized to perform non-contrast angiography-style imaging with ultrasound.  
Ultrasound imaging, specifically duplex ultrasonography (DUS), is globally accepted as the first-
line diagnosis of stenosis in peripheral vessels [103]. In DUS, a combined-imaging mode, conventional 
B-mode ultrasound is used to visualize the anatomy of the vessel and Doppler imaging is used to measure 
both systolic and diastolic flow velocities in the artery (Figure 3.3). Velocity values are then used to 
derive stenosis percentages, with higher velocities indicating more severe stenosis [104]. Another 
common ultrasound metric used to diagnose atherosclerosis is carotid intima-media thickness (IMT) 
[105], which are typically done in the common carotid artery, and have been used for many years as a 
biomarker to indicate overall patient plaque burden and cardiovascular risk [106]–[108]. 
 
Figure 3.3: Longitudinal duplex ultrasound images of a predominantly echolucent, concentric, carotid 
artery plaque with >60% stenosis. Asterisks represent point of maximal stenosis. Abbreviations: CFD, 
color-flow Doppler.  
 
 
33 
3.3.1 Plaque Echogenicity 
Vulnerable plaque characterization with ultrasound has classically been implemented by 
measuring plaque echogenicity (Table 3.1). In the late 1980s, studies revealed that vulnerable plaque 
features such as lipid/necrotic core and intraplaque hemorrhage tended to correlate with plaque 
echolucency on grayscale ultrasound whereas fibrosis and calcification were echogenic [109]. From this 
work, a qualitative plaque echolucency ranking system was proposed, named the Gray-Weale scale (after 
the author that developed it), which included four categories ranging from “uniformly echolucent” to 
“uniformly echogenic”. In the following years, the scale was modified/improved [110] and implemented 
in a number of clinical studies that showed association of plaque echolucency with plaque vulnerability 
[111]–[113]. Additionally, B-mode ultrasound was shown to be capable of directly visualizing fibrous cap 
thickness (down to ~500 µm) [114]. To help standardize grayscale measurements, a quantitative metric of 
plaque echogenicity scoring, termed grayscale median (GSM), was subsequently developed and is 
currently the subject of ongoing clinical trials [115]. In this method, a histogram of pixel intensity values 
is computed for a given plaque, and the median grayscale value is calculated and thresholded to determine 
plaque vulnerability [116]–[118].  
In a recent review of noninvasive plaque characterization techniques [3], the authors reported a 
wide range of sensitivities (ranging from 39% to 94%) and specificities (ranging from 57% to 80%) of 
echolucency-derived composition compared to histology. It has been proposed that the accuracy of 
grayscale ultrasound to characterize plaque is hampered by a number of factors: 1) the considerable 
overlap in echogenicity of many “soft” plaque features, 2) differences in ultrasonic beamforming methods 
between manufacturers, and 3) inter-operator variability.  
3.3.2 Virtual Histology 
One interesting ultrasonic technique that has been used extensively in the characterization of 
coronary plaques is known as Virtual Histology (VH) [119]. VH is a quantitative ultrasound (QUS) 
method that is implemented on an intravascular ultrasound (IVUS) array. VH not only interrogates the 
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backscatter amplitude but also the spectral characteristics of the raw ultrasonic radiofrequency (RF) data. 
After computing the frequency spectrum for a given region of interest in the RF data, spectral parameters 
such as maximum power, mid-band fit, slope, and y-intercept are calculated, which are fed into a 
statistical classification algorithm. Four tissue types are identified [120]: 1) fibrous, 2) fibro-fatty, 3) 
necrotic core, and 4) dense calcium, and fibrous cap  
thickness can be measured as the region of fibrous tissue separating necrotic core from lumen (Figure 
3.4).  
Since being developed in the early 2000s, IVUS-VH has been implemented in a large number of 
clinical trials including vulnerable plaque identification studies (PROSPECT trial [121]–[123]), 
longitudinal response-to-therapy studies [124], and stent deployment studies [125]. Early results from 
clinical trials have simultaneously demonstrated the efficacy of identifying vulnerable plaque features and 
confounded the vulnerable plaque hypothesis by elucidating the highly dynamic nature of coronary 
atherosclerosis [126]. 
 
Figure 3.4: Classification of various coronary plaques with virtual histology intravascular ultrasound. (a) 
Pathological intimal thickening with significant fibrous and fibro-fatty disposition (green color). (b) Early 
fibroatheroma. (c) Thick-cap fibroatheroma with necrotic core (red color) and calcifications (white color). 
(d) Thin-cap fibroatheroma. Abbreviations: F, fibrous; FF, fibro-fatty; NC, necrotic core; DC dense 
calcium. Reprinted under open access license from [120] (Copyright © 2009 The Korean Academy of 
Medical Sciences) 
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3.3.3 Advantages and Disadvantages 
There are a number of advantages of ultrasound imaging. First, the acoustic waves used in 
ultrasound are non-ionizing and do not increase patient risk of cancer. Second, the acquisition time is very 
fast due to the high speed of sound in tissue (~1540 m/s) allowing ultrasound images  
to be generated in real-time. Conventional raster-scanned B-modes can be generated up to 100 times per 
second, while novel plane-wave ultrasound techniques can exceed 1000 frames per second (these 
techniques will be discussed in the subsequent chapter). This makes ultrasound particularly suited to 
capturing high-speed motion (such as blood flow or cardiac dynamics), which is unparalleled in other 
modalities. Finally, ultrasound requires minimal hardware, which not only makes the systems inexpensive 
but also allows them to be very portable. Therefore, ultrasound is widely accessible and has potential to 
be used an atherosclerosis screening modality in the general population. 
While the mobility and speed of ultrasound are some of its greatest strengths, these features are 
also responsible for one of its greatest weakness – inter-operator variability. As opposed to MR or CT 
systems, where a patient lies in an immobile bore, the majority of clinical ultrasound images are produced 
Table 3.4: Diagnostic performance, strengths, limitations, and pitfalls of DUS in the evaluation of 
stenosis, plaque morphology, and composition. Table adapted from [103].  
DUS Stenosis (>70%) Plaque Morphology Plaque Composition 
Diagnostic performance Sensitivity 89% Specificity 84% 
Sensitivity 85% 
Specificity 84% 
Moderate correlation 
with histopathology 
Strength points Fast and cost-effective Detailed view of the plaque with high-resolution probes 
Faster as compared to 
CTA and MRA; use of 
power Doppler 
Limitations Operator dependent Calcium induced acoustic shadowing 
Heavily calcified plaques 
may hamper detection of 
other components 
Pitfalls Poorly reproducible Calcium can obscure subtle surface alterations 
Amorphous 
calcifications and 
hemorrhage are similar 
Abbreviations: DUS, duplex ultrasound; CTA, computed tomography angiography; MRA, magnetic resonance 
angiography;  
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dynamically by a hand-held transducer that is manipulated into position by a skilled technician. Even after 
years of training, error in probe placement, or incorrect angle measurement for Doppler studies can result 
in statistically-variable performance of the technique [127]. Indeed the U.S. Preventative Services Task 
Force currently does not recommend DUS for screening the general population for asymptomatic carotid 
stenosis of 60-99% because the specificity (which they estimate to be 92%) results in too many false 
positives [128]. As mentioned previously, inter-operator variability has also plagued echogenicity 
measurements and resulted in highly disparate accuracies for plaque characterization [3].  
Another limitation with ultrasound imaging is that only peripheral vessels can be reliably imaged. 
While ultrasound has the temporal resolution necessary to image the fast-moving heart, the frequencies 
and aperture sizes in transcutaneous cardiac imaging severely limit the spatial resolution. The major 
problem is the ribs; ultrasound is highly absorbed/reflected by bone, and, therefore, the ribs must be 
avoided, either by designing small-aperture phased-array probes to look between the ribs (which reduces 
the lateral resolution), or using a low-frequency array to image from below the ribs (which reduces the 
axial resolution). This difficulty with bone penetration also limits the use of ultrasound in cerebral 
arteries, which are covered by the skull, and imaging through heavy calcifications in plaque. 
The last challenge with ultrasound image is the presence of speckle and clutter. Speckle is 
phenomenon related to coherent imaging systems that appears as a granular “noise” or local intensity 
fluctuations in the image that is the result of constructive and destructive wave interference from 
subwavelength scatterers. Clutter is a term used to describe spurious echoes that originate from spatial 
locations other than the interrogated tissue volume (e.g. reverberation, side-lobes, grating-lobes, etc.). 
Both speckle and clutter can have substantial impact on the local grayscale intensity in a given region of 
an ultrasound image, which can confound plaque characterization. Multiple techniques have been 
developed to reduce both speckle (spatial compounding [129]), and clutter (harmonic imaging [130], 
coherence imaging [131]), however their impact on grayscale plaque imaging is not well characterized. 
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3.4 Optical Techniques 
Optical imaging refers to the use of electromagnetic radiation in the visible to near-infrared 
spectrum (wavelengths between 400 and 1500 nm) to interrogate atherosclerotic plaques. While there is a 
plethora of optical methods that vary considerably in their mode of operation, almost all of them are 
implemented on catheters for intravascular deployment due to the poor penetration depth of light in tissue. 
In this section, a summary of the more popular techniques will be given, with brief descriptions of the 
underlying physics that make them work. 
3.4.1 Optical Coherence Tomography 
Optical coherence tomography (OCT) is a high-resolution optical imaging technique (~10 µm) 
that uses low-coherence interferometry to produce two-dimensional images of optical scattering from 
tissue microstructure in a manner similar to ultrasound pulse-echo imaging [132]. OCT utilizes near-
infrared (NIR) light, with wavelengths from 1250 to 1350 nm, and measures an interference signal of the 
light backscattered from the tissue and the light backscattered from a reference mirror [133]. The 
frequency of the interference signal corresponds to the depth in the tissue. The two approaches to analyze 
the interference signal include a time-domain (TD) analysis and a frequency-domain (FD) analysis, with 
the latter being the faster of the two. In the TD approach, a reference arm is mechanically translated in the 
longitudinal direction interrogating one wavelength of NIR light at a time. In the FD approach, a 
broadband interference is acquired with no moving parts, and each individual wavelength is demodulated 
in software through the Fourier transform. The FD approach has largely supplanted the TD approach in 
clinical OCT systems due to its substantial increase in frame rate. 
OCT has been implemented successfully in a number of coronary plaque imaging products, and 
has been shown to be very sensitive to lipid/necrotic core, thin fibrous cap (<65 µm), calcification, 
thrombus, macrophage infiltrate, and IEL and EEL [133]. There are two significant limitations to OCT: 
first, the penetration depth is limited to ~2 mm, which means that the full extent of plaque burden cannot 
always be accurately identified, and second, arterial blood needs to be flushed away prior to imaging, 
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which may not always be tolerated well by the patient. To account for these limitations, newer hybrid 
OCT/IVUS systems are being developed to leverage the strengths of both imaging modalities.  
3.4.2 Optical Spectroscopy Methods 
Spectroscopy is a general term that refers to the measurement of radiation intensity as a function 
of wavelength or frequency. Spectroscopy takes advantage of the phenomenon that different substances 
absorb and scatter radiation to different degrees at various wavelengths, which can be used as a unique 
identifier or fingerprint of the material in question. Spectroscopic methods for characterizing plaque 
include diffuse reflectance near-infrared (NIR) spectroscopy [134], [135], Raman spectroscopy [136], and 
fluorescence spectroscopy [137], [138], which mainly differ by their optical excitation method. The end-
result of any of these methods is a spectra or “chemogram” that encodes the absorbance characteristics of 
the tissue, and then multivariate mathematical techniques such as principal component analysis (PCA) are 
used to classify the spectra uniquely to a known tissue type. The benefit of these techniques is that they 
give quantitative biochemical characterization of the underlying tissue composition, which may serve as a 
powerful predictor for plaque vulnerability. The drawback, however, is that the techniques do not provide 
anatomical/structural information about the plaque, meaning that these modalities typically need to be 
combined with either IVUS or OCT.  
3.4.3 Intravascular Photoacoustic Imaging 
Photoacoustic (PA) imaging is a powerful new technology that combines both light and sound to 
produce diagnostic medical images [139]. In PA imaging, short-duration (ns) laser pulses are used to 
irradiate the tissue. The absorption of the light by the tissue causes heating and thermal expansion, which 
generates a high frequency, broadband ultrasonic wave that can be detected with conventional 
transducers. The advantage of PA imaging is that the ultrasound image is weighted by an optical contrast 
mechanism that can be tuned specifically to various tissue types; in this way, the chemical specificity of 
optical imaging is retained while largely maintaining the depth of penetration of ultrasound. 
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In intravascular photoacoustic (IVPA) imaging, both a light source and an IVUS transducer are 
mounted on the tip of a catheter, which allows PA imaging to be used to classify atherosclerotic plaque. 
The laser source can then be tuned to accentuate various features, such as lipids (wavelength of 1210 nm), 
to improved IVUS visualization of plaque components [139]. With the development of tunable lasers, it is 
quickly becoming possible to capture PA scans with multiple wavelengths, which will only improve the 
specificity of the technique.  
3.5 Elasticity Imaging 
Elasticity imaging is a relatively new field of medical imaging that creates maps of the 
mechanical properties (i.e. elasticity and/or viscosity) of soft tissue. The hypothesis underlying these 
techniques is that certain pathologies, such as fibrosis or necrosis, will have predictable impacts on the 
mechanical properties of tissue, which can be used to infer disease states and progression. To measure 
elastic properties, a mechanical excitation source (either intrinsic or extrinsic) is used to apply a stress to 
the tissue and induce a deformation or strain, which is then measured with a medical imaging technique. 
The predominant imaging method has been ultrasound due to its unique ability to measure motion very 
precisely; however, novel elastographic techniques utilizing MRI and OCT have recently been developed 
as well. 
In the case of atherosclerosis plaque characterization, fibrosis and calcification are expected to 
stiffen arteries, while lipid deposition and necrosis are expected to soften arteries. In Lee et al. [140], 
radial Young’s modulus values for the different plaque components were measured to be 354 kPa for 
calcium, 81 kPa for fibrous, and 41 kPa for non-fibrous, while other groups have estimated the 
lipid/necrotic core to be 1 kPa [29], [141]. The following sections break down the various elastographic 
plaque imaging techniques by their respective excitation sources and indicate their strengths and 
weaknesses. 
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3.5.1 Intrinsic Motion Sources 
Intrinsic-motion elastographic imaging techniques do not introduce any additional mechanical 
stress into the body; they simply monitor deformations in the arterial wall induced by cardiac pulsation. 
This methodology has been implemented both noninvasively and invasively utilizing ultrasonic imaging 
to measure tissue deformation.  
In the noninvasive approaches, a transcutaneous linear array is used to image the artery in cross-
section and a speckle-tracking approach is used to capture tissue motion to predict the radial and/or 
circumferential strains on the artery. Technologies that utilize cross-correlation algorithms for speckle 
tracking are usually referred to as “strain imaging” [142]–[145], while technologies that utilize the 
Lagrangian speckle model estimator (LSME) have been dubbed noninvasive vascular elastography 
(NIVE) [146]–[149]. In a recent clinical study [149], Naim et al. compared NIVE strain measurements to 
MRI plaque characterization in 31 subjects with 50% or greater carotid stenosis. They demonstrated that 
strains were statistically lower in plaque containing lipid core, and reported sensitivities ranging from 77-
100% and specificity ranging from 57-79% for detecting lipid-rich plaque.  
Not only can strain imaging be used to directly image local plaque stiffness, but it can also be 
used to measure pulse wave velocity in a technique known as pulse wave imaging (PWI) [150]. As blood 
travels through the vasculature, it generates a pressure wave that travels down the length of the artery. 
The velocity of this wave is influenced by arterial stiffness, i.e. stiffer arteries lead to higher velocities, 
and can be related to Young’s modulus by the modified Moens-Korteweg equation [151]. PWI has been 
demonstrated most thoroughly in the aorta [152]–[155], and has recently been implemented in the carotid 
arteries for focal plaque characterization [156], [157]. 
The invasive techniques use a very similar approach, however, instead of a transcutaneous probe, 
an IVUS probe is used, and the method is referred to as IVUS elastography or IVUS palpography [158]–
[161]. As in the noninvasive approaches, various speckle-tracking algorithms are utilized to measure the 
compression of the artery from pulsation and estimate a 2D strain field. Due to the concentric geometry of 
the IVUS probe and position of the probe within the artery, radial displacements are much easier to 
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measure in IVUS palpography as compared to NIVE. IVUS palpography initially demonstrated high 
sensitivities (88%) and specificities (89%) in postmortem studies for detecting vulnerable plaque [161], 
however the modality has seen limited clinical use in the past decade. 
While intrinsic motion elastography techniques are elegant in that they do not require any 
additional hardware, using intrinsic motion presents a number of challenges. First, the frame rate of these 
techniques is inherently tied to the patient’s heart rate, which typically beats once or twice a second, 
meaning that imaging refresh rates can never be truly real-time (~30 times per second). Second, lateral 
motion tracking with ultrasound is substantially worse than axial motion tracking, which usually limits 
the estimation of the strain tensor to axial strain and shear components [162]. Third, complex geometries 
of atherosclerotic plaques can alter intraplaque strain fields and inhibit direct translation to plaque 
mechanical properties [163]. Finally, unwanted sources of motion, such as operator hand vibrations, can 
corrupt displacement measurements and need to be compensated for. 
3.5.2 Extrinsic Motion Sources 
Extrinsic-motion elastographic techniques utilize outside sources of mechanical stress to create 
deformations in tissue. These techniques are typically classified by the duration of the excitation, which 
can be applied 1) quasi-statically, 2) transiently, or 3) harmonically. Quasi-static excitation achieves a 
steady-state response of the tissue similar to manual palpation, while transient and harmonic excitations 
give dynamic responses utilizing impulses and frequency-oscillations, respectively. 
An example of quasi-static elastography is ultrasonic compression elastography [164]. In this 
technique, a handheld ultrasound probe is used to compress tissue while performing real-time imaging to 
measure the deformation. Displacements are monitored with speckle-tracking algorithms by comparing 
pre-compression and post-compression images, and are used to determine the strain field. Compression 
elastography has been studied extensively for the diagnosis of breast, liver, thyroid, and prostate 
pathologies [165], however, due to the relative success of intrinsic-motion techniques discussed in the 
previous section, has largely been unused for arterial imaging. 
42 
The techniques for dynamic elastography are much more diverse, and include vibrating the tissue 
with a mechanical shaker, as in magnetic resonance elastography (MRE), or exciting the tissue with 
acoustic radiation force (ARF). In MRE, an external vibrator is used to introduce low-frequency 
mechanical waves (called shear waves) into the tissue of interest, which are visualized using phase-
contrast MRI [166]. MRE is capable of capturing tissue motion in three dimensions and providing full 
reconstruction of the tissue modulus. The main clinical application of MRE has been in staging liver 
fibrosis [167], however a number of groups have been investigating MRE for measuring abdominal aorta 
stiffness [168]–[172]. In ARF-based techniques, a high-intensity acoustic pulse is used to generate 
displacements and shear waves in tissue. As ARF-based imaging is the focus of this dissertation, a 
thorough description of these techniques is given in the next chapter. 
3.6 Summary 
A number of vascular imaging techniques were presented, and their efficacy for imaging 
atherosclerosis was assessed. In the clinic today, angiographic-type modalities such as DUS and CTA 
continue to be the gold standard; however, early data from clinical trials utilizing MRI- or IVUS-based 
plaque characterization techniques have demonstrated that information beyond stenosis can be extremely 
useful in predicting patient risk. The improvements in atherosclerosis imaging have also led to a dramatic 
increase in our understanding of atherosclerosis pathology, which is beginning to shape the next 
generation of hypotheses about how to treat and manage cardiovascular disease. Unfortunately, many of 
the plaque characterization modalities have significant drawbacks in terms of cost (for MRI) and patient 
safety (for IVUS and CT), which may preclude them for being applied as screening tools for the general 
population. Advances to transcutaneous ultrasound, as will be described in the next chapter, have the 
potential to bring the diagnostic power of plaque characterization to a significantly wider range of patients 
and possibly lead to significant advances in the diagnosis and treatment of CVD.  
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CHAPTER 4 
 Radiation Force Elasticity Imaging 
Radiation force is a phenomenon in wave motion where part of the energy of the travelling wave 
is converted into momentum after experiencing absorption, scattering, or reflection. The first description 
of radiation force can be traced back to Johannes Kepler in the 17th century who suggested that energy 
from solar rays was responsible for deflecting comet tails [173]. Almost two centuries later, radiation 
force was found to be associated with acoustic waves as well, and emerged as a unique field of study in 
1902 after the extensive work of Lord Rayleigh [173], [174]. However, it wasn’t until 1990, when 
ultrasound was already an established field, that acoustic radiation force (ARF) was proposed to be 
utilized as an extrinsic excitation source for elasticity-based medical imaging techniques [175]. Over the 
last few decades, a multitude of ARF elasticity imaging methods have been developed and 
commercialized for clinical adoption. 
In this chapter, a brief background on the physics underlying soft-tissue biomechanics and ARF 
are given first, followed by a review of the different ARF imaging methods that are currently used for 
arterial imaging. Specific attention will be given to acoustic radiation force impulse (ARFI) imaging, a 
qualitative technique, which is the focus of this dissertation. Finally, the bioeffects that govern patient 
safety of all ARF-based imaging as well as some of the challenges in implementing the techniques are 
discussed briefly to conclude.  
The derivations in this chapter are adapted from Palmeri et al. [176] and Doherty et al. [177]. 
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4.1 Soft-Tissue Biomechanics 
To understand the physics behind ARF elasticity imaging, the biomechanics and wave 
propagation in soft tissue will be explored in detail first. The elastodynamic equation of motion in solids 
is primarily based on three fundamental properties: 1) the constitutive equation that relates stress to strain, 
2) the balance of linear momentum, which utilizes Newton’s second law, and 3) the infinitesimal strain 
tensor that relates strain to displacement.  
Soft tissues are often approximated as linear, isotropic, perfectly elastic solids with the following 
balance of linear momentum equation, 
 ∇ ∙ 𝝈 +  𝒇 = 𝜌𝒂 (4.1) 
and constitutive stress-strain equation, 
 𝝈 = 𝜆𝜓 + 2𝜇𝜺 (4.2) 
 𝜓 = 𝑡𝑡(𝜺)𝑰 = ∇ ∙ 𝒖 (4.3) 
where ∇ ∙ is the divergence operator, 𝝈 is the Cauchy stress tensor, 𝒇 represents an external, steady-state 
force (e.g. gravity), 𝜌 is material density, 𝒂 represents an externally applied acceleration (e.g. radiation 
force), 𝜆 is the Lamé modulus, 𝜓 is the material dilatation, 𝜇 is the shear modulus that describes the 
material resistance to shear, 𝜺 is the infinitesimal strain tensor, 𝑡𝑡(∙) is the trace operator, 𝑰 is the identity 
matrix, and 𝒖 is the particle displacement vector.  
Using the infinitesimal strain approximation, the strain (𝜺) can be defined as the symmetric 
gradient of displacement (𝒖) represented by the following equation, 
 
𝜺 = 12 (∇𝒖 + (∇𝒖)𝑇) (4.4) 
where (∙)𝑇 is the transpose operator. Substituting equation (4.4) into (4.2), and differentiating yields an 
expression for the divergence of stress as a function of particle displacement, 
 ∇ ∙ 𝝈 =  𝜆∇𝜓 +  𝜇�∇2𝒖 + ∇(∇ ∙ 𝒖)� (4.5) 
where ∇ is the gradient operator, and ∇2 is the Laplacian operator. Substituting equation (4.5) into 
equation (4.1), and assuming no external body forces, 𝒇 = 0, as well as substituting the second derivative 
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of displacement for the applied acceleration, 𝒂 = 𝜕2𝒖
𝜕𝑡2
,  an expression for particle displacement as a 
function of time (𝑡) and space can be derived, 
 (𝜆 + 𝜇)∇𝜓 + 𝜇∇2𝒖 = 𝜌 𝜕2𝒖
𝜕𝑡2
 
(4.6) 
or,   
 (𝜆 + 𝜇)∇(∇ ∙ 𝒖) + 𝜇∇2𝒖 = 𝜌 𝜕2𝒖
𝜕𝑡2
  . (4.7) 
From equation (4.7), two different types of wave equations can be derived to describe elastic 
wave propagation. These two waves are known as dilatational waves (P-waves) and shear waves (S-
waves), and can be analyzed separately by performing a Helmholtz decomposition, which resolves a 3D 
vector field into the sum of the rotation-free component (dilatation wave) and divergence-free component 
(shear wave).  
In dilatational waves, the particle motion is in the same direction as the wave propagation, and 
there is no particle rotation. This is described mathematically by taking the divergence of the equation of 
motion,   
 
∇ ∙ �(𝜆 + 𝜇)∇(∇ ∙ 𝒖)  + 𝜇∇2𝒖 = 𝜌 𝜕2𝒖
𝜕𝑡2
� 
(4.8) 
 (𝜆 + 𝜇)∇2 (∇ ∙ 𝒖)���
𝜓
+ 𝜇∇2 (∇ ∙ 𝒖)���
𝜓
= 𝜌 𝜕2
𝜕𝑡2
(∇ ∙ 𝒖)���
𝜓
 
(4.9) 
where ∇ ∙ ∇2𝒖 = ∇2(∇ ∙ 𝒖) and ∇ ∙ ∇𝒖 = ∇2𝒖 . After combining terms, equation (4.9) becomes 
 (𝜆 + 2𝜇)∇2𝜓 = 𝜌 𝜕2𝜓
𝜕𝑡2
  . (4.10) 
This equation can be rewritten in the familiar “wave equation” format to represent the propagation of 
dilatation (𝜓), 
 
∇2𝜓 = 1
𝑐𝐿
2
𝜕2𝜓
𝜕𝑡2
 
(4.11) 
where the dilatational or longitudinal wave speed (𝑐𝐿) is, 
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𝑐𝐿 = �(𝜆 + 2𝜇)𝜌 =  �𝐾 + 43𝜇𝜌   . (4.12) 
The shear (𝜇) and Lamé (𝜆) moduli are related to the material Young’s modulus (𝐸), which 
describes resistance to uniaxial compression, and material bulk modulus (𝐾), which describes resistance 
to uniform compression, via the Poisson’s ratio (𝜈), which describes the deformation that occurs 
orthogonal to the applied force. 
 𝐸 =  𝜇(3𝜆 + 2𝜆)
𝜆 + 𝜇  (4.13) 
 
𝜈 = 𝜆2(𝜆 + 𝜇) (4.14) 
 
𝜇 =  𝐸2(1 + 𝜈) (4.15) 
 
𝐾 =  𝐸3(1 − 2𝜈) (4.16) 
Most soft tissues are assumed to be incompressible (𝜈 = 0.5), which simplifies the relationship of shear 
and Young’s modulus (𝜇 =  𝐸 3⁄ ).  
The second type of wave that can be derived from equation (4.7) is a shear wave, which is a 
transverse wave where the particle motion is orthogonal and the deformation does not cause a volume 
change. Mathematically, this can be represented by taking the curl (∇ ×) of the equation of motion, 
 
∇ × �(𝜆 + 𝜇)∇(∇ ∙ 𝑢�⃗ )  + 𝜇∇2𝑢�⃗ = 𝜌 𝜕2𝑢�⃗
𝜕𝑡2
� 
(4.17) 
 (𝜆 + 𝜇)∇ × �∇(∇ ∙ 𝑢�⃗ )�  + 𝜇∇ × (∇2𝑢�⃗ ) = 𝜌 𝜕2
𝜕𝑡2
(∇ × 𝑢�⃗ )����
𝜽
  . (4.18) 
By definition, ∇ × �∇(∇ ∙ 𝑢�⃗ )� = 0, and using the identity ∇ × (∇2𝑢�⃗ ) = ∇2(∇ × 𝑢�⃗ ), equation (4.18) can be 
simplified to, 
 
𝜇∇2𝜽 = 𝜌 𝜕2𝜽
𝜕𝑡2
 
(4.19) 
and rewritten as a “wave equation” to represent the propagation of the transverse component (𝜽), 
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∇2𝜽 = 1
𝑐𝑇
2
𝜕2𝜽
𝜕𝑡2
 
(4.20) 
where the transverse wave speed (𝑐𝑇) is, 
 
𝑐𝑇 = �𝜇𝜌  . (4.21) 
 The derivation thus far has modelled soft tissue as being perfectly elastic; however, it is well 
known that biological tissues are viscoelastic. Viscosity is a measure of a material’s resistance to 
deformation or flow, and adds a time-dependency to the mechanical response of tissue. This can be 
represented by allowing the Lamé constants to take on complex values, 𝜆∗ and 𝜇∗, which modifies 
equation (4.12) to the following in viscoelastic solids [176], 
 
𝑐𝐿
∗ = �(𝜆∗ + 2𝜇∗)
𝜌
  . (4.22) 
 A common 1D solution to the longitudinal wave equation (4.11) for particle displacement (𝑢) as a 
function of position (𝑥) and time (𝑡) using the complex wave speed in (4.22) is the following, 
 𝑢(𝑥, 𝑡) = 𝐴0𝑒−𝛼𝛼+𝑗(𝜔𝑡−𝑘𝛼) (4.23) 
where 𝐴 is the original wave amplitude, 𝑘 represents the wave number (𝜔/𝑐𝐿∗), 𝜔 is the angular 
frequency, and 𝛼 is the frequency-dependent attenuation coefficient of the material. Finally, taking the 
temporal derivative of equation (4.23) yields a solution for the particle velocity (𝑣), 
 𝑣(𝑥, 𝑡) = 𝑗𝜔𝐴0𝑒−𝛼𝛼+𝑗(𝜔𝑡−𝑘𝛼)  . (4.24) 
4.2 Acoustic Radiation Force Theory 
Acoustic radiation force (ARF) is a unidirectional body force (i.e. a force per unit volume) 
generated from the transfer of momentum from an acoustic wave to the propagating medium [176]. The 
transfer of momentum occurs with energy-loss mechanisms such as absorption, scattering, and/or 
reflection, therefore the derivation of acoustic radiation force cannot be directly obtained from the purely 
elastic stress-strain relationships developed in the previous section. Classically, the derivation of ARF has 
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been approached by modelling the tissue as a linearly viscous fluid, where the balance of linear 
momentum equation is given by the Navier-Stokes equation [178]. Using a perturbative expansion of 
equation (4.1) with respect to density (𝜌), pressure (𝑝), and particle velocity (𝒗), the radiation force can be 
related to the change in momentum from second-order terms as [176], 
 𝑭 = ∇𝑝2 − 𝜇𝑓∇2𝒗2 (4.25) 
 𝑭 = 𝜌〈𝒗1∇ ∙ 𝒗1 + 𝒗1∇𝒗1〉 (4.26) 
where 〈 〉 represents the time-average quantity, 𝒗1 and 𝒗2 are the first and second-order terms in the 
expansion of particle velocity, 𝑝2 is the second-order pressure term. For a plane wave, equation (4.26) can 
be reduced to, 
 𝑭 = 2𝜌〈𝒗∇𝒗〉  . (4.27) 
Substituting the solution to the attenuating wave equation (4.24) into (4.27), the magnitude of acoustic 
radiation force can be expressed as, 
 |𝑭| = 𝐴02𝑒−2𝛼𝛼𝜌𝛼  . (4.28) 
Therefore, at any spatial location the magnitude of ARF can be simplified to, 
 |𝑭| = 2𝛼𝛼
𝑐𝐿
 
(4.29) 
where 𝛼 [Np/cm] is the absorption coefficient of the tissue, and 𝛼 [W/cm2] is the temporal average 
intensity of the acoustic beam at a given point in the tissue. The units of 𝐹 are given as force per unit 
volume [kg/(s2cm2)], or [dynes/(1000cm3)], and the units of 𝑐𝐿 are [m/s].  
While (4.29) is an extremely useful approximation, it must be noted that it generally 
underestimates the true radiation force magnitude experienced in tissue due to the underlying second-
order approximation. In tissue, an acoustic wave with high amplitude and short duration experiences 
significant nonlinear distortion, which results in the formation of harmonics and consequently, an increase 
in absorption [179]. In 2012, Dontsov and Guzina  proposed a revised formulation of the classic ARF 
equation that included higher-order nonlinear terms [180]: 
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|𝑭| = �𝐶
𝐾
− 1� �2𝛼𝛼
𝑐𝐿
+ 1
𝑐𝐿2
𝜕𝛼
𝜕𝑡
�  . (4.30) 
 In this formulation, two additional terms are added: 1) a non-linear multiplier (𝐶 𝐾⁄ − 1) and 2) a 
modulation-driven term 𝑐𝐿−2 𝜕𝛼 𝜕𝑡⁄ . In a Newtonian fluid, 𝐶 𝐾⁄ = 2, however in biological tissue the 
𝐶 𝐾⁄  factor  ranges from 8 to 25 [181], which can explain discrepancies in force magnitude which arise 
when using (4.29).  
4.3 Vascular ARF-Based Imaging Methods 
As mentioned previously, ARF can be utilized as an extrinsic motion source for diagnostic 
elasticity imaging of tissue. The primary benefit of ARF, in contrast to other extrinsic motion sources 
such as a mechanical vibrator or cardiac pulsation, is that ARF is highly controllable and can achieve a 
level of spatial precision that is simply not possible with the other techniques. From equation (4.29), it 
can be seen that ARF will be generated wherever acoustic energy is deposited, and will be particularly 
strong in areas of high acoustic intensity. Diagnostic ultrasound pulses are typically too low-energy to 
generate a measurable deformation, and therefore to utilize ARF for imaging purposes, acoustic intensity 
is increased either by increasing the driving voltage of the transducer or by increasing the duration of the 
output sound pulse.  
ARF-based imaging techniques are typically categorized by their excitation duration (impulsive or 
harmonic) and by the location of the tracking beams that are utilized to monitor the deformation (on-axis 
or off-axis). On-axis tracking methods measure deformation directly in-line with the acoustic radiation 
force beam, while off-axis methods monitor shear wave propagation that is induced by the radiation force. 
The primary radiation force-based imaging techniques that have been developed for vascular imaging 
include vibroacoustography, shear wave elasticity imaging, shear/lamb wave dispersion vibrometry, and 
acoustic radiation force impulse imaging.  
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4.3.1 Vibroacoustography 
Vibroacoustography (VA) is an on-axis technique that uses harmonic radiation force to elicit an 
acoustic response (acoustic emission) in the tissue [182], [183]. The acoustic emission is produced by 
focusing two continuous-wave (CW) ultrasound beams of slightly different frequency at the same spatial 
location in the tissue. The ARF exerted on the tissue by the two beams generates a vibration with 
frequency equal to the difference in frequency between the excitation beams (typically on the order of 
kHz). This acoustic emission is then captured with a low frequency receiver (hydrophone). VA images, 
unlike conventional ultrasound images, have the unique property of being speckle-free, which can 
improve image quality significantly. 
In the context of atherosclerotic arteries, VA imaging has been shown to be particularly sensitive 
to arterial calcifications as shown by ex vivo studies done on breast tissue [184] and ex vivo and in vivo in 
porcine arteries [185]. Pislaru et al. [185] artificially induced arterial calcification in 11 farm pigs and 
found VA to have high sensitivity (100%), specificity (86%), positive predictive value (77%) and 
negative predictive value (100%) to calcium. However, because of the model used in these studies, the 
sensitivity of VA to lipid/necrotic core or hemorrhage could not be evaluated, and therefore the capability 
of VA to detect vulnerable plaque characteristics remains to be determined. 
4.3.2 Shear Wave Elasticity Imaging and Supersonic Shear Imaging  
Shear wave elasticity imaging (SWEI) [186] and its successor, supersonic shear imaging (SSI) 
[187], are techniques that use off-axis tracking of shear waves to make images of tissue elasticity. These 
two methods are largely considered “quantitative” because the shear wave velocity can be directly related 
to tissue modulus following equation (4.21). Pulse sequences for SWEI require three types of pulses: 
reference, pushing, and tracking. However, instead of tracking displacements in the region of excitation, 
displacements are tracked at a number of positions lateral to the region of excitation. A minimum of two 
tracking positions spaced some distance apart laterally are necessary to make a single shear wave 
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measurement, however 2D images are produced by tracking many lateral locations after many sequential 
ARF bursts. 
In contrast, SSI is a massively parallelized version of SWEI that utilizes plane-wave 
beamforming and coherent compounding to achieve very high 2D framerates (3-5 kHz). In SSI, only one 
ARF excitation is necessary to generate a full 2D image, whereas in SWEI, each lateral tracking line 
requires an ARF excitation. Additionally, SSI utilizes multiple ARF bursts focused at different axial 
depths to create a constructively interfering planar shear wave (propagating in a Mach-cone) in the tissue. 
In this way, the entire imaging depth of field is traversed by a shear wave. SWEI and SSI datasets are 
motion tracked using correlation or phase-based estimators, and the displacement matrices are then used 
to calculate shear wave velocity. Classically, the method for estimating shear wave velocity was via 
inversion of the Helmholtz equation [187], [188], however, due to the challenge of noisy ultrasound data 
and computation time, time-of-flight methods have become preferred in modern implementations [189]–
[192]. Because time-of-flight techniques follow the wave packet in the time domain, these methods yield 
a measurement of “group” shear wave velocity, which is not to be confused with the “phase” velocity, 
which represents the velocity of single frequency component of the shear wave. SWEI technology has 
been implemented commercially by a number of ultrasound developers including Siemens (Virtual 
TouchTM Quantification), Philips (ElastPQ), and GE (Shear Wave elastography). SSI is currently 
implemented on the Supersonic Imagine Aixplorer® (ShearWaveTM Elastography). 
While shear wave imaging techniques can be utilized to give quantitative shear modulus values 
by following (4.21), this simple relationship is only applicable in tissues that are homogeneous, linearly 
elastic materials. Arteries, however, are nonlinear, anisotropic, and highly heterogeneous [193]. 
Mechanical wave propagation in an artery is more properly modelled as a guided Lamb wave, which is 
similar to a shear wave in that the particle motion is perpendicular to wave propagation, but, unlike a 
shear wave, is dispersive even in the absence of viscosity due to the unique geometry of the propagating 
medium. Dispersion is a property whereby different frequencies of the wave packet travel at different 
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speeds, and if not taken into account, can significantly confound the relationship between shear wave 
velocities and shear modulus.  
A number of groups have investigated ARF-induced wave propagation in normal arteries [194]–
[196] and atherosclerosis phantoms [197] using the guided-wave model, while others have reported shear 
wave-derived Young’s modulus values in vivo in atherosclerotic carotid arteries for the purpose of 
identifying vulnerable plaques [198], [199]. Ramnarine et al. [198] recruited 81 patients with carotid 
stenosis that underwent SSI and it was demonstrated that patients with focal neurological symptoms had 
significantly lower mean Young’s modulus values than plaques in asymptomatic patients. The authors 
followed up this work  by comparing SSI-derived Young’s modulus values to carotid endarterectomy 
(CEA) specimens  in 25 patients [199], and found that the mean Young’s modulus was significantly lower 
in plaques that had “unstable” plaque characteristics (large necrotic core, and hemorrhage) as compared to 
“stable” plaques. While these clinical studies corroborate the hypothesis that vulnerable/symptomatic 
plaques are composed of mechanically softer components, the quantitative values of modulus that are 
reported in the studies are unreliable because they are derived from the simple shear wave equation 
(4.21). In a phantom study, Widman et al. [197] demonstrated substantial underestimation of true 
modulus, particularly in the stiffer phantom components, when using equation (4.21) as compared to the 
Lamb wave model. While SWEI/SSI may be able to discriminate vulnerable plaque features in vivo 
qualitatively, it remains to be seen whether quantitative assessment is feasible. 
4.3.3 Shear/Lamb Wave Dispersion Vibrometry and Spectroscopy 
Shear wave dispersion ultrasound vibrometry (SDUV) [200] and lamb wave dispersion 
ultrasound vibrometry (LDUV) [201] are complimentary off-axis techniques that measure mechanical 
wave propagation in a manner similar to SWEI. As opposed to SWEI, which typically implements an 
impulsive (i.e. broadband) ARF excitation to measure “group” shear wave velocity, SDUV utilizes 
harmonic (i.e. narrow-band) shear waves and measures “phase” velocity for a range of frequencies. In the 
initial description of the technique, harmonic shear waves were generated with AM-modulation of CW 
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ultrasound [200], however newer implementations have utilized pulsed ARF bursts at the desired 
frequency [202], or even single broadband pulses with frequency decomposition techniques to gather 
similar data (in a method known as shear wave spectroscopy, SWS) [203]. Once phase velocity is 
measured for a given range of frequencies, the data can be fit to either a simple two-parameter Voigt 
model (for SDUV), or more complex models such as the Lamb-wave model (for LDUV) as necessary. 
The main benefit of the SDUV/LDUV techniques over conventional SWEI is that viscosity can be 
measured in addition to elasticity (whereas SWEI only measures elasticity). 
LDUV has been applied to arterial mimicking phantoms (polyurethane tubes) and non-diseased 
ex vivo porcine arteries to try to quantitatively estimate tissue modulus [204]. Using this technique, Bernal 
et al. [204] measured shear moduli of 24 - 46 kPa for 10 - 100 mmHg static pressures in ex vivo arteries, 
which slightly underestimated in vivo stiffnesses of 130 kPa in systole and 80 kPa in diastole measured by 
SSI and a similar model by Couade et al. [195]. While LDUV techniques have shown promising results in 
early experiments, they have yet to be demonstrated in larger in vivo clinical studies or in atherosclerotic 
plaque.  
4.3.4 Acoustic Radiation Force Impulse Imaging 
In acoustic radiation force impulse (ARFI) imaging, which is the focus of this dissertation, a 
single ultrasound transducer is used to both induce and monitor on–axis deformation in order to generate 
qualitative images of tissue stiffness [205]. At a single lateral location, an ARFI pulse sequence consists 
of three pulse types: 1) reference pulses that precede the ARF burst and are used as a baseline for tissue 
position, 2) pushing (ARF) pulse that consist of a high-intensity impulse to displace the tissue, and 3) 
tracking pulses that monitor the tissue dynamics following the ARF burst. Tissue displacement is 
measured using correlation or phase-shift estimation techniques on raw RF data from the reference and 
tracking pulses [206]. The pulse sequence and motion estimation is repeated at a number of lateral 
positions across the imaging field of view (FOV) to build up a 3D data set consisting of tissue 
displacement as a function of axial position, lateral position, and time. From this data, 2D parametric 
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images can be rendered by extracting various features from displacement vs. time curves at a given spatial 
location, such as peak displacement (PD) and time to 67% recovery from the peak (RT).   
Displacements induced in ARFI are typically small (1-10 µm) and the tissue fully recovers to its 
baseline position quickly (4-6 ms). Areas of higher displacement are indicative of mechanically softer 
regions in the tissue, while smaller displacements indicate stiffer regions. Calculating quantitative tissue 
modulus from ARFI-measured displacements is currently not feasible due to uncertainties in the exact 
magnitude of force delivered to the tissue, which is materially-dependent as shown in equation (4.29). 
However, novel methods that fit ARFI-derived displacement profiles to biomechanical models, as done in 
viscoelastic response (VisR) imaging [207], may be capable of determining quantitative parameters in the 
future. ARFI has been commercialized on the Siemens ACUSON S2000 and S3000 scanners under the 
brand name Virtual TouchTM Imaging (VTI). 
Using ARFI to characterize atherosclerotic plaque was first proposed by Trahey et al. [208]. The 
initial studies were performed ex vivo in femoral and popliteal arteries acquired from amputated human 
legs, and showed that regions of higher displacement (i.e. qualitatively soft) correlated with areas of 
lipid/necrotic core from matched histological sections, while regions of lower displacement (i.e. 
qualitatively stiff) correlated with areas of fibrosis and calcification. Subsequent studies done both ex vivo 
and in vivo in a porcine model of spontaneous atherosclerosis corroborated these initial findings with 
matched histology in a small number of animals [209], [210], and were followed up by in vivo human 
studies in the carotid and popliteal arteries [211]–[213]. While these preliminary results utilizing ARFI 
imaging have been encouraging, all the studies cited thus far were performed either with very small 
sample sizes or were done without histological validation, making it difficult to quantify accuracy of 
ARFI for various plaque features. The subsequent chapters in this dissertation will thoroughly detail 
experiments undertaken to quantify ARFI performance for plaque characterization. 
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4.4 Challenges/Future Developments 
Thus far, the theory and implementation of ARF have been discussed thoroughly; however, the 
safety and challenges of various techniques have not been given much consideration.  In this section, the 
bioeffects of ARF-based imaging is explored first, followed by a number of phenomena that can 
negatively affect atherosclerosis imaging. Novel developments and technical improvements in ARFI used 
to mitigate or overcome these challenges are presented where applicable.  
4.4.1 Bioeffects 
Clinical ultrasound imaging, as with any medical device, is regulated in the United States by the 
Food and Drug Administration (FDA). When it comes to ultrasound safety, the two major bioeffects that 
the FDA is concerned about are thermal effects (tissue heating) and mechanical effects (cavitation), both 
of which can be exacerbated with the high-intensity acoustic pulses necessary for ARF pushing pulses. A 
third concern, which is unique to vulnerable plaque imaging, is the possibility of instigating rupture of a 
thin fibrous cap with ARF. So far, the FDA has cleared ARF-based imaging technology for abdominal, 
breast, thyroid, small parts, and musculoskeletal exams, but has not yet cleared the technology for 
vascular application. 
Thermal Effects 
Thermal effects of ultrasound relate to the heating of tissue as acoustic energy is introduced into 
the body. Heating is primarily the result of frictional mechanisms and is directly related to the intensity of 
the acoustic pulse. If the tissue is exposed to elevated temperatures for long periods, cell death can occur. 
Historically, the FDA has limited ultrasound output intensity (spatial-peak, temporal-average, or ISPTA) to 
≤720 mW/cm2 for general imaging. However with the advent of novel pulsing schemes, an additional 
metric was introduced, termed the thermal index (TI), which is determined by the following formula 
[214], 
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𝑇𝛼 =  𝑊𝑝
𝑊𝑑𝑑𝑑
 
(4.31) 
where 𝑊𝑝 is the relevant (attenuated) acoustic power at the depth of interest, and 𝑊𝑑𝑑𝑑 is the estimated 
power necessary to raise the tissue equilibrium temperature by 1 °C according to a chosen specific tissue 
model. On modern systems, the TI is displayed on the ultrasound screen to give the sonographer an 
indication of how much heating will occur with a given imaging mode. Temperature increases below 6 °C 
are usually accepted as an upper limit on TI and additional tissue heating above 6 °C needs to be justified. 
Although equation (4.31) is useful in most cases, it does not take into account the temporal duration of the 
pulse train, which may include significant “off” time, and therefore is limited [214].  
The American Institute of Ultrasound in Medicine (AIUM) proposed revised recommendations 
for tissue heating which allow going above 6 °C, if the exposure is for a short time [215]. For example, no 
adverse biological effects have been observed for temperature increases of 12.6 °C for 5 s, 14.9 °C for 1 s, 
and 18.6 °C for 0.1, suggesting that substantial heating can occur and still be within a safe regime if the 
pulse is short. Heating from general ARF imaging though, has been shown to not exceed 1 °C of  
temperature rise with FEM and thermocouple measurements [216], [217], suggesting that much higher 
acoustic intensities could be utilized safely. 
Mechanical Effects 
 Mechanical bioeffects in ultrasound imaging primarily refer to cavitation – a phenomenon 
characterized by the formation and/or destruction of bubbles in tissue. When a gas bubble experiences an 
ultrasonic field it expands and contracts with the rarefaction and compression of the ultrasound wave. If 
the rarefaction component (i.e. negative pressure) of the ultrasound pulse is too high, the bubble can 
expand so much that a vacuum is generated and the bubble instantaneously collapses in on itself. This 
event causes rapid temperature increase that can be damaging to cells [218]. Cavitation potential is 
captured by a metric termed the “mechanical index” (MI) which is given as, 
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𝑀𝛼 =  𝑝−
�𝑓0
 (4.32) 
where 𝑝− is the derated peak rarefactional pressure in units of MPa, and 𝑓0 is the ultrasound center 
frequency in units of MHz. MI is limited by the FDA to a value of 1.9 for diagnostic imaging. In general 
the risk of caviation is much higher in organs containing stabilized gas bodies, such as the intestine or the 
lung, or when exogenous microbubble contrast agents are used for imaging [218]. In organs not known to 
contain well-defined gas bodies (e.g. spinal cord), the risk is thought to be much lower with no adverse 
bioeffects up to a MI of 4 [218].  
In ARF imaging, many superficial organs (e.g. carotid arteries) can be evaluted with pulse 
sequences that fall below the FDA limit of 1.9, however when deeper penetration is necessary (e.g. in 
obese patients, or in deeper organs such as the liver) MI limits may need to be exceeded in order to 
generate a measureable ARF deformation. A recent study by Church et al. [219] revisited the derivation 
of equation (4.32) with an improved biomechanical model and long ARF pulse durations, and found that 
the exponent of 0.5 on frequency may be too conservative (it should be closer to 0.75). These results 
suggest that higher acoustic outputs can be utilized (particularly for generating ARF with higher 
frequencies), however additional studies are necessary to confirm this assertion.  
Plaque Disruption 
The last bioeffect that should be considered when implementing ARF-based elasticity for 
atherosclerosis imaging is the potential for plaque disruption. To date, no studies have reported adverse 
events when implementing ARF on plaques in either animals or humans; however, the concept that an 
ARF pulse may impart enough stress on the fibrous cap to cause a rupture is not an unreasonable concern. 
To date, only one study has been published that has specifically evaluated the stress imparted by ARF on 
a fibrous cap using FEM simulations [220]. In this study, the authors segmented a number of plaque 
geometries taken from the MRI literature and implemented them in the ARFI FEM framework developed 
by Palmeri et al. [176] to determine the stress imparted on the fibrous cap by ARFI. The results 
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demonstrated that the maximum von Mises stress of an ARFI excitation was ≤1.2 kPa, which, compared 
to the circumferential stress from blood pulsation, was considerably small [220]. In the biomechanics 
literature, a value of 300 kPa is typically cited as the critical stress necessary to cause plaque rupture [26]. 
While this study is encouraging, it does suggest that ARFI can impart an additional stress on the fibrous 
cap that may be non-negligible if combined with blood pressure. Therefore, it is advisable that ARF-
based imaging be gated to diastole to ensure that circumferential stress is at a minimum prior to imaging.  
4.4.2 Physiologic Motion 
One of the main advantages for using ultrasound to measure ARF-induced deformation is that 
that it is particularly sensitive to motion. The drawback however is that it is sensitive to non-ARF motion 
as well, such as sonographer hand trembling or physiologic motion (breathing, pulsation, etc.), which can 
introduce unwanted artifacts into ARF elastograms. In vascular ARF imaging, arterial pulsation is 
perhaps the greatest source of unwanted motion, and must be filtered out prior to making an image. This 
is commonly done by implementing interpolation-based motion filters that assume the underlying non-
ARF motion is either linear or quadratic, and that the unwanted motion is primarily in the axial direction 
[205], [221], [222]. An example of a linear motion filter applied to an ARFI displacement curve is given 
in Figure 4.1. 
4.4.3 Jitter 
Jitter is a term used to describe the error, or variance, associated with an ultrasonic displacement 
estimate. Jitter errors are the result of signal decorrelation, noise, and finite window length that causes a 
slight shift in the correlation peak between two successive A-lines [223]. Jitter represents a fundamental 
lower limit of unbiased displacement estimator performance in ultrasound tracking, and the standard 
deviation of jitter (𝜎�) can be predicted using the Cramér-Rao lower bound (CRLB) as, 
 
𝜎� ≥ �
32𝑓03𝜋2𝑇(𝐵3 + 12𝐵)� 1𝜌2 �1 + 1𝑆𝑆𝑆2�2 − 1� (4.33) 
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where 𝑓0 is the ultrasound center frequency, 𝑇 is the tracking kernel length, 𝐵 is the bandwidth, 𝜌 is the 
correlation coefficient, and 𝑆𝑆𝑆 is the signal-to-noise ratio of the received RF data. In ARF-based 
imaging, correlation coefficients between successive A-lines is typically high (0.999) because of the small 
displacements (1-10 µm) induced by ARF and under these conditions the CRLB can reach as low as 0.5 
µm. However, if ARF-induced displacement falls below this level, it is usually undetectable using 
conventional motion tracking algorithms. Simulation studies have demonstrated that normalized cross-
correlation (NCC) algorithms produce the lowest jitter magnitudes, followed by the Loupas [224] and 
Kasai [225] autocorrelation methods [206]. The CRLB can be exceeded by using biased estimation 
techniques, such as a Bayesian estimator [226], [227], however these methods are currently very 
computationally expensive and require substantial optimization before they can be implemented on 
commercial systems. 
 
 
Figure 4.1: Motion filtering of ARFI displacement profiles. (a) ARFI displacement curve corrupted by a 
constant velocity, non-ARFI motion. (b) An idealized fit to the non-ARFI motion estimated from the first 
and last data points (i.e. time points where ARFI-induced motion is assumed to be zero). (c) Motion-
filtered ARFI displacement curve with linear motion profile subtracted from raw ARFI data. Common 
parameters measured from ARFI displacement curves to produce 2D images include peak displacement 
(PD), time-to-peak (TTP), and recovery time (RT) to two-thirds of peak displacement. 
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4.4.4 Displacement Underestimation 
A significant source of bias in ARFI imaging occurs due to differential motion decorrelation, or 
tissue shearing, under the imaging point spread function (PSF). In on-axis techniques, such as ARFI, the 
same transducer is typically used to both induce and track displacements. This creates a situation where 
scatterers on the edge of the tracking resolution cell tend to displace less than scatterers in the middle of 
the tracking resolution cell due to the non-uniformity of applied radiation force (which follows a sinc2 
pattern in the lateral and elevation directions). The consequences of this phenomenon are two-fold. First, 
peak displacement measured in the ROE will tend to underestimate true tissue peak displacement due to 
averaging of scatterer motion under the resolution cell. This can lead to a reduction in contrast in peak 
displacement images because soft features may appear stiffer than they truly are due to underestimated 
displacement. Second, due to the non-uniform displacement of scatterers, the correlation between the 
reference pulse and tracking pulses immediately following the ARF excitation will decrease. This 
reduction in correlation will ultimately lead to an increase in jitter and, therefore, noisier images. 
Differential motion decorrelation was first explored analytically by McAleavey et al. [228] under 
simplifying assumptions that modeled the displacement field and tracking beam pattern as Gaussians and 
ignored the effects of non-axial motion. In this work, expressions were derived for echo correlation, jitter, 
and mean ARF displacement as functions of lateral and elevational beam widths for pushing and tracking 
pulses. A significant conclusion was that displacement underestimation can be mitigated by adjusting the 
ratio of pushing and tracking beam widths; specifically, when the pushing beam width is much wider than 
the tracking beam width, the peak displacement estimate matches the true tissue displacement much more 
closely than when the pushing and tracking beam widths are identical. In a common imaging scenario (1D 
linear array) where control over F/# can only be exerted in the lateral dimension, measured peak 
displacement could be only 1 √2⁄  of the true tissue peak displacement.  
The expressions derived by McAleavey et al. were later improved by Dhanaliwala et al. [229] by 
adding additional terms to account for the effect of mechanical coupling of tissue in three dimensions. In 
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the original derivation, McAleavey et al. assumed that the dimensionality of the tissue region displaced by 
ARF was equal to the width of the two-way response of the pushing beam. Dhanaliwala et al., using 3D 
finite element simulations, demonstrated that the displaced tissue region is actually wider than the 
pushing beam width due to mechanical coupling and adjusted McAleavey’s expression accordingly. 
Using the Dhanaliwala modification, the expression for the jitter lower bound (𝜎�) in ARFI imaging can be 
rewritten as the following [229]: 
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𝐿𝛼 =  𝐷𝛼𝑇𝛼 , 𝐿𝑦 = 𝐷𝑦𝑇𝑦  (4.35) 
Where A is the maximum scatterer displacement, c is the speed of sound, and Dx, Tx, Dy, Ty, are 
displacement and tracking beam widths in the lateral and elevational dimensions, respectively. Likewise, 
the expression for mean ARFI-derived displacement (?̂?) can be written as the following: 
 
?̂? =  2𝐴𝐿𝛼𝐿𝑦
�(2𝐿𝛼2 + 1)�2𝐿𝑦2 + 1� (4.36) 
Finally, using equations (4.34) and (4.36) and scaling by 𝑐𝐿 2⁄  to maintain consistent units, an expression 
for the upper bound of SNRARFI can be written as the following: 
 
𝑆𝑆𝑆�𝐴𝐴𝐴𝐴 ≤
?̂?
𝜎�𝑐𝐿
2
 (4.37) 
Using equation (4.37) it can be shown that increasing ARF-induced displacement has diminishing returns 
in terms of improving SNRARFI due to displacement underestimation and differential motion decorrelation 
[229].  
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Interestingly, underestimation bias in on-axis displacement measurements is not constant with 
time. Palmeri et al. [230], [231], using 3D FEM simulations, demonstrated that underestimation is worst 
in the early times points following the ARF excitation, but resolves over time at a rate corresponding to 
the shear wave speed of the material. Therefore, stiffer materials with faster shear wave speeds are less 
susceptible to underestimation bias compared to softer materials with slower shear wave speeds. These 
results were experimentally validated in optically translucent tissue mimicking phantoms as part of this 
dissertation and are presented in Appendix A. 
To mitigate differential motion decorrelation in post-processing, Mauldin et al. proposed using 
principal component analysis (PCA) as either a filter prior to conventional time-delay estimation [232], or 
as a unique time-delay estimator itself [233]. In PCA, a linear transformation is used to convert a set of 
possibly correlated variables (e.g. scatterer displacements encoded as phase shifts in RF data) into a set of 
uncorrelated variables or basis vectors, with the stipulation that the basis vectors are orthogonally 
distributed. While PCA-based approaches are not necessarily able to resolve underestimation bias 
completely, results suggest that they are more robust to decorrelation, and provide estimates with lower 
jitter compared to conventional estimation techniques such as the Loupas autocorrelation method [224]. 
4.4.5 Clutter 
Clutter is a noise artifact found in ultrasound imaging that is characterized as diffuse echoes 
overlaying the signal of interest. Clutter echo sources include sound reverberation between tissue layers 
(coherent ring down), scattering from off-axis tissue structures, ultrasound beam distortion (phase 
aberration), returning echoes from previously transmitted pulses, and random acoustic/electronic noise  
[234]. Clutter is particularly a problem in ultrasonic blood flow estimation where the stationary echoes 
from sound reverberation can be 20-40 dB stronger than the echoes from blood [235]. Motion estimators 
will preferentially track the strongest echoes, and will therefore output a value of zero for blood velocity 
in the presence of stationary clutter. Similarly in ARF-based techniques, if a strong off-axis clutter signal 
is present, the measured displacement will be biased by the motion of the clutter [206]. 
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One of the most successful clutter rejection techniques in ultrasound imaging has been the use of 
tissue harmonic imaging (THI) [130]. In THI, sound is transmitted into the tissue at a given center 
frequency but instead of listening for echoes at the fundamental frequency, echoes at the second harmonic 
are received (either through bandpass filtering, or pulse inversion techniques). The main mechanism 
through which THI improves clutter has been demonstrated through nonlinear acoustic simulation and is 
through a reduction of reverberation artifact [236].  
Doherty et al. [237] and Song et al. [238] were the first to propose the use of harmonic sequences 
to track ARFI- and SWEI-induced displacements, respectively, to improve clutter suppression. For ARFI, 
Doherty et al. [237] implemented two conventional THI methods –bandpass filtering and pulse inversion. 
In the bandpass approach, conventional ARFI ensembles are acquired with a broadband transducer, and a 
bandpass filter is used to isolate the harmonic component in each tracking line prior to motion estimation. 
In the pulse inversion approach, tracking pulses of opposite polarity are transmitted serially, and the 
echoes are summed to cancel out the fundamental signal. One of the disadvantages of the pulse inversion 
approach is that the PRF of the ARFI ensemble is effectively cut in half. To mitigate this, the authors 
developed a fully sampled pulse inversion sequence to maintain PRF, which utilized a sliding window 
when summing pulses of opposite polarity.  
The results of this work demonstrated a marked improvement in both B-mode and ARFI image 
quality of the carotid when using THI tracking pulses (particularly with the fully sampled pulse inversion 
sequence). In the pulse inversion images, the lumen/plaque border is much clearer and a region of 
increased displacement becomes visible that was otherwise obfuscated in the fundamental image. As was 
the case in conventional B-mode imaging, harmonic ARFI is likely to replace fundamental ARFI in the 
future for a majority of clinical applications due to improvements in contrast and image quality. 
4.4.6 Depth-of-Field 
One of the major challenges with conventional ARFI imaging is the limitation in depth of field. 
ARFI pulses are typically tightly focused in order to increase acoustic intensity and deposit more 
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radiation force. Consequently, tissues outside of the focal zone do not displace very far, resulting in non-
uniform contrast through depth. Two methods have been proposed to overcome this limitation: 1) acquire 
multiple, separate ARFI images with the push beam focused at different depths and blend  the data in post 
processing [239] , or 2) implement multiple pushes in rapid succession [240] as is done in SSI imaging 
(see section 4.3.2). While the first method is feasible, a significant drawback is the length of the 
acquisition, where physiological motion and mis-registration can introduce artifacts. However, using the 
second method, ARFI acquisition time is unchanged because all pushes happen in succession in the 
ensemble. Rosenzweig et al. [240] demonstrated that using rapid multi-focal-zone ARFI acquisitions 
substantially improves ARFI depth-of-field, increases CNR by up to 40% compared to conventional 
single-focal-zone ARFI, and incurs less than 20% loss in contrast compared to sequential multi-focal-
zone ARFI.  
The main drawback to using rapid multi-focal-zone ARFI is the acoustic energy that is delivered 
to the patient. Unlike SSI, where only three ARF excitations are required to generate a 2D image, multi-
focal-zone ARFI image may require upwards of 100 ARF excitations to capture a 2D image. Therefore, 
the benefits in image quality have to be weighed against the potential bioeffects when using rapid multi-
focal-zone ARFI. 
Improving ARFI contrast through depth can also be achieved by applying depth-dependent gain 
(DDG) normalization in a manner similar to time-gain compensation (TGC) that is done in conventional 
B-mode (Figure 4.2). During ARFI excitation, non-uniform force is deposited through depth in the tissue 
due to focusing and tissue-dependent attenuation, which can lead to spatial gradients in otherwise 
homogeneous tissue. To account for this, the ARFI displacement response can be normalized by the 
applied force field [241], which can either be measured experimentally in a phantom or predicted with 
FEM simulation. While this technique works well in tissue with largely homogeneous attenuation 
coefficients, it can be challenging in heterogeneous tissues in which the applied force field is not so easily 
predicted.  
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4.4.7 Real-Time ARFI 
Real-time implementation of ARFI imaging (i.e. 20-30 frames per second) is challenging due to a 
number of factors: thermal safety, frame acquisition time, and data transfer/processing rates. While no 
commercial implementations of real-time ARFI exist at this time, a substantial amount of research has 
gone into developing solutions that may enable real-time ARFI in the future. Thermal safety and frame 
acquisition time can be addressed by utilizing parallel-receive beamforming techniques [242] and clever 
beam sequencing approaches [243]. This section will focus on the third area challenging real-time 
implementation, namely, computation time. 
To address the computation time requirements for ARFI processing, ultrasound researchers have 
turned to using graphical processing units (GPU). GPUs are specialized computer circuits that include 
hundreds of processing cores for highly parallelized computation. Rosenzweig et al. [244] demonstrated 
that a GPU-based implementation of the ARFI processing chain can substantially improve computation 
performance (by approximately 40×)  and enable ARFI frame-rates of less than a second. To achieve this, 
 
Figure 4.2: B-mode and qualitative ARFI imaging of a phantom with a soft spherical inclusion (8 kPa) 
embedded in a stiffer background (25 kPa). The spherical inclusion (outlined in yellow) is nearly invisible 
on B-mode imaging (a), but is obvious as an area of increased peak displacement (PD) in the ARFI image 
(b). The quality of an ARFI imaging can be improved by applying lateral interpolation and a smoothing 
filter, such as a two-dimensional (1 mm2) Wiener filter (c). Finally, depth-dependent gain (DDG) 
normalization can be applied, in a manner similar to time-gain compensation, to improve the uniformity 
of the ARFI image through depth. 
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the authors developed custom implementations of cubic spline interpolation and Loupas’ autocorrelation 
estimator [224] written in Compute Unified Device Architecture (CUDA), a programming interface 
developed by NVIDIA to facilitate using GPUs for general purpose processing. Using the GPU 
processing chain, the authors showed that displacement estimate computation was no longer the rate-
limiting step; instead, displaying the image to the monitor took the most time due to an additional RAM 
copy. 
The greatest challenge with implementing ARFI on the GPU is the significant development time 
that is needed to efficiently port algorithms into a parallelized environment. Cubic spline interpolation, for 
example, is not well suited for parallel execution because the solution is dependent upon all data points. 
Nevertheless, once a parallel version of a given algorithm is developed, the GPU can serve as a powerful 
tool to speed up lengthy computations and make real-time implementations feasible. 
4.5 Summary 
In conclusion, ARF-based elasticity imaging techniques have opened a new frontier for elasticity 
imaging, and have shown great promise for characterizing atherosclerotic plaques based on mechanical 
stiffness. The main advantage of ARF imaging is that it can be readily implemented into the current 
clinical workflow without additional overhead, allowing physicians to probe an entirely new biomarker 
for plaque vulnerability. The rest of this dissertation will be focused on validating ARFI imaging 
specifically for plaque characterization against histology to quantitatively demonstrate its efficacy for 
detecting various vulnerable plaque features such as necrotic core, which to date has only been done in 
small sample animal studies. In the next chapter, results from a preliminary blinded reader study done in 
ex vivo porcine femoral plaques will be presented. These methods will then be utilized and improved 
upon in subsequent chapters that detail further studies done in human carotid plaques. 
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CHAPTER 5 
 Acoustic Radiation Force Beam Sequence Performance for Detection and Material 
Characterization of Atherosclerotic Plaques: Preclinical, Ex Vivo Results. 
 
The following chapter presents preclinical data demonstrating performance of acoustic radiation 
force (ARF)-based elasticity imaging with five different beam sequences for atherosclerotic plaque 
detection and material characterization. Twelve trained, blinded readers evaluated parametric images 
taken ex vivo under simulated in vivo conditions of 22 porcine femoral arterial segments. Receiver 
operating characteristic (ROC) curve analysis was carried out to quantify reader performance using 
spatially matched histology for validation. The beam sequences employed had high sensitivity and 
specificity for detecting Type III+ plaques (Sens: 85%, Spec: 79%), lipid pools (Sens: 80%, Spec: 86%), 
fibrous caps (Sens: 86%, spec: 82%), calcium (Sens: 96%, Spec: 85%), collagen (Sens: 78%, Spec: 77%), 
and disrupted internal elastic lamina (Sens: 92%, Spec: 75%). 1:1 single-receive tracking yielded the 
highest median areas under the ROC curve (AUC), but was not statistically significantly higher than 4:1 
parallel-receive tracking. Excitation focal configuration did not result in statistically different AUCs.  
5.1 Introduction 
One aspect of ARFI-based plaque characterization that has not yet been extensively investigated 
is the difference in performance between various beam sequence configurations. As described in the 
previous chapter, an ARFI-based beam sequence consists of two types of ultrasonic pulses: long-duration 
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ARF excitation pulses, which deform the tissue, and standard B-mode pulses, which track the 
deformation. Previous studies have shown that the beamforming of these pulses can significantly impact a 
number of factors, including displacement tracking accuracy, contrast-to-noise ratio (CNR), tissue 
heating, and frame rate [228], [230], [231], [241], [242]. For example, it has been modeled that the focal 
configuration, or F/# (which is given by the ratio of focal depth, z, to aperture width, d), of the excitation 
pulse can mitigate displacement underestimation due to shearing artifact [228], [230]. Shearing artifact is 
a phenomenon that occurs when the distribution of scatterer motion within the point spread function 
(PSF) of the tracking beam is non-uniform and leads to averaging, and consequently underestimation, of 
ultrasonic displacement tracking. A large F/# excitation pulse (relative to the tracking pulse) deposits 
energy over a wide lateral region of tissue within the tracking resolution cell to create a relatively uniform 
displacement field and less shearing. A large F/# excitation also changes the ARF distribution in the axial 
dimension; the axial range over which displacement is constant is increased while the force magnitude in 
a given position decreases [241].  
In addition to F/#, receive beamforming methods such as parallel receive tracking, where multiple 
A-lines are beamformed from a single transmit event, can be used to reduce the number of ARF 
excitations necessary to interrogate a given lateral range, thereby decreasing tissue heating and increasing 
frame rate [242]. Depending on the parallel beam spacing and excitation pulse beamwidth, the 
displacements observed in the A-lines furthest from the region of excitation (ROE) could be due entirely 
to shear wave propagation, which may not be uniform in a heterogeneous medium such as an atheroma. 
In this chapter, the performance of ARF-based techniques for atherosclerosis imaging is 
quantitatively assessed with a reader validation study. Atherosclerotic arteries were harvested from a 
dietary hypercholesterolemic porcine model and imaged ex vivo under simulated in vivo conditions. 
Twelve blinded readers were recruited and trained to read images created with ARF-based techniques. 
Plaque detection and characterization performance for each reader was assessed using receiver operating 
characteristic (ROC) curve analysis and a pathologists reading of spatially matched histology. ARF-based 
imaging performance results assessed under simulated in vivo conditions are compared to published in 
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vivo MRI and CT results to demonstrate the potential relevance of ARF-based ultrasound methods to 
detecting and characterizing atherosclerotic plaques.  
5.2 Methods 
5.2.1 Animal Model 
Diet-induced hypercholesterolemic (DH) pigs were used as the model for atherosclerosis. DH 
pigs are genetically normocholesterolemic (NC) swine that are fed a high-fat diet (20% beef tallow, 1% 
cholesterol or ~10 g cholesterol daily, 0.75% cholate) to induce hypercholesterolemia and cause the 
animals to develop atherosclerotic lesions spontaneously that closely mimic histopathology seen in 
humans. Detailed descriptions of the lipid and hemostatic profiles of DH swine, as well as a summary of 
the atherogenic diet, are available in a previous manuscript [67]. For this study, nineteen phenotypically 
normal pigs were selected from the closed colony at the Francis Owen Blood Research Laboratory at the 
University of North Carolina, Chapel Hill, and thirteen of those pigs were put on an atherogenic diet for 
12 months prior to imaging. The remaining six were continued to be fed a regular low-fat diet (3.58% 
crude fat including 60 to 65 mg cholesterol total daily), the same diet that the DH pigs were on prior to 
this study. All animal procedures were approved by the University of North Carolina Institutional Animal 
Care and Use Committee (IACUC). 
5.2.2 Ultrasonic Imaging, Data Collection, and Data Processing  
Left and right iliac arteries were harvested from all pigs (13 DH and 6 NC), yielding 38 arteries, 
each ~20 to 25 cm in length. The mean (± standard deviation) age of DH animals at necropsy was 3.8 (± 
0.8) years, while the mean age of NC animals was 4.6 (± 2.2) years. These arteries were stripped of 
excessive adventitial connective tissue, mounted, and pressurized statically to 80 mmHg in a saline water 
bath kept at room temperature (22 °C), as illustrated in Figure 5.1. To assist in mounting, a scaffold was 
erected across the top of the water tank with two clamps that extended into the water. The arteries were  
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fitted with barbed plastic tubing connectors inserted into either end of the vessel, and each end was placed 
in a clamp to hold the artery in place. Using the clamps, arteries were stretched to approximately 1.5 
times their recoil length to estimate in vivo lengths [245]. One end of the vessel was attached, via the 
barbed connector, to a hose coming from a Masterflex LS 7550-30 computerized pump drive (Cole-
Parmer Instrument Co. Chicago, IL, USA), while the other end was connected to a hose that lead to a GE 
Druck DPI 104 digital pressure gauge (Druck Ltd. Leicester, UK). To convert the output of the flow 
pump from pulsatile to laminar flow, a Windkessel-type pulse damper (EW-07596-20, Cole-Parmer 
Instrument Co. Chicago, IL, USA) was placed in series with the water pump and the artery. In some 
cases, branch points in the arteries that were cut during tissue harvesting were sutured closed to maintain 
 
Figure 5.1: Pressurization apparatus for ex vivo imaging. Excised arteries were mounted in a saline water 
bath between ~20 kPa tissue mimicking gelatin phantoms and statically pressurized to 80 mmHg to 
simulate in vivo imaging conditions during diastole. The saline bath was kept at room temperature (22 
°C). 
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pressure in the artery. Branch points that had sutures in the imaging field of view (FOV) were not 
included as candidate imaging locations.  
To simulate in vivo imaging conditions, two homogeneous soft tissue mimicking phantoms with a 
Young's modulus of ~20 kPa were created and placed above (~15-18 mm thickness) and below (~30-40 
mm thickness) the vessel during imaging. The phantom recipe consisted of the following ingredients 
(with percent composition by mass in parentheses): type-A gelatin (13%; Acros Organics, Geel, 
Belgium), Photo-Flo (2%; Eastman Kodak Co., Rochester, NY, USA), n-propanol (1%), powdered 
graphite (1%), and de-ionized water (83%). The acoustic attenuation of the phantom was determined to be 
0.2 (± 0.02) dB/cm/MHz, based on 5 repeated measurements. A modulus of ~20 kPa was selected to 
mimic the modulus of soft tissue (e.g. muscle) surrounding peripheral vessels in vivo [246]. Phantom 
modulus values were determined by measuring shear wave velocities in the phantom materials (in 
separate, homogeneous, 64 cm3 blocks) using a time-to-peak algorithm [189]. The arterial mimicking 
phantoms were poured from the same phantom mixtures as those measured. The SWV and Young’s 
modulus measurement methods were validated in a model 049A Computerized Imaging Reference 
Systems phantom (CIRS, Norfolk, VA, USA) with 25 kPa background material; the measured SWV was 
2.81 ± 0.08 m/s, which matches the expected SWV of 2.89 m/s for a 25 kPa material. The arteries were 
not completely embedded in the tissue mimicking material to preserve the tissue for histological 
processing after imaging. The phantom above the artery was held in place by the transducer, while the 
phantom below the artery was held in place by weights. Pressure was applied, via the transducer face, to 
the upper pad such that it would not float away or move during acquisition.  
Imaging was performed with a Siemens SONOLINE Antares™ imaging system (Siemens 
Medical Solutions USA, Inc., Ultrasound Division), equipped for modifiable beam sequencing for 
research purposes and a VF7-3 transducer. The transducer was secured in a holder connected to a digital 
three-axis motion controller mounted on an optical air table (Newport Corp., Irvine, CA, USA). The 
transducer was positioned to image the arteries longitudinally and was translated down the length of each 
artery to generate up to four non-overlapping FOVs. 
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ARF ensembles consisted of two reference lines, one ARF excitation impulse, and 60 tracking 
lines with an 11.5 kHz pulse repetition frequency (PRF). ARF excitations were 300 cycles at 4.21 MHz, 
and both tracking and reference lines were two cycles at 6.15 MHz. Two types of ARF excitations were 
combined with three types of tracking to generate five total beam sequences (Figure 5.2). The two types 
of excitations included: 1) single excitation with an F/1.5 focal configuration (SP1.5), and 2) single 
excitation with an F/3 focal configuration (SP3). The three types of tracking included: 1) single-receive 
(SRx) in the ROE, 2) 4:1 parallel-receive (ParRx) in the ROE [242], and 3) 4:1 parallel-receive lateral to 
the ROE (LatRx), the last being a method comparable to shear wave elasticity imaging (SWEI) [186]. On 
transmit, SRx tracking pulses had either an F/1.5 or F/3 focal configuration, matching the corresponding 
excitation F/#. On receive, all sequences used dynamic focusing and aperture growth (F/0.75). Figure 5.2 
depicts the different beam sequences and associated labeling scheme used in this study. For SRx tracking, 
40 ROEs and tracking locations laterally spaced 0.53 mm apart were used for an overall lateral FOV of 
2.1 cm. ParRx tracking used 15 ROEs laterally spaced 1.4 mm apart and 60 tracking locations spaced 
0.35 mm apart for a 2.1 cm lateral FOV. LatRx tracking was performed using a single ROE centered 
laterally, with 60 tracking locations laterally spaced 0.35 mm apart spanning a 2.1 cm lateral FOV. ARF 
ensembles were acquired using wiperblading, a scanning mode that acquired lines in a non-serial order 
across the lateral FOV to minimize heating and reduce interference between consecutive ARF excitations. 
A single ensemble was captured from the far left of the FOV, then the center, then one position to the 
right of the far left, then one position right of center, etc., such that no two ensembles were captured in 
two consecutive lateral locations.  
One-dimensional normalized cross correlation using an interpolation factor of 4, a search window 
length of 80 µm, and a kernel length of 376 µm (i.e. 1.5λ, where λ is the wavelength of the tracking pulse 
assuming a speed of sound of 1540 m/s) was applied to the raw, radio frequency (RF) data ensembles to 
measure axial motion induced by ARF [206]. ARF displacement profiles were then processed to reject 
luminal and reverberation signals using a previously described algorithm [247]. The algorithm was also 
implemented to automatically segment arterial wall tissue. Finally, parametric images were adaptively 
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rendered by automatically adjusting color scale limits according to the median parameter value measured 
in the segmented arterial wall (which ranged from zero to median + [3 × parameter standard deviation]). 
Rendered parametric images included peak displacement (PD) and recovery time (RT) for non-LatRx 
sequences and shear wave velocity (SWV) for all LatRx sequences. SWV was calculated using lateral 
time-to-peak (TTP) methods [189] with least-squares linear regression for regions measuring 0.5 mm 
axially and 3 mm laterally. Due to this windowing approach and the positioning of the ROE, the effective 
FOV in the LatRx images was reduced by ~6 mm (3 mm lost on the edges from windowing, and 3 mm 
lost due to the ROE). Matched B-modes were acquired and used for histological registration but were not 
presented to the readers during the course of the reader evaluation study. 
A total of 22 arterial locations were imaged, each using the five different beam sequences with 
four matched acquisitions per sequence to ensure successful data acquisition. Twelve imaging locations 
focused on distal and ten on proximal arterial walls (where “proximal” and “distal” are relative to the 
transducer). The number of imaging locations was determined by the number of areas where plaques 
developed in the arteries. Due to the spontaneous nature of plaque generation in these animals, it was not 
 
Figure 5.2: Diagrams of the five different ARFI beam sequences that were investigated in ex vivo reader 
study. Downward arrows represent excitation beams, while upward arrows represent tracking beams. The 
width of the downward arrows signifies the focal configuration (F/#), with the narrow arrows representing 
F/1.5 and the wide arrows representing F/3. Figures are not drawn to scale. 
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guaranteed that disease would be present in every DH pig; only 6 of the 26 DH arteries yielded plaques 
that could be imaged, and from these 6 arteries, 10 non-overlapping imaging FOVs, each containing 
plaques, were acquired. Similarly, 12 non-overlapping “control” data sets were taken from 5 NC arteries. 
Therefore, data from 11 harvested arteries were included in this study. 
Following ex vivo imaging, the upper tissue-mimicking phantom was removed, and a biologically 
inert carbon particle solution (undiluted Carbon Black Dispersate No. 8; Eberhard Faber, Bedminster, NJ, 
USA) was deposited from a 28-gauge syringe onto the exterior of the proximal arterial wall following the 
entire length of the transducer. While the carbon was being deposited, the needle was visualized with B-
mode to ensure that the particles were co-located with the imaging plane. Approximately 10 deposits were 
made along the imaging FOV. The nature of the carbon particles was such that they diffused into the 
outermost adventitial layers of the vessel, making a semi-permanent dark stain that remained even after 
formalin fixation. This stain served as the marker for the imaging plane, and all sectioning was performed 
using it as a reference. The carbon particles were both macroscopically visible during sectioning and 
microscopically visible after histological processing. 
5.2.3 Histology 
After imaging, arteries were removed from the pressurization apparatus and fixed in 10% 
buffered formalin. Using the macroscopically visible carbon markings, portions of the arteries 
corresponding to the imaging plane were cut out with a scalpel and embedded in paraffin for spatially 
matched histological analysis. The arteries were sectioned and stained with hematoxylin and eosin 
(H&E), Von Kossa (VK) for calcium, Lillie’s modified Masson's Trichrome (LMT) for collagen and 
fibrin, and Verhoeff-Van Gieson (VVG) for elastin. Slides containing the stained sections were digitized 
using an Aperio Scanscope (Aperio Technologies Inc., Vista, CA, USA) at 20× magnification. 
The microscopy images were then divided into four laterally adjacent, equally sized subsections 
spatially corresponding to four laterally adjacent, equally sized quarters in the ARFI images. A 
pathologist with experience in atherosclerosis then graded each subsection using the criteria established  
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by the American Heart Association (AHA) Committee on Vascular Lesions (Table 5.1). First, the 
pathologist graded plaque absence or presence on a 7-point scale, indicating the grade of the plaque when 
applicable (Table 5.2). If a plaque was present in a given subsection, the pathologist also graded the 
compositional and structural features of the plaque (including collagen deposition, calcium deposition, 
degradation of the IEL, the presence of lipid pools, and ﬁbrous caps) on 3- or 5-level scales (Table 5.2). 
The pathologist’s analysis was facilitated using a custom graphical user interface (GUI) developed in 
Matlab (Mathworks Inc., Natick, MA, USA). Table 5.3 lists the pathologist’s analysis for the entire data 
set, which shows the sample sizes in the gold standard used to assess performance. 
5.2.4 Reader Training 
All 110 parametric image sets (5 beam sequences × 22 non-overlapping arterial FOVs) were 
evaluated by 12 trained, blinded readers with varying backgrounds in biomedical imaging and levels of 
prior experience analyzing ARFI/SWEI images (ranging from less than one year (n = 7) to greater than 
ten (n = 1) years). Prior to beginning the study, each reader underwent a training regimen. The readers 
were given a handout that included a number of items: instructions on the reader graphical user interface  
Table 5.1: Classification system for atherosclerotic plaques established by the AHA 
Committee on Vascular Lesions. 
Type Plaque Composition 
I Isolated macrophage foam cells 
II Multiple foam cell layers formed, fatty streak 
III Pre-atheroma with isolated extracellular lipid pools 
IV Atheroma with confluent extracellular lipid core  
Va Fibroatheroma surrounded by fibromuscular tissue layers with lipid or necrotic 
core (sometimes classified as simply type V) 
Vb Calcification predominates (sometimes classified as Type VII) 
Vc Fibrous tissue changes predominate, absent/minimal lipid core (sometimes 
classified as Type VIII) 
VI Fissured, ulcerated, hemorrhagic, thrombotic lesion 
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(GUI), a brief tutorial on the manifestation of atherosclerosis, examples of images from previous studies 
with matched histology, and a table of expected responses of ARFI/SWEI parameters for each class of a 
plaque feature (Table 5.4).  
As part of the atherosclerosis tutorial, the readers were told that 1) plaques are generally fibrotic, 
2) calcium depositions tend to be focal, and 3) fibrous caps may develop on top of large lipid pools or 
necrotic regions. Furthermore, the readers were instructed to 1) make no assumptions of the number of 
plaques in an image, 2) assess each subsection independently of other subsections in an image set, and 3) 
make no assumptions about mutual exclusion of plaque features (e.g. if calcium is observed, this does not 
exclude the possibility of a lipid pool or any other feature). Table 5.4 was modeled after a cardiovascular 
MRI study [98] and modified to reflect ARF-based imaging characteristics. Response predictions for each 
category were assigned based on published vascular data with matched histology when possible 
Table 5.2: Rating system used by the pathologist. 
Rating 
Category Pathologist’s Rating Levels 
Plaque 
Detection 
Plaque Not 
Present Type I Type II Type III Type IV Type V Type VI 
Collagen 
Severe 
Decrease 
(>50%) 
Mild 
Decrease 
(<50%) 
No 
Change 
Mild 
Increase 
(<50%) 
Severe 
Increase 
(>50%) 
- - 
IEL Intact Somewhat Disrupted 
Heavily 
Disrupted - - - - 
Calcium None Low High - - - - 
Lipid Pool None Small Large - - - - 
Fibrous Cap None Small Large - - - - 
Ordinal Value 1 2 3 4 5 6 7 
*Ratings were done in a qualitative fashion, i.e. the ratings of “High” and “Low”, or “Large” and 
“Small”, were subjectively determined by the pathologist rather than being determined by a quantitative 
measurement. Ratings for collagen were made in regards to the “average” atherosclerotic plaque, e.g. a 
collagen rating of 2 indicates a mild decrease in the collagen levels relative to an average plaque as 
judged by the experience of the pathologist. Dashed vertical bars indicate where each rating system was 
dichotomized to perform ROC analysis (see ‘ROC Analysis’). Ordinal values that are used for statistical 
analysis are given at the bottom of the table. 
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[208]–[210]. In the cases where no published literature existed, grades were predicted from unpublished 
preliminary data collected by the authors. Readers were allowed to reference all training materials during 
the image evaluation without restriction.  
 
5.2.5 Reader Evaluation Study 
A custom GUI was developed to show the image sets in a random order to the reader and to save 
responses to the reader’s hard drive. Upon starting, the GUI loaded the first of 110 image sets displaying 
the full 2.1 cm FOV captured in each parametric image. The reader was then prompted to assign an 
overall image quality rating of 1 (“very bad”) to 5 (“very good”) to the set. This perceptual image quality 
value was later used as an exclusion criterion for reader responses (described further in the section titled  
Table 5.3: Number of plaque types and features as determined by the pathologist collapsed according to 
the dichotomization thresholds. Each entry represents the number of image subsections under each 
rating, with each row totaling 88 (22 arterial FOVs × 4 subsections/FOV), the total number of 
subsections rated by the pathologist. 
Rating Category True Negatives  True Positives 
Plaque Detection 
None, Type I - II Type III – V(a/b/c)* 
71 17 
Collagen 
No Plaque Present or Decreased 
Compared to Average Plaque 
Comparable or Increased Compared to 
Average Plaque 
65 23 
IEL 
Intact Degraded 
64 24 
Calcium 
Not Present Present 
82 6 
Lipid Pool 
Not Present Present 
73 15 
Fibrous Cap 
Not Present Present 
73 15 
*The pathologist could rate up to Type VI plaques, but no arteries in this study developed plaques of 
this type 
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“ROC Analysis”). Next, a black box outline was overlaid on the parametric images representing the first 
of four equally spaced subregions (-1.0 cm to -0.5 cm in the lateral dimension). The reader was then 
asked to assign a rating for plaque presence for the boxed subregion using a five-point scale: 1 (plaque 
definitely absent), 2 (plaque probably absent), 3 (unsure if plaque absent or present), 4 (plaque probably 
present), 5 (plaque definitely present). If the reader believed that a plaque was present in a given 
subregion, she/he was also asked to judge the compositional and structural elements of the plaque 
(including collagen deposition, calcium deposition, degradation of the IEL, the presence of lipid pools, 
and fibrous caps). After the reader finished rating the first subsection, the GUI moved the black box to the 
second of the four subregions (-0.5 cm to 0 cm in the lateral dimension), and the reader was again asked 
for a rating. This process continued until all four subregions of the image set were rated. Table 5.5 lists 
the rating system used by the readers and the ordinal numbers associated with each response. As 
mentioned previously, multiple matched acquisitions were taken. Two of the four acquisitions were 
selected for each image set and randomized across reader such that six readers read acquisition 1 and six 
readers read acquisition 2.  
Table 5.4: Expected ARF-induced responses of different plaque features in parametric 
images, presented to the reader as part of the training regimen. 
Tissue Classification PD RT SWV 
Collagen Deposition - -/0 + 
Disrupted IEL 0 + -/0 
Calcium Deposition - 0 + 
Lipid Pool/Necrosis +++ 0 - 
Fibrous Cap - -/0 + 
A ‘-’ indicates that the metric should be low relative to adjacent arterial tissue (i.e. peak 
displacement of calcium should be relatively low). A ‘+’ indicates that the metric should be 
high relative to adjacent arterial tissue (i.e. recovery time of a disrupted IEL should be 
relatively high). A ‘0’ indicates that the metric should remain unchanged. A ‘/’ is used to 
indicate a situation where two results may occur (i.e. recovery time with collagen deposition 
may be decreased, or may be unchanged). Multiple symbols, e.g. ‘+++’, indicate that the 
metric is expected to change substantially. 
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5.2.6 ROC Analysis 
The performance of different beam sequences to detect and materially characterize atherosclerotic 
plaques was evaluated using receiver operating characteristic (ROC) curve analysis, with area under the 
curve (AUC) used as a metric of performance. A detailed description of ROC calculation from ordinal 
reader responses is given in Section 5.6 along with an example from the data set. Briefly, the ROC 
analysis was performed by first dichotomizing the pathologist’s response into “case” (feature is present) 
and “control” (feature is absent) groups for each plaque feature. Next, frequencies of ordinal reader 
responses were organized along pathologist ratings of “case” or “control”. The “case” and “control” rows 
in this frequency table were then assumed to be discrete random variables latently distributed as normal 
distributions, and the parameters of these distributions were estimated with maximum likelihood 
estimation (MLE) and AUC values were calculated. Following the multi-reader methods of [39], 
Table 5.5: Rating system used by the readers. 
Rating Category Reader’s Rating Levels 
Plaque Detection 
Plaque 
Definitely 
Not 
Present 
Plaque 
Probably 
Not Present 
Unclear 
Plaque 
Probably 
Present 
Plaque 
Definitely 
Present 
- 
Collagen 
Definitely 
Not 
Present 
Probably 
Not Present Unclear 
Probably 
Present 
Definitely 
Present - 
Calcium 
Definitely 
Not 
Present 
Probably 
Not Present Unclear 
Probably 
Present 
Definitely 
Present - 
Lipid Pool 
Definitely 
Not 
Present 
Probably 
Not Present Unclear 
Probably 
Present 
Definitely 
Present - 
IEL Definitely Intact 
Probably 
Intact Unclear 
Probably 
Disrupted 
Definitely 
Present - 
Fibrous Cap Not Present 
Definitely 
Intact 
Probably 
Intact Unclear 
Probably 
Disrupted 
Definitely 
Disrupted 
Ordinal Value 1 2 3 4 5 6 
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summary ROC curves were created for sequences with the highest AUC values, and “optimal” operating 
points were chosen from the median summary curves to report sensitivity and specificity. The operating 
point was selected by maximizing the sum of sensitivity and specificity. Image sets that were rated by 
readers as having an image quality of “Very Bad” or “Bad” were excluded from the ROC analysis. ROC 
computation was performed using the R programming language and development environment (R 
Foundation for Statistical Computing, Vienna, Austria). 
To test for performance differences between beam sequences, pairwise Wilcoxon rank sum tests 
were performed on the resulting distributions of AUCs. To assess inter-reader variability for a given beam 
sequence and feature, pairwise Spearman’s rank correlation coefficients (SCC) were computed for every 
reader combination. Finally, to highlight the impact of reader experience, the AUC of Reader 1 (the most 
experienced reader in the study) was compared to the median AUC for a given beam sequence by 
subtracting the median from Reader 1’s AUC. 
5.3 Results 
The results for plaque detection are presented first, followed by the results for the five plaque 
components investigated for plaque characterization (calcium, lipid pools, fibrous caps, degraded IEL, 
and collagen). The responses of one reader were excluded from the results because she/he did not fully 
complete the evaluation. Finally, due to the large number of beam sequences and plaque features, ROC 
curves are not shown for brevity. 
5.3.1 Plaque Detection 
Figure 5.3(a) shows boxplots of AUC and SCC for plaque detection across all five beam 
sequences. SP3-SRx yielded the highest median AUC (0.899) for plaque detection, followed by SP1.5-
ParRx (0.854). Summary ROC curve analysis for this sequence showed an optimal operating point 
corresponding to a sensitivity of 0.847 and a specificity of 0.791. The two LatRx sequences (SP3-LatRx 
and SP1.5-LatRx) had the two lowest median AUCs (0.771 and 0.758, respectively), but had large IQRs 
and were not statistically different from SP3-SRx, the highest median AUC sequence. Mean shear wave 
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group velocity was 6.6 ± 1.1 m/s (range: 4.4 – 8.1 m/s) in control arteries, and 6.7 ± 2.6 m/s (range: 4.0 – 
13.2 m/s) in disease arteries. SP3-SRx also had the highest SCC between readers with a median value of 
0.583.  
It is important to note that the dichotomization threshold used for the plaque detection ROC 
analysis was Type III plaques (i.e. plaques rated as Type I or Type II were counted as true negatives). 
Therefore, the AUCs reported in Figure 5.3(a) are only valid for plaques of Type III (pre-atheroma) and 
above. Performance was compromised when the threshold was set to include Type I (isolated macrophage 
foam cells) and Type II (fatty streaks) plaques, with the highest median AUC dropping to 0.612. This 
suggests that beam sequences used in this study do not perform well at detecting the earliest stages of 
plaque formation.  
5.3.2 Plaque Characterization 
The median beam sequence AUCs for calcium detection ranged from 0.914 to 0.779 (Figure 
5.3(b)). SP1.5-LatRx had the highest median AUC of 0.914, but was also seen to have a high IQR, and 
was not statistically different from any of the other sequences. SP3-SRx had the second highest median 
AUC of 0.892, but had a much smaller IQR and was statistically different from SP3-ParRx (p < 0.009). 
The summary ROC curve for SP3-SRx showed generally high performance for calcium detection, with an 
optimal operating point for the “average” reader at 0.964 sensitivity and 0.852 specificity. The median 
(25th and 75th percentiles) SCC across all sequences was 0.56 (0.36 - 0.66). The AUCs for Reader 1 were, 
on average, substantially lower than the medians for each beam sequence (by 19.6 percentage points). 
Reader 1’s AUC with SP3-SRx (52.0 percentage points lower than the median), was a considerable 
outlier despite the sequence having the highest median AUC for calcium detection across all the readers. 
Examples of plaques with calcium are shown in Figure 5.4(a) and (b).  
The median beam sequence AUCs for lipid pool detection ranged from 0.888 to 0.726 (Figure 
5.3(c)). SP3-SRx had the highest median AUC of 0.888 and was statistically different from SP1.5-LatRx 
(p < 0.04). The summary ROC curve for SP3-SRx lipid pool/necrotic core detection showed an optimal  
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Figure 5.3: Boxplots of AUC and SCC vs. beam sequence for plaque detection and individual 
plaque features: calcium, lipid pool, fibrous cap, degraded IEL, and collagen deposition. 
Whiskers represent the highest and lowest data points still within 1.5 IQR, and outliers are 
depicted with circles. AUC value of the most experienced reader is indicated with an ‘x’. 
Letters ‘a’ through ‘g’ are used to indicate statistical differences (α = 0.05), where each letter 
identifies the sequence for comparison (a = SP3-SRx, b = SP1.5-ParRx, c = SP3-ParRx, d = 
SP1.5-LatRx, e = SP3-LatRx). Sequences marked with multiple letters were statistically 
different from multiple sequences. 
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operating point for the “average” reader at 0.797 sensitivity and 0.857 specificity. The median (25th and 
75th percentiles) SCC across all sequences was 0.56 (0.39 - 0.67). The AUCs for Reader 1 were, on 
average, slightly lower than the medians for each beam sequence (8.8 percentage points). Examples of 
plaques with lipid pools are shown in Figure 5.4(a) and (b). 
The median beam sequence AUCs for fibrous cap detection ranged from 0.916 to 0.721 (Figure 
5.3(d)). SP3-SRx had the highest median AUC of 0.916, followed by SP1.5-ParRx with a median AUC of 
0.825. The SP3-SRx sequence was statistically different from every other sequence (p < 0.03) except 
SP3-LatRx. The summary ROC curve for SP3-SRx showed an optimal operating point for the “average” 
reader at 0.855 sensitivity and 0.819 specificity. The median (25th and 75th percentiles) SCC across all 
sequences was 0.50 (0.32 - 0.64). The AUCs for Reader 1, as with lipid pools, were, on average, slightly 
lower than the medians for each beam sequence (by 5.9 percentage points).  
The median beam sequence AUCs for degraded IEL detection ranged from 0.889 to 0.692, with 
SP3-SRx having the highest median AUC (Figure 5.3(e)) and being statistically different from SP1.5-
LatRx. The corresponding summary ROC curve for the “average” reader using a SP3-SRx sequence 
revealed a sensitivity of 0.916 and specificity of 0.754 for detecting degraded IEL. The median (25th and 
75th percentiles) SCC across all sequences was 0.49 (0.34 - 0.63). The AUCs for Reader 1 varied 
considerably around the corresponding median AUC value for each beam sequence. For SP1.5-LatRx, 
Reader 1’s AUC was very high, 0.986 (29.3 percentage points higher than the median), but low for SP3-
SRx, 0.603 (20.2 percentage points lower than the median). An example of a plaque with a degraded IEL 
and heavy collagen deposition is shown in Figure 5.4(c). 
The median beam sequence AUCs for collagen deposition detection ranged from 0.832 to 0.726 
(Figure 5.3(f)). SP1.5-ParRx had the highest median AUC but was followed closely by SP3-SRx, and 
SP3-ParRx, all of which were statistically different from the lowest median AUC sequence (SP1.5-
LatRx). The summary ROC curve for SP1.5-ParRx showed an optimal operating point for the “average” 
reader at 0.784 sensitivity and 0.765 specificity. The median (25th and 75th percentiles) SCC across all 
sequences was 0.54 (0.38 - 0.65). The AUCs for Reader 1 were, on average, slightly lower than the  
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Figure 5.4: Three examples of ARFI images with matched histology. Stains include hematoxylin and 
eosin (H&E) (shown in (a.1), (b.1), and (c.1)); Lillie’s modified Masson's trichrome (LMT) staining 
collagen blue (shown in (a.2), (b.2), and (c.2)); Von Kossa (VK) staining calcium black (shown in 
(a.3) and (b.3)); and Verhoeff-Van Gieson (VVG) staining elastin black (shown in (c.3)). Black 
arrows are used to indicate plaque features (C = calcium, L = lipid, F = fibrous cap or fibrosis). In (a), 
an advanced Type Vb atheroma is seen with a large calcium deposit located to the left part of a lipid 
pool. In (b), an advanced type Vb atheroma is seen with a large calcium deposit underneath a small 
lipid pool and fibrous cap. In (c), a type IV plaque is shown with significant collagen deposition and 
degradation/duplication of the IEL.   
85 
medians for each beam sequence (6.1 percentage points). Reader 1’s AUCs for SP1.5-LatRx and SP3-
LatRx were the furthest from the median, at 10.1 and 16.9 percentage points lower, respectively. 
 To give the results of this study context to the field of atherosclerosis imaging, ARFI 
performance numbers (ex vivo in porcine femoral arteries) are loosely compared in Table 5.6 to published 
numbers for two other non-invasive atherosclerosis imaging modalities where the data was taken in vivo 
in human carotid arteries: MRI, and X-ray CT [3], [248].  
5.3.3 Image Exclusions  
Out of 1210 image set readings (22 arteries × 5 beam sequences × 11 readers), 432 were excluded 
by reader assessment of perceptual image quality, resulting in an overall exclusion fraction of 0.357. 
Figure 5.5(a) shows the image exclusion fraction by artery. The median exclusion fractions for control  
Table 5.6: Comparison of ARF beam sequence sensitivity and specificity for plaque detection and 
characterization (measured ex vivo in porcine femoral arteries under simulated in vivo conditions) versus 
published sensitivity and specificity for MRI and CT (measured in vivo in human carotids) [3], [248].  
 ARF-Based Ultrasound CT MRI 
 (Ex vivo, procine femoral) (In vivo, human carotid) 
 Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity 
Detection       
Type III-Va,b,c 85% 79% - - 80-84% 90-98% 
Type unreported - - 88-95% 90-96% - - 
       
Characterization       
Calcium 96%* 85%* 100% 100% 76-80% 86-94% 
Lipid/necrotic 80%* 86%* 76% 74% 91-98% 65-100% 
Fibrous cap 86%* 82%* - - 81% 90% 
Degraded IEL 92%* 75%* - - - - 
Collagen 78%† 77%† 86% 94% - - 
Values marked with ‘*’ are reported from SP3-SRx sequence results. Values marked with ‘†’ are reported 
from SP1.5-ParRx sequence results. 
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and diseased arteries were similar, at 0.309 and 0.400 respectively, and these groups were not statistically 
significantly different (p > 0.11). Figure 5.5(b) shows the image exclusion rate by reader. The median 
exclusion fractions for readers with greater than one year of experience and less than one year of 
experience were substantially different, 0.109 and 0.455 respectively, and these groups were statistically 
significantly different (p < 0.02). Figure 5.5(c) shows the image exclusion rate by beam sequence. SP3-
LatRx had the highest exclusion fraction (0.628), while the SP1.5-ParRx had the lowest exclusion fraction 
(0.128).  
5.4 Discussion  
Comparing the distributions of AUC values achieved by the readers (Figure 5.3), a number of 
observations can be made about the performance of different beam sequences for detecting and materially 
characterizing atherosclerotic plaques. Overall, the F/# of the excitation pulse did not have much of an 
impact on readers’ AUCs for plaque detection or characterization. A large F/# excitation when tracking 
within the ROE could be beneficial for two reasons: first, the shearing in the tracking resolution cell 
would be reduced, improving displacement underestimation [230]; and second, the axial range over which 
 
Figure 5.5: Image exclusion results. (a) Fractional image exclusion rate versus artery. The exclusion rate 
for control arteries was not statistically different (p > 0.11) from the exclusion rate for disease arteries. (b) 
Fractional image exclusion rate versus readers. The exclusion rate for readers with less than 2 years of 
experience was statistically higher from the exclusion rate for readers with greater than 2 years of 
experience (p < 0.02). Note that Reader 1 was the most experienced reader and had the lowest fractional 
exclusion rate, 0.007. (c) Fractional image exclusion rate versus beam sequence. 
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the displacement is constant would be increased [241]. In this study though, there was no statistically 
significant differences in AUC performance for plaque detection or component characterization between 
the F/1.5 and F/3 parallel-receive tracking sequences (SP1.5-ParRx and SP3-ParRx). In combination with 
displacement tracking lateral to the region of excitation to observe shear wave propagation, F/1.5 and F/3 
also did not have statistically different AUCs. Similar to the within-ROE tracking case, a larger F/# with 
lateral tracking could be advantageous because it would increase the axial range over which the shear 
wave is travelling parallel to the arterial wall. The lateral time-to-peak algorithm used to measure shear 
wave group velocity in this study assumed that the shear waves propagate parallel to the lateral 
dimension, an assumption more quickly violated with a more focused excitation [189]. In this study 
though, axial range likely was not a factor because none of the plaques exceeded ~2 mm in thickness, 
which could explain the lack of statistical differences in AUCs between F/1.5 and F/3. 
 The investigation of different tracking methods centered on two main questions: 1) what is the 
impact on performance of single versus parallel-receive tracking and 2) what is the performance of shear 
wave tracking lateral to the region of excitation? Parallel-receive tracking (ParRx), in which four tracking 
lines are simultaneously beamformed in positions centered around the region of excitation (ROE), results 
in slightly poorer lateral resolution and CNR relative to single-receive tracking (SRx) [242], [249]. This 
loss of resolution is attributable to both the widening of the tracking point spread function (PSF) and the 
increased beam spacing with fewer ARF excitations that, ultimately, could negatively affect the detection 
of small, focal features, such as small calcifications. Despite these drawbacks, the readers achieved 
comparable AUCs with parallel-receive sequences as compared to the single-receive sequences; for lipid 
pools, degraded IEL, and collagen neither SP1.5-ParRx nor SP3-ParRx was statistically different from 
SP3-SRx, the highest median AUC sequence, and for calcium and overall plaque detection, only one of 
the two parallel-receive sequences was statistically lower. Only in the case of fibrous caps were both 
parallel-receive sequences statistically significantly lower than SP3-SRx. Given that single-receive 
tracking did not appear to have a large impact on reader AUC, parallel-receive tracking may be favored 
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due to the factor of four reduction in incident acoustic energy and up to a factor of four increase in frame 
rate.  
For lateral receive tracking, the results of this study showed that in the case of calcium, a stiff 
material, AUCs were not statistically significantly different from the sequence with the highest sensitivity 
and specificity. However, in the case of lipid pools, a soft material, the LatRx sequences exhibited 
relatively low AUC performance. Lipid pools are generally comprised of water, phospholipids, 
cholesterol monohydrate (present as plate-like crystals), and cholesterol esters (present as oils) [250], 
[251], and exist in either liquid or liquid-crystalline form, which may not support shear wave propagation. 
Therefore, poor LatRx performance in lipid regions may be related to inhibited shear wave propagation 
through the lipid region. Further studies are needed to understand the shear wave dynamics in such media. 
While the AUC results presented in this study may indicate that SWV images yielded lower 
sensitivity and specificity, the sequence implementation must be taken into careful consideration. In both 
LatRx sequences, the FOV was significantly reduced compared to the within-ROE sequences due to two 
design choices. First, to measure SWV with more accuracy, a sliding window of ~3 mm (laterally) was 
used, meaning that 1.5 mm was lost from the left and right edges of the image from windowing. Second, 
the ROE, which was located in the center of the FOV in this case, was not moved during the sequence 
and, consequently, no SWVs were measured within it, reducing the FOV by an additional 2-3 mm. On top 
of the FOV reduction, the LatRx image sets were seen to have smaller magnitude displacements achieved 
away from the region of ARF excitation (due to high levels of shear wave attenuation), yielding noisy 
velocity measures near the edges of the image. As derived from the Cramér-Rao Lower Bound [223], the 
magnitude of jitter error for the imaging parameters used in this study was estimated to be ~0.75 µm 
(assuming 50% fractional bandwidth, 0.999 correlation coefficient, and 30 dB SNR). In the LatRx data, 
displacements at the edges of the image (8 mm laterally from the ROE) were measured to be ~1 µm, 
suggesting that the SWV values plotted on the edge of the FOV were calculated from displacement just 
above the absolute lower bound of the displacement tracking algorithm. Finally, it should be noted that 
shear wave reflections and the irregular boundary conditions created by the lesions may have impacted 
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the time-to-peak estimates (and consequently the SWV measurements) drastically [252]. More 
sophisticated shear wave excitation techniques such as supersonic shear imaging (SSI) or signal 
processing techniques such as directional filtering could have improved the LatRx images and 
subsequently the AUCs achieved by the readers with these sequences [187], [195], [253]. 
It is interesting that, while the mean shear wave group velocity between control and diseased 
arteries was not statistically different, the standard deviation and range of group velocities was larger for 
diseased arteries. Direct artery-to-artery comparisons of SWVs can be confounded by variables such as 
pre-tension [254] and wall thickness [195], therefore an in-depth analysis of SWV as it pertains to plaque 
detection and material and structural characterization was outside the scope of this manuscript. 
Table 5.6 shows a comparison of the sensitivities and specificities of the highest median AUC 
sequence to two other non-invasive atherosclerosis-imaging modalities, MRI and CT. While the ARF-
based approaches described here interrogate the mechanical properties of arteries to delineate plaque, 
MRI evaluates the nuclear magnetic resonance properties, and CT exploits x-ray attenuation properties 
[255]. Another important difference between the ARFI, MRI and CT data presented in Table 5.6 is that 
the CT and MRI performance numbers are reported for in vivo human carotid arteries, while the ARFI 
numbers are reported for ex vivo porcine femoral arteries under simulated in vivo imaging conditions. 
Therefore, the comparison in Table 5.6 is shown simply to give the results in this study context to the 
field of non-invasive atherosclerosis imaging and highlight the current state of the art. CT performs well 
for hard features (calcium, collagen), but does not do as well for soft features (lipid pools), while MRI has 
the reverse trend, leading experts [3] to conclude that MRI may be more promising to stratify the 
vulnerability of a plaque to rupture. Comparing the performance numbers for ARFI, it appears that ARFI 
is most sensitive to calcium deposits, but is also generally sensitive to soft components such as lipid 
pools. ARFI also had high sensitivity for detecting degraded IEL, which was particularly interesting 
because this feature is not currently detectable by other imaging modalities. As noted previously [210], 
degradation of the IEL appears to change the elastic properties of the arterial wall substantially. 
Therefore, although the actual feature is far below the resolution of the imaging system, the IEL’s impact 
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on mechanical properties is detectable and could prove to be an important advantage of using ARF-based 
elastography techniques.  
On average, the inter-reader agreement across all beam sequences and plaque features in this 
study was moderate. The median SCCs ranged from 0.641 (SP3-SRx, lipid pools) down to 0.390 (SP3-
LatRx, fibrous caps), with generally large IQRs across all sequences. As expected from the high AUC 
values, SP3-SRx had the best inter-reader agreement, with SCCs being statistically higher than most other 
sequences for any given feature (in the case of lipid pools and fibrous caps, SCCs for SP3-SRx were 
statistically higher than all other sequences). The variability of the SCCs was most likely a consequence 
of the range of experience levels between the readers, with seven out of the eleven readers having never 
seen an ARFI image before the training regimen. For these readers, the training regimen was largely 
responsible for their performance, and readers had to rely heavily on the guidance table (Table 5.4) when 
interpreting images. Since ARF-based atherosclerosis imaging is a relatively new field, the training set 
was limited to one or two examples of each compositional element with one or two beam sequences. 
Providing training that is more comprehensive for the readers would likely improve the readers' ability to 
accurately characterize atherosclerotic plaques and reduce inter-reader variability.  
Another interesting observation regarding reader experience was that the most experienced 
reader, Reader 1, had an equal or lower AUC than the median for most beam sequence and plaque feature 
combinations (Figure 5.3). One explanation for this phenomenon is that Reader 1 rated more of the “poor 
quality” images than the inexperienced readers, and therefore had a more challenging task. As seen in 
Figure 5.5(b), the experienced readers had a significantly lower exclusion rate compared to the 
inexperienced readers; in fact, out of the experienced readers, Reader 1 had the lowest exclusion rate, 
excluding only 1 out of 110 images. This suggests that as a reader gains experience, she/he is able to 
make relatively accurate assessments on images that an inexperienced reader would not be able to read. 
It would be expected that in vivo sensitivity numbers may initially be poorer than those reported 
in this study due to a number of physiological challenges (motion artifact, intraluminal pressure variation, 
oblique imaging perspectives, increased imaging depths in obese patients, etc.), but with the development 
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of real time ARFI imaging solutions [244], clever beam sequencing [243], [256], and improvements to 
motion filtering [221], [222] equal or better sensitivities may be achievable.  
Finally, due to the extreme complexity and heterogeneity of the atherosclerotic disease process, a 
larger study than this would provide the possibility of performing a more robust statistical analysis of 
detection of all compositional elements. The arteries included in this analysis provided a broad spectrum 
of atherosclerotic manifestations, but a wide range of possibilities was not represented. For example, this 
analysis did not include arteries with intra-plaque hemorrhage or ruptured plaques, preventing any 
assessment of beam sequence performance for detecting thrombus formation. A recent review concluded 
that thrombi forming at the sites of plaque rupture have an important role in promoting the rapid 
progression of the underlying lesion which can lead to future ischemic events [11]. Therefore, 
performance for detecting thrombus and plaque hemorrhage should be assessed. This study also did not 
quantify the effect of lesion size on reader performance. It has previously been shown that the resolution 
limit of transcutaneous ARFI ultrasound is generally between 0.5 to 1.0 mm, depending on the imaging 
parameters used and the underlying mechanical properties of tissue [257]. These numbers though, were 
derived from experiments done in phantoms and porcine liver, so their pertinence to heterogeneous tissue 
such as atherosclerotic plaque is unclear. Quantifying the resolution limits of ARFI on features and 
structures in plaques is further explored in Chapter 7. 
5.5 Conclusion 
Based on the sensitivity and specificity numbers calculated in this ex vivo study, ARF-based 
ultrasound has been demonstrated to be relevant for detecting type III and higher plaques in peripheral 
vasculature, and for characterizing plaque features such as calcium and collagen deposits as well as lipid 
pools and fibrous caps (the latter two features being linked to plaque vulnerability). This study also 
showed that ARFI is relevant for detecting degraded IEL, while no other imaging method has been 
demonstrated in this regard. As such, degraded IEL detection may prove to be a significant advantage of 
ARF-based imaging. Furthermore, this study demonstrated that 1:1 single-receive tracking yielded the 
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highest median AUC values for plaque detection and for delineating all of the compositional elements 
evaluated. In many cases though, AUCs from the 4:1 parallel-receive sequences were comparably high 
and not statistically significantly different from the single-receive tracking sequence, suggesting these 
sequences may be preferred for in vivo application due to their improved frame rate and lower energy 
requirements. ARF-based imaging modalities are relatively facile, as even relatively unskilled readers 
achieved high performance marks, but more extensive reader training may improve AUC values further. 
Overall, these results add to the growing body of evidence that suggests ARF-based imaging is relevant to 
detecting plaques and describing their composition and structure with potential application to diagnosis, 
monitoring, and assessment of lipid lowering treatment efficacy. 
5.6 Addendum 
5.6.1 ROC Calculation 
The general setting and notation of the ROC calculation can be described as follows. There are I 
blinded readers involved, indexed by i = 1, 2, … , I; J images involved, indexed by j = 1, 2,… , J; and K 
subsections involved, indexed by k = 1, 2, … , K, that represent the number of sections into which each 
image is broken. The value Xi,j,k will represent the evaluation of the ith reader on the kth subsection of the 
jth image. On the histological side, a similar labeling scheme is used; Yj,k denotes the histological 
evaluation on the kth section of jth image, which represents the gold standard. For this study, one 
pathologist was recruited to read the gold standard histology slides so the ith indexing is omitted for 
simplicity for Y. 
Recall from the section titled “Reader Evaluation Study”, each reader rated features on a graded 
scale that has a naturally increasing order (e.g. “Definitely Not Present”, “Probably Not Present”, 
“Unclear”, “Probably Present”, “Definitely Present”). To represent these rating levels numerically, each is 
assigned a monotonically increasing integer; the possible values of Xi,j,k are 1, 2, …, n, where a value of 1 
is equivalent to a “Definitely Not Present” response, a value of 2 is equivalent to a “Probably Not 
Present” response, etc. Similarly, the pathologist’s ratings, Yj,k, are represented numerically as 1, 2…, m. 
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It is important to note that values of m and n (i.e. the maximum possible value for Yj,k and Xi,j,k, 
respectively) are not necessarily the same, and depend on the feature that is being rated (e.g. for calcium, 
m = 3 and n = 5). 
To begin the ROC calculation, all pairs of (Xi,j,k , Yj,k) are organized into an m-by-n frequency 
table, which represents the histogram of reader responses given the corresponding histological responses. 
Next a threshold, t, is chosen on Yj,k to dichotomize the m levels of the gold standard into “control” and 
“case” classes. In other words, a Yj,k value less than or equal to t means the kth section of the jth image does 
not have the feature in question; whereas a Yj,k value greater than t means the kth section of the jth image 
does have the feature present. After dichotomization, the m-by-n table becomes a 2-by-n table. 
Following Ch. 4.2.2 of [258] the two rows of the frequency table are considered as two discrete 
random variables latently distributed as normal distributions (referred to as Z1 and Z2 for “control” and 
“case” respectively), whose parameters can be determined with maximum likelihood estimation (MLE). 
The correspondence between the discrete Xi,j,k distribution and the continuous normal distributions is 
described by n-1 parameters, or cuts, (referred to as c1, c2, …, cn-1) which can take on any value between -
∞ to ∞. Without loss of generality, Z1 can be assumed to have zero mean (μ1 = 0) and standard deviation 
of 1 (σ1 = 1) by rescaling the n-1 cuts appropriately. This assumption does not change the discrete 
probability mass distribution of Xi,j,k, and consequently, Z2 can be described as a function of μ2, σ2, c1, c2, 
…, cn-1, and solved for by maximizing the log-likelihood function: 
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where ),;( σµxΦ is the cumulative distribution function (CDF) of the normal distribution, and the Em,n 
variables represent the frequency counts of reader responses. The resultant parameter estimates are 
denoted as (?̂?2, 𝜎�2, ?̂?1,…, ?̂?𝑛−1) and from these parameters a continuous ROC curve can be drawn based 
on ?̂?2 and 𝜎�2. 
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 Note that this statistical analysis assumes all subsections as independent, but, due to the study 
design, not all subsections are truly independent from each other. Although readers were asked to rate 
each subsection independently of any other subsection, readers viewed each arterial segment in its 
entirety while rating each of the four individual subsections. This means that there is an inherent 
correlation structure in the reader response data, as readers most likely rated plaques based on information 
from adjacent subsection. Therefore, the rational for assuming independence needs to be justified as this 
assumption was made in this study. 
Mathematically, the correlation structure between subsections in an MLE operation would be 
represented as follows (in a simple example where MLE is being used to estimate the mean, μ, from some 
number of observations, {𝑌𝑖}𝑖=1𝑛 ): 
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The center matrix represents the “correlation structure” between 4 subsections viewed simultaneously. 
Unfortunately, quantifying the true correlation structure in a study where human observers are looking at 
images is difficult because each reader combines information in a unique and subjective way. In the ROC 
analysis presented in this manuscript, the correlation structure matrix is set to the identity matrix to 
indicate observations are independent from each other. Statistical theory indicates that using the identity 
matrix (i.e. assuming independence) can still achieve a consistent estimate of 𝜇2 and 𝜎2 (if the true 
correlation structure was known, the estimate of 𝜇2 and 𝜎2 would be consistent and efficient), as the 
correlation structure mostly affects more subtle statistics like the variance of ?̂?2 and 𝜎�2 [259]. 
5.6.2 ROC Example 
To demonstrate these methods, the AUC will be calculated for Reader 5 using beam sequence 
SP3-ParRx to identify lipid pools. The m-by-n frequency table depicting reader response vs. pathologist 
response is as follows (Note: Reader 5 rated one image set as having “Bad” image quality, so responses 
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for only 84 subsections are given, out of a maximum of 88): see Table 5.7. The next step is to 
dichotomize the pathologist’s responses. In the case of lipid pools, the pathologist used a 3-point scale (1 
– no lipid pool, 2 – small lipid pool, and 3 – large lipid pool), and the threshold was chosen such that t > 
1, indicating that both small and large lipid pools would be counted as “positives”, as shown in Table 5.8. 
 Finally the distributions Z1 and Z2 are estimated; μ1 and σ1 are assumed to be 0 and 1 respectively, 
and ?̂?2 and 𝜎�2 are calculated to be 4.52 and 2.57, respectively, from MLE. These distributions are 
depicted graphically in Figure 5.6(a). Note that the area under the ROC curve (AUC) can be computed at 
this point without actually plotting the ROC curve itself as the AUC is defined as the P(Z2 > Z1). Once the 
distributions are known, a continuous ROC curve can be plotted by sliding the decision threshold 
(indicated by a vertical line in Figure 5.6(a)), and computing the false positive rate (FPR, the x-axis of the 
ROC curve) and the true positive rate (TPR, the y-axis of the ROC curve). The FPR is given as the 
probability that Z1 is greater than the decision threshold, while the TPR is given as the probability that Z2 
is greater than the decision threshold. The continuous ROC curve is depicted in Figure 5.6(b), with an 
AUC value of 0.95. 
Table 5.7: Reader response for lipid pools versus pathologist response. 
 Reader 5 response 
Pathologist Response  Def. Not Pres. (X=1) 
 Prob. Not Pres. 
(X=2) 
 Unclear 
(X=3) 
Prob. Pres. 
(X=4) 
 Def. Pres. 
(X=5) 
None (Y=1) 42 15 0 12 0 
Small (Y=2) 1 0 0 8 1 
Large (Y=3) 0 0 0 5 0 
 
Table 5.8: Reader response for lipid pools versus dichotomized pathologist response. 
 Reader 5 response 
Pathologist Response  Def. Not Pres. (X=1) 
 Prob. Not Pres. 
(X=2) 
 Unclear 
(X=3) 
Prob. Pres. 
(X=4) 
 Def. Pres. 
(X=5) 
None (Y=1) 42 15 0 12 0 
Small or large (Y=2,3) 1 0 0 13 1 
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Figure 5.6: Example of ROC curve calculation. (a) Estimated normal distributions representing the 
variables “control” (Z1) and "case" (Z2) which depict Reader 5’s responses for lipid pools using SP3-
ParRx. For the Z1 distribution, the mean (μ1) and standard deviation (σ1) were assumed to be 0 and 1 
respectively. For the Z2 distribution the mean and standard deviation were estimated by maximum 
likelihood estimation (MLE) as follows; ?̂?2 = 4.52 and 𝜎�2 = 2.57. The vertical line represents one possible 
decision threshold and the corresponding regions of the two distributions are labeled accordingly (TN – 
true negative, FN – false negative, FP – false positive, TP – true positive). An ROC curve is computed by 
sliding the decision threshold along the X-axis to compute both false positive rate (FPR) and true positive 
rate (TPR). (b) Corresponding ROC curve depicting Reader 5’s performance using beam sequence SP3-
ParRx to identify lipid pools. The result for the reader is depicted as a solid line, while the result for a 
random classifier is depicted as a dashed line. The discrete operating points (estimated with MLE) are 
depicted as square boxes plotted on top of the reader curve. In this case, the area under the curve is 0.95. 
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CHAPTER 6 
 ARFI-Derived Carotid Plaque Stiffness Measurements Compared with Histology I: 
Preliminary Results 
 
The following chapter presents in vivo ARFI images taken from four patients undergoing 
clinically indicated carotid endarterectomy and compared to histology in case-study format. In two type 
Va plaques, characterized by lipid/necrotic cores covered by fibrous caps, mean ARFI displacements in 
focal regions were high relative to the surrounding plaque material, suggesting soft features covered by 
stiffer layers within the plaques. In two type Vb plaques, characterized by heavy calcification, mean ARFI 
peak displacements were low relative to the surrounding plaque and arterial wall, suggesting stiff tissue. 
These initial results demonstrate the feasibility and challenges of transcutaneous ARFI for characterizing 
the material and structural composition of carotid atherosclerotic plaques via mechanical properties, in 
humans, in vivo. 
6.1 Introduction 
As described previously, stroke is one of the leading causes of death and long-term disability in 
the United States. It is estimated that 87% of all strokes are related to ischemia secondary to 
atherosclerotic disease with 15-20% attributable to plaques located in the carotid arteries [260]. Degree of 
carotid stenosis is a standard metric in the evaluation of cerebrovascular risk and, as of today, is one of 
the most valued parameters used to guide the course of medical treatment in the clinic [261]. In 
   
© 2015 Elsevier. Portions reprinted, with permission, from T. J. Czernuszewicz, J. W. Homeister, M. C. Caughey, 
M. A. Farber, J. J. Fulton, P. F. Ford, W. A. Marston, R. Vallabhaneni, T. C. Nichols, and C. M. Gallippi, “Non-
invasive in Vivo Characterization of Human Carotid Plaques with Acoustic Radiation Force Impulse Ultrasound: 
Comparison with Histology after Endarterectomy,” Ultrasound Med. Biol., vol. 41, no. 3, pp. 685–697, 2015. 
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asymptomatic patients with high grade stenosis, it has been shown that prophylactic carotid 
endarterectomy (CEA) can reduce the absolute risk of stroke by ~5% as compared to medical 
management [61]. Based on these numbers though, 20 patients must undergo CEA to prevent one stroke, 
and potential non-stroke complications in CEA patients such as myocardial infarction or cranial nerve 
injury could reduce quality of life. Some have even questioned the applicability of these data to today’s 
patients given the significant improvements in pharmaceutical therapies, e.g. statins, anti-hypertensives, 
etc., and reduction in smoking rates [62], [63]. Current estimates suggest that only 5% of patients with 
asymptomatic carotid stenosis will benefit from prophylactic CEA [62]. Therefore, there is a great need 
for an improved method of predicting which patients are at high risk for stroke to enhance the benefit and 
cost-efficacy of CEA (as well as other interventions).  
Many have argued that plaque vulnerability based on plaque structure and composition is a more 
appropriate biomarker, compared to luminal stenosis, for predicting future thromboembolic events [19]. 
Vulnerable plaque has been studied extensively in the coronary arteries [2]. For carotid arteries, the 
literature is somewhat sparser, but it has been shown that the same general compositional elements 
correlate with plaque instability, i.e. thin fibrous cap, large lipid/necrotic core, and dense macrophage 
infiltrate [38]. Although the mechanisms are not completely understood and may include destabilizing 
effects of matrix metalloproteinases [262] and endothelial cell apoptosis [263], it is thought that at least 
one of the reasons these compositional elements confer a higher risk for rupture is that the softer plaque 
components (e.g. lipids, inflammation, etc.) significantly increase the local circumferential stress 
experienced by the fibrous cap [26]. When local stresses exceed the ultimate stress (i.e. maximum stress 
at failure), plaque rupture occurs, and an ischemic event is likely to follow. The “critical” fibrous-cap 
thickness in carotid plaques, based on CEA specimens, has been reported as a minimum thickness of 
<200 µm and a representative/average thickness of <500 µm, which is higher than the <65 µm critical 
thickness reported in coronary arteries [21]. 
A relatively new approach to characterizing material properties of arteries with ultrasound has 
been the use of elasticity imaging. Unlike conventional B-mode ultrasound, which generates images of 
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the acoustic properties of tissue, elasticity imaging generates images of the mechanical properties of 
tissue. Typically, these methods work by measuring a strain that is the result of either an intrinsic (e.g. 
cardiac pulsation) or extrinsic (e.g. ARFI) stress. In ARFI imaging, which is the focus of this current 
work, radiation-force impulses are generated by a commercially available ultrasound scanner to focally 
displace tissue (on the order of 1-10 µm). The resulting displacements in the region of excitation (ROE) 
are monitored with correlation-based motion tracking methods and used to qualitatively infer tissue 
stiffness, which indicates plaque composition. Although the numbers vary widely in the literature, studies 
on the mechanical properties of atherosclerotic plaques have shown significant differences in the radial 
Young’s modulus of various plaque components suggesting applicability of elasticity imaging; in Lee et 
al. [140] calcified tissue was shown to be significantly stiffer (~354 kPa) than non-fibrous (~41 kPa) or 
fibrous tissue (~81 kPa), whereas lipid/necrotic tissue has been estimated to be the softest component (~1 
kPa) by other groups [29], [141].  
Although ARFI has begun to be translated to in vivo settings in humans, these preliminary 
experiments were not performed with histological validation. The goal of this study is to compare ARFI 
images of human carotid plaques taken in vivo to CEA specimens characterized histologically and test the 
hypothesis that ARFI can be used to characterize human carotid plaque, in vivo. In this chapter, data is 
presented from a select few patients and analyzed qualitatively in a case-study format. In subsequent 
chapters, ARFI performance for identifying features is assessed quantitatively across a larger patient pool. 
6.2 Methods  
6.2.1 Patients 
Data sets were obtained from eight patients scheduled for CEA in an on-going clinical study 
(ClinicalTrials.gov number, NCT01581385) at the University of North Carolina (UNC) at Chapel Hill. 
Selected subjects either had symptomatic carotid artery disease with a stenosis or lesion in the carotid 
artery thought to be the source of emboli, or asymptomatic carotid artery disease with a >60% internal 
carotid artery (ICA) stenosis. Carotid duplex ultrasounds were performed by the IAC-accredited UNC 
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Peripheral Vascular Lab (PVL) as part of the patients’ standard medical care. The degree of stenosis was 
determined with an internally validated velocity profile criteria (Table 6.1). Subjects were considered 
symptomatic if they had a history of amaurosis fugax, transient ischemic attack (TIA), or minor (non-
disabling) stroke referable to the carotid artery distribution. Institutional review board (IRB) approval was 
obtained for both the patient consent forms and the study protocol, and informed consent was obtained 
from each study participant. A comprehensive list of patient characteristics is given in Table 6.2. 
6.2.2 Ultrasonic Imaging and Data processing 
Investigative B-mode and ARFI imaging were performed with a Siemens Acuson Antares 
imaging system (Siemens Medical Solutions USA, Ultrasound Division), equipped with the Axius Direct 
Ultrasound Research Interface (URI) that allowed customizable beam sequencing and access to the raw 
radiofrequency (RF) data, and a VF7-3 linear array transducer. ARFI ensembles consisted of 2 reference 
pulses, one acoustic radiation force (ARF) excitation pulse, and 60 tracking lines with an 11.5 kHz pulse 
repetition frequency (PRF). ARFI excitations were 300 cycles (~71 µsec) at 4.21 MHz with a scanner 
output power of 55%, and both tracking and reference lines were two cycles at 6.15 MHz. The focal 
configuration, or f-number (F/#, defined as the ratio of focal depth, z, to aperture width, d), of the 
excitation pulse was set to 1.5. The reference/tracking pulses used an F/1.5 configuration on transmit and 
Table 6.1: UNC stenosis grading scale 
Class Vel. Systolic (cm/sec) 
Vel. Diastolic 
(cm/sec) Category 
1 < 160 < 80 0-39% 
2 > 160 < 80 40-59% 
3 > 160 80-109 Possibly > 60% 
4 > 160 > 110 60-99% 
5 0 0 Occluded 
6* See comment See comment See comment 
*This grade is only given in special circumstances where 
further comments by the sonographer are necessary. 
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dynamic focusing and aperture growth on receive (F/0.75). The focus in elevation, set by a cylindrical 
lens, was 3.8 cm. The ARFI beam sequence acquired 40 ensembles spaced 0.35 mm apart, generating an 
effective lateral field of view (FOV) of 1.4 cm. ARF ensembles were acquired using wiperblading, a 
scanning mode that acquired lines in a non-serial order across the lateral FOV to minimize heating and 
reduce interference between consecutive ARF excitations. A single ensemble was captured from the far 
left of the FOV, then the center, then one position to the right of the far left, then one position right of 
center, etc., such that no two consecutive ensembles were captured in two adjacent lateral locations. One 
spatially matched B-mode frame (220 A-lines, 0.18 mm spacing) preceded each two-dimensional (2D) 
Table 6.2: Patient characteristics 
Patient ID A B C D 
Gender (M/F)  M F M M 
Age (years) 57 53 72 65 
Stenosis grade Class 6* Class 4 Class 4 Class 4 
Doppler-indicated systolic 
velocity (cm/s) 
402 
 
295 
 
458 
 
455 
 
Doppler-indicated diastolic 
velocity (cm/s) 54 115 138 143 
Arterial location of Doppler 
measurement LCCA-Mid RICA-Prox. RICA-Prox. LICA-Prox. 
Symptomatic  Y Y N N 
   Amaurosis fugax N Y - - 
   TIA Y Y - - 
   Completed stroke N N - - 
ARFI focal depth (cm) 3.0 2.6 2.3 2.0 
Peripheral vascular disease N Y N N 
Diabetes mellitus Y Y N N 
Hyperlipidemia Y Y Y Y 
Hypertension Y Y Y Y 
Smoking history Y Y Y Y 
*Due to stenosis in CCA, sonographer noted that velocities in ICA might underestimate grade of ICA 
stenosis. 
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ARFI acquisition for anatomical reference. The MI.3 of the ARFI sequences employed in this study was 
1.81, measured at a focal depth of 2 cm that was representative of the imaging depths investigated in this 
study. The ISPTA.3 was measured to be 1.67 W/cm2. Acoustic intensity measurements were made using an 
Onda HGL-0200 hydrophone (Onda Corp., Sunnyvale, CA) in a water tank (21 °C)  and the phantom-
substitution technique described in Palmeri et al. [176]. Heating associated with ARFI sequences was 
estimated (neglecting perfusion and other cooling effects) to be below 1°C in tissue [176], [216].  
Images were acquired the day of surgery prior to patient sedation by a registered sonographer 
trained in ARFI and peripheral vascular imaging. The carotid bifurcation and ICA were imaged 
longitudinally, using electrocardiogram (ECG) gating to capture sequences during diastole. The ARFI 
imaging focal depth was chosen based on the location of the plaque, which in all cases in this study was 
the distal (relative to the transducer) arterial wall. Two repeated acquisitions were acquired in case of 
scanner failure or unexpected patient motion. The number of repeated acquisitions was limited to two in 
order to reduce the time of patient imaging and prevent delays to the surgical procedure. Raw RF data 
was saved to the hard drive of the scanner and transferred to a computer for offline post-processing using 
custom software implemented in MATLAB (Mathworks Inc., Natick, MA). Of the repeated acquisitions, 
the one included for analysis was chosen subjectively for best image quality based on the authors’ 
experience evaluating arterial ARFI images. 
Axial displacements induced by ARF were measured using one-dimensional normalized cross 
correlation applied to the RF data ensembles as described by Pinton et al. [206]. Specific parameters of 
the motion tracking algorithm included; 4× spline-based upsampling of RF data (natively sampled at 40 
MHz), 376-µm kernel length (i.e. 1.5λ, where λ is the wavelength of the tracking pulse assuming a speed 
of sound of 1540 m/s), and an 80-µm search region. Motion tracking error for this imaging configuration 
based on the Cramér-Rao Lower Bound was estimated to be 0.7 µm, assuming 53% fractional bandwidth, 
0.999 correlation coefficient, and 40 dB SNR [223]. Linear motion filtering was applied to the 
displacement profiles to reduce artifacts introduced by physiological motion [205], [221]. From the 
acquired ARFI data, 2D parametric images of peak ARFI-induced displacement (PD) were generated. For 
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analysis, ARFI images were overlaid on top of spatially matched B-mode images with transparency in 
order to better visualize anatomical structure. B-mode images were generated from raw RF data, and were 
calculated as the log compressed, absolute value of the Hilbert-transformed RF data. Interpretation of 
ARFI images was performed by a single reader not blinded to the histological images.  
6.2.3 Histology 
After CEA specimens were extracted en bloc, the vascular surgeon placed a colored suture to 
indicate specimen orientation (proximal vs. distal relative to the heart), and specimens were photographed 
and immediately transferred to 10% neutral-buffered formalin for a minimum of 48 hours. Once fixed, the 
specimens were cut with a scalpel into two halves following the surgeon’s anterior/longitudinal 
arteriotomy (Figure 6.1). The arteriotomy was assumed to approximately follow the ultrasound-imaging 
plane as both ultrasound and the surgical approach followed an anterior trajectory to avoid the 
sternocleidomastoid muscle.  In all samples obtained in this study, the surgical arteriotomy extended 
through the length of the sample and was easily identifiable without extra marking. To preserve sample 
orientation in histological slides, sutures were removed and replaced with tissue marking dyes 
(Polysciences Inc., Warrington, PA) that would remain on the exterior of the sample after histological 
staining. After mark-up, gross microscopic images were taken of the luminal face of each sample for 
reference with a Leica MZ9.5 dissecting microscope (Leica Microsystems GmbH, Wetzlar, Germany) at 
6.3× magnification, and samples were embedded in paraffin.  
The samples were sectioned (5-µm slice thickness) and stained with hematoxylin and eosin 
(H&E), Von Kossa (VK) for calcium, and either Lillie’s modified Masson’s trichrome (LMT) or a 
combined Masson’s elastin (CME) stain for collagen and elastin fibers. A detailed guide to histological 
stains is given in Table 6.3. De-calcification was not performed on any of the samples in order to preserve 
calcium for histological staining. For samples with heavy calcification, paraffin blocks were left to soak 
for 3 days in water to achieve usable sections. Approximately 1 mm of tissue was sectioned from each 
half of the specimen using a serial-interrupted protocol where 6 serial sections were taken (to allow  
104 
multiple stains), followed by a 100 µm skip, and another 6 serial sections, etc. Slides containing the 
stained sections were digitized using a Scanscope digital-slide scanner (Aperio Technologies Inc., Vista, 
CA) at 20× magnification. The slides that qualitatively matched the plaque morphology from B-mode 
were chosen, and a blinded pathologist with experience in atherosclerosis examined and annotated the 
digitized slides using ImageScope (Aperio Technologies Inc., Vista, CA), a freely-available slide 
viewing/annotation software package. The following features, if present, were identified: fibrous 
cap/tissue, lipid/necrotic core, calcium, foam cells, vascularity, intra-plaque hemorrhage, and surface 
thrombus. As was done in Redgrave et al. [38], lipid/necrotic core was defined as amorphous material 
containing cholesterol crystals, intra-plaque hemorrhage was defined as an area of erythrocytes within the 
plaque causing disruption of the plaque architecture, and surface thrombus defined as an organized 
collection of fibrin and erythrocytes in the lumen. Plaques were then assigned a rating using the American 
Heart Association (AHA) classification scale (see Chapter 2). Alignment between ARFI images and  
 
Figure 6.1: Example of a sample preparation for histology. Panel (a) shows a top-view photograph of the 
raw sample from the common carotid of Patient A. The suture placed by the surgeon indicates proximal 
vs. distal end of the sample (with respect to the heart). The anterior surgical arteriotomy is evident on the 
top surface of the sample. To prepare samples for histology, the suture is removed and replaced with 
tissue marking dye and the sample is cut into two halves following the arteriotomy that approximates the 
ultrasound plane. Side views of the cut sample are shown in panel (b). Note the green and black tissue 
marking dyes in panel (b); green indicates suture position and black indicates the opposite side of the 
arteriotomy (i.e. the distal wall in the ultrasound image). 
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histological sections was achieved by manually identifying unique features in both ARFI and histology 
images (i.e. large calcium deposits or plaque morphological features such as the plaque shoulder).  
6.3 Results 
Carotid plaques were imaged without adverse event from five males and three females 
immediately prior to undergoing CEA. Data from four patients was excluded for various reasons; in two 
patients the extracted sample was damaged/lost during surgery, in a third patient, ARFI imaging was 
incorrectly focused on a portion of arterial wall rather than plaque, and in a fourth patient the ARFI image 
could not be successfully matched to histology due to lack of common morphology. Patient 
characteristics and labeling scheme for included patients are presented in Table 6.2. Matched B-mode and 
ARFI ultrasound images are presented with corresponding histological sections in Figure 6.2 through 
Figure 6.5. All images (both ultrasonic and histologic) are oriented such that the cephalad portion (i.e. 
towards the patient’s head) of the artery is always on the left side of the image. 
Figure 6.2 shows the imaging results from a symptomatic 57 year-old male (Patient “A”) with a  
Table 6.3: Histological stain guide 
Stain Feature Color 
Hematoxylin and Eosin (H&E) Nuclei Dark blue 
Cytoplasm/extracellular matrix Pink 
Erythrocytes Red 
Von Kossa (VK) Calcium Black 
Cytoplasm/extracellular matrix Pink 
Combined Masson’s Elastin 
(CME) 
Elastin fibers, nuclei Black 
Collagen Green 
Erythrocytes, thrombus, cytoplasm, muscle 
fibers, keratin 
Red 
Lillie’s Modified Masson’s 
Elastin 
Nuclei Black 
Collagen Blue 
Erythrocytes, thrombus, muscle fibers, fibrin Red 
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Figure 6.2: Type Va plaque from the CCA of a 57 year-old, symptomatic male (patient A). B-
mode imaging (a) shows an echolucent plaque with two echogenic foci separated by 
approximately 10 mm (white arrows). ARFI imaging (b) shows that the plaque is generally 
low displacing except for a higher-displacing region located above the leftmost echogenic 
foci. ARFI magnification image is shown in (c); the solid white outline indicates extent of the 
plaque in the ultrasound image, the magenta outlines indicate the echogenic foci, and the 
yellow outline indicates the higher-displacing region. Histological staining with H&E (d), VK 
(e), and CME (f) shows a type Va plaque with a necrotic core and mild intra-plaque 
hemorrhage (yellow outline) and fibrous cap (f, black arrows). Two calcifications are seen at 
the bottom of the plaque (f, magenta arrows) separated by approximately 10 mm. Inset panel 
shows higher-magnification image of the necrotic/hemorrhagic region, which is denoted by 
cholesterol clefts (f.1, black arrows) and extravascular erythrocytes stained red (f.1). CCA, 
common carotid artery; CME, combined Masson’s elastin; VK, Von Kossa. 
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past medical history of hypertension, hyperlipidemia, non-insulin dependent diabetes mellitus, and 
smoking (quit ~13 years). Indications for surgery included paresthesia (left face) and previous TIA. 
Duplex ultrasound revealed significant stenosis in the left CCA and ICA (it was noted that velocities may 
be underestimated in the ICA due to CCA occlusion). CEA was performed on both CCA and ICA, and 
results are shown for the CCA. B-mode imaging shows a generally echolucent plaque (Figure 6.2a), with 
two echogenic foci located at lateral positions 1.8 mm and 11.6 mm. ARFI imaging (Figure 6.2b) shows 
that the plaque exhibits generally low displacement throughout except for a focal, higher-displacing 
region located towards the right part of the plaque. A low-displacing region separating a high-displacing 
region from lumen has previously been shown to be indicative of fibrous cap ([210]). A magnification of 
the ARFI image is provided in Figure 6.2c, with the higher-displacing region outlined in yellow (mean 
PD: 3.11 ± 3.6 µm), the echogenic regions outlined in magenta (mean PD: 1.18 ± 0.4 µm), and the plaque 
outlined in white (mean PD excluding yellow and magenta regions: 1.25 ± 0.7 µm).  Histological staining 
(Figure 6.2d, e, f) shows a type Va plaque with a necrotic core (Figure 6.2f, yellow outline) covered by a 
fibrous cap (Figure 6.2f, black arrows). Two calcium deposits are also apparent (Figure 6.2f, magenta 
arrows) on the bottom center and bottom right of the specimen separated by ~10 mm. A magnification of 
the necrotic core located above the left-most calcium deposit is displayed in the inset panel (Figure 6.2f.1) 
showing cholesterol clefts and extravascular erythrocytes, indicating mild intra-plaque hemorrhage.  
Figure 6.3 shows the imaging results from a 53 year-old symptomatic female (Patient “B”) with a 
past medical history of hypertension, hyperlipidemia, diabetes mellitus, smoking, peripheral vascular 
disease, and claudication. Records note that the patient previously experienced right-sided facial droop, 
some right arm weakness, and symptoms consistent with amaurosis fugax (specifically, unable to see out 
of right eye for a few minutes). B-mode imaging shows a plaque in the distal wall with a number of small 
echogenic foci scattered throughout, suggesting small calcium deposits (Figure 6.3a, white arrows), and a 
focal stenosis extending ~4 mm into the lumen (Figure 6.3a, asterisk). ARFI imaging (Figure 6.3b), 
focused at a depth of 2.6 cm, shows that the plaque exhibits generally low displacement throughout 
except for a higher-displacing region located underneath the shoulder of the plaque, suggesting fibrous  
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Figure 6.3: Type Va plaque from the ICA of a 53 year-old, symptomatic female (patient B). B-
mode image (a) shows a plaque on the distal wall with a protruding shoulder region (a, asterisk) 
and a number of small echogenic foci scattered throughout (white arrows). ARFI imaging (b) 
shows that the area beneath the shoulder region displaces farther than the rest of the plaque. ARFI 
magnification image is shown in (c); the solid white outline indicates extent of the plaque in the 
ultrasound image, the yellow outline indicates the higher displacing region, and magenta outlines 
indicate echogenic foci. Histological staining with H&E (d) and VK for calcium (e) shows a type 
Va plaque with a protruding shoulder region (d, asterisk) and small, submillimeter calcifications 
(e, magenta arrow). LMT staining for collagen shows abundant fibrosis in the shoulder region, 
indicated by the deep blue color (f, black arrows), which covers a cellular area with inflammation 
and a small, developing necrotic core. Inset panels show higher-magnification images of the 
cellular area just above the necrotic core (d.1), the cellular area with the necrotic core (f.1) and the 
fibrous cap (f.2). The region of inflammation from histology is outlined in yellow. ICA, internal 
carotid artery; CCA, common carotid artery; LMT, Lillie’s modified Masson’s trichrome; VK, 
Von Kossa; I, inflammation; NC, necrotic core; CA, calcium. 
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cap. A magnified version of the ARFI image is depicted in Figure 6.3c, with the higher-displacing region 
outlined in yellow (mean PD: 2.77 ± 1.7 µm), the echogenic regions outlined in magenta (mean PD: 0.85 
± 0.3 µm), and the plaque outlined in white (mean PD excluding yellow and magenta regions: 1.35 ± 0.8 
µm). Histological staining (Figure 6.3d, e, f) shows a type Va plaque with a cellular region with 
inflammation and early necrotic-core formation (Figure 6.3f, yellow outline) covered by a fibrous cap 
(Figure 6.3f, black arrows). Small, sub-millimeter calcifications are also apparent (Figure 6.3e, magenta 
arrow). Figure 6.3f.1 and Figure 6.3f.2 show magnified versions of the necrotic/inflamed region and 
fibrous-cap regions, respectively.  
Figure 6.4 shows a highly occlusive plaque located in the bifurcation of an asymptomatic 72 year-
old male (Patient “C”) with a history of hyperlipidemia, hypertension, and smoking. Duplex imaging 
studies measured a Class 4 stenosis with peak systolic and diastolic velocities of 458 cm/sec and 138 
cm/sec, respectively, in the proximal portion of the right ICA. B-mode imaging shows a very complicated 
and obstructed lumen (Figure 6.4a) with large shadowing artifact (Figure 6.4a, white arrows) in the distal 
wall, suggesting heavy calcification. In this imaging plane, the proximal wall is not clearly defined and 
tissue appears to extend from the proximal wall to make contact with the calcification in the distal wall. In 
the ARFI image (Figure 6.4b), focused at a depth of 2.3 cm, there is a large displacement contrast 
between plaque in the distal wall (Figure 6.4b, asterisk) and the tissue that connects to the proximal wall 
(Figure 6.4b, dagger). Figure 6.4c shows a magnification of the ARFI image with the distal plaque 
outlined in solid white line (mean PD: 2.1 ± 1.5 µm). Mean PD of the tissue connecting to the proximal 
wall was measured to be 6.0 ± 3.4 µm.  Histological staining shows a type Vb plaque with a large calcium 
deposit indicated by black stain outline (Figure 6.4d, asterisk), measuring approximately 7.9 mm laterally 
and 4.5 mm axially, located in the arterial wall distal to the transducer. The tissue extending from the 
calcification and connecting up to the proximal wall is comprised of collagen fibers (Figure 6.4d.1 and 
Figure 6.4e.1). As seen in the higher-magnification images, the collagen fibers appear loosely packed and 
disorganized and do not follow the longitudinal histology plane, suggesting that this tissue may be from 
the split in the bifurcation. Note that the disruptions in continuity of tissue surrounding the calcium  
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Figure 6.4: Type Vb plaque from the ICA of a 72 year-old, asymptomatic male (patient C). B-mode 
image (a) shows a complicated lumen with a large area of shadowing (a, white arrows) from plaque in the 
distal wall. ARFI imaging (b) shows lower displacement in the area of the calcium deposit (asterisk) and 
higher displacements in the adjacent tissue connecting to the proximal wall (dagger). ARFI magnification 
image is shown in (c) with a white outline indicating the plaque that is above the shadowed region. 
Histological staining with H&E (d) and LMT for collagen (e) shows a large calcification (asterisk) 
indicated by the black stain. The dotted black lines indicate the extent of the ARFI FOV. Magnification 
insets shows that the tissue connecting the calcification to the proximal wall is comprised of loosely 
packed (d.1) and disorganized (e.1) collagen fibers. ICA, internal carotid artery; CCA, common carotid 
artery; PW, proximal wall (with respect to transducer); DW, distal wall (with respect to transducer). 
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deposit are artifacts of histological processing and are not indicative of plaque rupture. 
Figure 6.5 shows a calcified plaque from a 65 year-old male (Patient “D”) with a history of 
asymptomatic carotid artery stenosis. Previous cerebral angiogram of this patient demonstrated a 70% 
stenosis in the left ICA, and was corroborated by duplex scanning which measured peak systolic and 
diastolic velocities of 455 cm/sec and 143 cm/sec, respectively. B-mode imaging (Figure 6.5a) shows 
slight shadowing (Figure 6.5a, white arrows) below plaque located in the distal wall. In the ARFI image 
(Figure 6.5b), focused at a depth of 2.0 cm, the portion of the plaque encroaching into the lumen appears 
to consist primarily of low-displacing tissue except for a small high-displacing region located toward the 
bottom of the plaque, which could suggest a fibrous cap. Mean PDs in the plaque (excluding the high-
displacing area) were measured to be 1.85 ± 1.0 µm (Figure 6.5c, white outline) and 8.27 ± 12.5 µm in 
the high displacing area (Figure 6.5c, yellow outline). Large amounts of calcium deposition in this sample 
can be observed in the gross microscopic image of this sample (Figure 6.5d, dashed black outline), and 
confirmed by dark staining on H&E and VK (Figure 6.5e, f) making this a type Vb plaque. In the CME 
stain (Figure 6.5g), there is evidence of degraded collagen surrounding parts of the calcification (Figure 
6.5g.1, black arrow).  
6.4 Discussion 
This work represents a preliminary study of ARFI imaging for characterizing carotid plaque 
composition in patients undergoing CEA. From the patients that were imaged, a range of atherosclerotic 
lesions were observed during histological analysis including plaques with heavy calcium deposition, loose 
and dense fibrosis, necrotic cores containing crystallized cholesterol, and mild intra-plaque hemorrhage. 
Agreeing with previous animal and ex vivo studies [208]–[210], ARFI imaging showed regions of 
contrast that were consistent with underlying compositional elements determined from histology. 
In this study, large lipid/necrotic core, dense inflammation, and/or intra-plaque hemorrhage was 
seen on histology in two of the four CEA specimens (patients A and B). ARFI images of plaques 
containing these features were characterized by an identifiable area of increased peak displacement (~3×  
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Figure 6.5: Type Vb plaque from the ICA of a 65 year-old, asymptomatic male (patient D). B-mode 
image (a) shows a plaque extending significantly into the lumen with faint shadowing (white arrows) in 
the distal wall. ARFI imaging (b) shows a plaque with low displacement, except for a focal area of higher 
displacements located near the bottom of the plaque. ARFI magnification image is shown in (c); the solid 
white outline indicates extent of the plaque in the ultrasound image, and the yellow outline indicates the 
higher-displacing region. Gross macroscopic en face image of plaque (d) show areas of mineralization 
protruding into the lumen (dashed black outline). H&E, VK, and CME stains are shown in (e), (f), and 
(g), respectively. VK staining shows extensive calcification (asterisk). CME staining shows degraded 
collagen in areas surrounding the calcification (g.1, black arrow). Note that the lateral extent of the 
calcification was not captured in histology due to poor adhesion to the slide. ICA, internal carotid artery; 
CCA, common carotid artery. 
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greater) below an area of lower displacement that has previously been shown to indicate a soft necrotic 
core covered by a stiff fibrous cap [210]. Indeed, in patient A, the plaque was composed of a large 
necrotic region (as seen by the cholesterol clefts left on histology) covered by a fibrous cap, and  in 
patient B, the plaque had a cellular region of inflammation and early necrotic core surrounded by a large 
amount of fibrosis. By measuring the thickness of the low-displacing region separating the high-
displacing region from the lumen, ARFI imaging may be able to estimate fibrous cap thickness, another 
potential indicator of plaque vulnerability [21], however this analysis was outside the scope of this 
manuscript. 
The other two examples presented in this work included predominately calcified plaques. In 
general, ARFI displacements were low, which could be expected of a stiff calcification, but relatively 
higher ARFI displacements were also observed. In patient C, higher-displacing tissue was seen to extend 
up to the proximal wall from the calcification in the distal wall, and in patient D, a focal region of high 
displacement was noted in the bottom of the plaque (having a similar signature to patients A and B). In 
both of these cases, histology indicated that tissue surrounding the calcification was partially composed of 
loose/degraded collagen deposition, which could explain the higher displacements observed in these 
regions. The magnitude of displacements though, in these regions, was similar or greater to those seen in 
plaques with necrotic core, which would be expected to be mechanically softer than collagen. Likewise, 
the magnitude of displacements in the calcified regions of these plaques was similar to regions of dense 
collagen in the type Va examples, despite calcium being the stiffest plaque component [140]. One 
explanation for these confounding results may be that the applied force was not constant across the area 
of the plaque due to boundary conditions and/or variations in the absorption coefficient of plaque 
components.  For example, calcium in particular has been shown to be highly absorbing [264], which 
could increase the magnitude of radiation force for a given acoustic intensity level. If the calcium deposit 
experiences more force, it may displace just as far as mechanically softer, less-absorbing tissue despite 
inherently having a higher Young’s modulus value. Conversely, depending on the magnitude of 
attenuation, some parts of the plaque could experience less radiation force due to the exponential decay in 
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acoustic intensity of the ARF pulse through depth. An example of this can be seen in patient D (Figure 
6.5b, white arrows); the soft tissue underneath the calcification appears to displace less than the 
surrounding, but this is most likely an artifact of unequal force distribution rather than a true contrast in 
tissue stiffness. These results suggest that ARFI measurements of displacement need to be interpreted 
with care and should be evaluated qualitatively taking boundary conditions and absorption into account. 
There are a number of other factors that could influence the appearance of plaques in ARFI 
images. First, mechanical-wave propagation away from the ROE can affect both apparent lesion size and 
contrast [231], [241]. Typically, these effects are seen later in the ARFI imaging time-course and would 
not be expected to significantly alter a measurement of peak displacement, which is usually computed 
from the early time samples. To test this, we examined the median time-to-peak values for patients A and 
B, and found that a majority of the peak displacements occurred within 0.26 or 0.35 ms after the ARF 
excitation, suggesting minimal impact of mechanical-wave propagation on the PD images. Second, 
boundary artifacts of the cross-correlation method could affect the resolution of the ARFI images and 
impact low-displacing feature size measurements. The resolution of ARFI, like conventional compressive 
elastography, is comparable to the B-mode resolution and is dictated by both ultrasound parameters 
(frequency, bandwidth, etc.) and signal-processing parameters (kernel size and kernel step) [206], [265], 
[266]. Pinton et al. [206] examined the impact of kernel size on estimation of a step displacement and 
showed that as the kernel size increased, the slope of the measured step response decreased, effectively 
reducing the contrast of the ‘edge’. For our ARFI images, a kernel size of 1.5λ was utilized suggesting 
features of ~400 µm axially could be detected given sufficient mechanical contrast. As has been 
hypothesized previously [267], it is possible that as the size of a plaque feature, such as fibrous cap, 
decreases, the feature will move in unison with underlying softer features, such as necrotic cores, making 
it difficult to resolve on an ARFI image even if the feature thickness exceeds axial resolution limits of the 
system. Despite this limitation, ARFI imaging may be able to infer the presence of a thin fibrous cap by 
virtue of the proximity of a high-displacing region to the lumen.  
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A significant challenge in this study was ensuring spatial alignment between the ultrasonic and 
histologic imaging planes. In order to accomplish this, the following general regions had to be identified 
on the specimen: cephalad vs. thoracic and distal vs. proximal (in relation to the transducer). Identifying 
distal vs. proximal wall was the more difficult task and relied on the assumption that the anterior 
arteriotomy made by the surgeon approximated the ultrasonic imaging plane. This assumption was based 
on the fact that the position of the patient during imaging and surgery was consistent (patient was in a 
supine position with head tilted away ~45 degrees from midline), and both imaging and surgery followed 
a trajectory just anterior to the sternocleidomastoid muscle. Although care was taken to ensure alignment, 
it was possible that the surgical cut did not exactly follow the ultrasonic imaging plane. Specifically, three 
degrees of freedom (translation in elevational dimension, rotation around lateral dimension, and rotation 
around axial dimension) could not be precisely controlled. Complicating alignment even further was the 
fact that histological specimens were both unpressurized and fixed, which could have caused significant 
changes in tissue size [41]. In order to overcome the limitations of alignment inherent in CEA histological 
validation, comparison between ARFI and other in vivo plaque characterization technologies, such as 
MRI, may be required, although aligning MRI and ARFI imaging planes could also pose significant 
challenges. 
While these results are encouraging, there are a number of steps necessary to continue the 
development of ARFI for plaque characterization. First, given the small sample size of this pilot study, 
ARFI-derived plaque composition could not be statistically correlated with patients’ symptoms. Much 
larger clinical end-point studies will need to be performed to confirm that ARFI-derived elastograms are 
relevant to predicting ischemic events. Second, atherosclerotic lesions imaged in this study were 
significantly advanced (all patients were Class 4 on the UNC Doppler-indicated stenosis scale) and may 
not be representative of earlier stage plaques. Prior non-validated studies in humans though [212], have 
shown that ARFI is capable of revealing areas of mechanical contrast similar to those seen in this study, 
suggesting that the technique may be relevant in plaques not indicated by Doppler for surgery. Third, 
ARFI beam sequences were designed conservatively; the number of ARFI interrogations was kept to a 
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maximum of 40, consequently limiting the imaging FOV to ~1.5 cm, and the output power of the scanner 
was kept relatively low (55% of total output). Under this regime, the full lateral extent of the plaque was 
not imaged in some cases, and the induced displacements sometimes challenged the limits of the 
displacement-tracking algorithm, which was estimated to be ~0.7 µm. In the future, more interrogation 
points along the lateral dimension could be acquired such that the full lateral extent of the plaque would 
be covered. Also, increasing the radiation force amplitude could improve the contrast and signal-to-noise 
ratio (SNR) of the images particularly for stiff plaque features where displacements were seen to fall 
below 1 µm.  
6.5 Conclusion 
In this chapter, ARFI imaging was applied successfully in a small number of patients undergoing 
clinically indicated CEA. With matched histology, it was shown that plaques composed of lipid/necrotic 
core, mild intra-plaque hemorrhage, inflammation, and loose/degraded collagen deposition had focal 
regions of relatively high peak displacements. On the contrary, plaques composed of dense collagen 
deposition and/or calcium were generally low displacing. Overall, these results represent the first 
comparison of histology and in vivo ARFI imaging of carotid plaque. Identification of plaque mechanical 
properties with ARFI could substantially improve plaque vulnerability assessment ultimately leading to 
better patient risk stratification not only in asymptomatic patients with high-grade stenosis, but also in 
patients with <60% occlusion where Doppler ultrasound may be less reliable [75], [95]. In the following 
chapter, this analysis will be extended to a larger patient pool and ARFI sensitivity and specificity for 
characterizing atherosclerotic features will be quantified with receiver operating characteristic (ROC) 
curve analysis. 
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CHAPTER 7 
 On the Feasibility of Quantifying Fibrous Cap Thickness with Acoustic Radiation Force 
Impulse Ultrasound: A Simulation Study 
 
In this chapter, the feasibility of using transcutaneous acoustic radiation force impulse (ARFI) 
ultrasound to quantify fibrous cap thickness is assessed using finite element method (FEM) modeling. 
Fibrous caps with varying thickness (0.1 – 1.0 mm) were simulated using a simple layered geometry, and 
their mechanical response to an impulse of radiation force was solved using FEM modeling. Ultrasound 
tracking of FEM displacements was performed in Field II utilizing three center frequencies (6, 9, and 12 
MHz) and eight motion tracking kernel lengths (0.5λ - 4λ). Additionally, fibrous cap thickness in two 
carotid plaques imaged in vivo was measured with ARFI and compared to matched histology. The results 
of this study demonstrate that 1) tracking pulse frequencies around 12 MHz are necessary to resolve caps 
around 0.2 mm, 2) large motion-tracking kernel sizes introduce bias into thickness measurements and 
overestimate the true cap thickness, and 3) color saturation settings on ARFI peak displacement images 
can impact thickness measurement accuracy substantially. 
7.1 Introduction 
As described previously, fibrous cap (FC) thickness is an important indicator of plaque 
vulnerability. The fibrous cap serves as a stiff protective layer covering the developing necrotic core. If 
the fibrous cap becomes thin and mechanically unstable, radial stress imparted by blood pulsation can 
exceed the maximum failure stress of the cap and result in rupture [26]. In the Oxford Plaque Study [38], 
one of the largest histological studies done on carotid plaque, the authors reported that a minimum FC 
thickness of <0.2 mm and a representative FC thickness of <0.5 mm were independently associated with 
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plaque rupture [21].  Therefore, an ideal noninvasive carotid plaque imaging system should be able to 
resolve FCs of 0.5 mm or less in order to detect plaques that may be vulnerable to rupture. 
Among noninvasive imaging technologies, magnetic resonance imaging (MRI) was the first to 
report direct measurement of FC thickness in vivo with resolution down to 0.25 mm [86], [90], [93]. 
Subsequent prospective MRI studies demonstrated that the presence of a thin/ruptured FC carried the 
highest hazard ratio (HR: 17.0) for future cerebrovascular event compared to all other plaque features 
[99]. High-resolution computed tomography (CT) has also been shown to be sensitive to FC thickness in 
small sample patient studies [76]. However, wide-scale implementation of MRI and CT technology may 
be precluded due to the high monetary cost of both modalities, ionizing radiation in the case of CT, and 
specialized surface coils in the case of MRI that are necessary to achieve the appropriate resolution for FC 
thickness measurement. 
Given the relevance of FC thickness to predicting future ischemic events [99], implementing a 
cost-effective, ultrasound-based imaging solution to noninvasively quantify FC thickness may be highly 
impactful and could revolutionize plaque risk stratification. Indeed, high-resolution B-mode assessment 
of FC thickness was proposed a decade ago [114], with the authors demonstrating that thicknesses of 
<0.65 mm were associated with cerebrovascular symptoms. However, despite these promising initial 
results, there has been a notable lack of publications on the topic, and measuring FC thickness has not 
seemed to translate into the clinic. One explanation could be that the inherent contrast in echogenicity 
between fibrous and necrotic components is highly variable, which leads to conflicting performance 
results when utilizing echogenicity outside of a highly-controlled research setting [3]. Ultrasound FC 
thickness measurement may be improved with ultrasound methods that do not strictly rely on 
echogenicity. 
The objective of this chapter is to analyze the feasibility of ARFI imaging for transcutaneous 
measurement of FC thickness by using finite element method (FEM) and Field II-based simulations 
[176], [230] and by analysis of in vivo performance. A simple FEM mesh with multiple layers 
representing lumen, FC, and necrotic core (NC) is developed and ARFI is simulated for a range of FC 
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thicknesses. Various imaging and signal processing parameters are investigated to determine their impact 
on thickness measurement. Based on work previously  done in compressive elastography [266] and time-
delay estimation simulations [206], it is hypothesized that the resolution of ARFI for detecting FC 
thickness will be mainly dictated by the imaging pulse center frequency, and the length of the motion 
tracking kernel size. Additionally, we hypothesize that mechanical interaction between the FC and NC 
and ARFI displacement underestimation may influence FC measurement performance. These hypotheses 
are first tested in silico and then demonstrated clinically for two fibroatheromatous carotid plaques with 
validation by spatially-matched histology [268]. Overall, this study serves as a first evaluation of 
transcutaneous ARFI’s ability to quantify FC thickness.  
7.2 Methods 
7.2.1 Finite Element Method Simulations 
Soft tissue dynamics in response to an impulse of acoustic radiation force were simulated using 
previously developed finite element method (FEM) models [176] utilizing LS-DYNA (Livermore 
Software Technology Corporation, Livermore, CA), a commercially-available multi-physics solver. A 
fibrous cap covering a necrotic core was abstracted as a thin layer of stiff material covering a layer of soft 
material (Figure 7.1). Ten FEM models were generated with FC thicknesses of 0.1 mm to 1 mm, all 
covering a soft NC region with thickness of 1 mm. The models implemented a rectangular mesh with 
131,712 elements with variable node spacing and quarter-symmetry boundary conditions about the 
transducer’s axis of symmetry. The non-symmetry faces as well as the bottom face of the mesh were fully 
constrained, while the top face of the mesh (representing the lumen/FC border) was left unconstrained. 
From the axis of symmetry, the mesh extended 5.5 mm in the lateral dimension and 5.5 mm in the 
elevational dimension, and 20 mm in the axial dimension (with a 20 mm offset from the transducer face). 
Nodal spacing in the region of the FC and NC was set to 0.02 mm, while the rest of the mesh was 0.25 
mm. The fine nodal spacing the region of the FC was necessary in order to have multiple elements in the 
thinnest simulated FC (0.1 mm). 
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 Following the methods of Ohayon et al. [29], fibrosis was modeled as stiff transversely-isotropic 
material, while NC was modeled as soft isotropic material. For FC, LS-DYNA material model 
*MAT_002 was implemented with the same mechanical properties in the circumferential (θ) and 
longitudinal (z) directions and different ones in the radial (r) direction, while NC was implemented with 
*MAT_001, an isotropic elastic material model. The mesh was oriented such that the radial direction 
corresponded to the axial direction of the ultrasound transducer, while longitudinal and circumferential 
directions corresponded to lateral and elevational directions, respectively. Specific material parameters 
for both material models are given in Table 7.1. A perfect matching layer (PML), six elements wide, was 
defined around the mesh to simulate an infinite medium and remove spurious wave reflections from the 
 
Figure 7.1: Schematic of the layered model used to approximate an atherosclerotic plaque. (a) ARFI peak 
displacement image of a carotid plaque (white outline) with histologically-validated fibrous cap and 
necrotic core (yellow outline) [268]. The various tissue layers that comprise the ARFI image are shown in 
the zoomed inset panel. The fibrous cap appears as a region of low displacement (blue pixels) above a 
region of high displacement (red pixels), which represents the necrotic core. (b) Simple layered geometry 
abstracted from the ARFI imaging including a stiff layer to represent the fibrous cap on top of a soft layer 
to represent the necrotic core. ARFI, acoustic radiation force impulse; IJV, internal jugular vein; FEM, 
finite element method. 
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boundaries of the model. The PML was implemented using the built-in PML models *MAT_230 
(isotropic elastic) and *MAT_245 (orthotropic elastic) and matched to the material parameters of the NC 
and FC, respectively. 
Following Palmeri et al. [176], the ARF field was simulated by first computing the acoustic 
intensity at each nodal location using Field II, a linear acoustics modeling package [269], [270]. A 
transducer was simulated using xdc_focused_array with a transmitting frequency of 4.2 MHz and focal 
configuration of F/1.5. Field II-derived intensity values were converted to point-load forces (?⃗?) using the 
expression  [230]: 
 
 
?⃗? =  2𝛼𝛼
𝑐
 (7.1) 
where α is the absorption coefficient of the medium (assumed to be 0.5 dB/cm/MHz), 𝛼 is the temporal-
average beam intensity, and c is the speed of the sound through the medium (assumed to be 1540 m/s). 
Point loads were then superimposed on the FEM mesh, and a load curve was defined to simulate a 70-µs 
ARF burst starting at 0.2 msec. The simulation was allowed to run for 4 ms total, and data were sampled 
every 0.1 ms, approximating a conventional ARFI ensemble with 10 kHz pulse repetition frequency 
(PRF). Note that luminal blood was not simulated with the FEM model, but implemented within the 
ultrasound simulation described below. 
Table 7.1: Material model constants. 
 Young’s Moduli 
(kPa) Poisson Ratios Shear Moduli (kPa) 
 Ea Eb Ec ν ba ν ca ν cb Gab Gbc Gca 
Fibrous (MAT_002) 2312 2312 115.6 0.27 0.07 0.07 910.2 1175 1175 
Necrotic (MAT_001) Isotropic material with E = 1 kPa, and ν = 0.499 
*The subscripts a, b, and c represent longitudinal, circumferential, and radial directions, 
respectively, and lateral, elevation, and axial, respectively, in the ultrasonic coordinate definition.  
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7.2.2 Ultrasound Simulations 
The method of simulating ultrasound imaging of ARF-induced dynamics and luminal blood flow 
was adapted from those described by Palmeri et al. [230]. First, a three-dimensional Field II scatterer 
phantom with fully developed speckle (11 scatterers per resolution cell) was defined to span a volume of 
11 mm × 11 mm × 40 mm (lateral × elevation × axial). Nodal displacements output by LS-DYNA were 
loaded into MATLAB (Mathworks Inc., Natick, MA) and used to linearly-interpolate scatterer positions 
for every time step in the ARFI ensemble. To simulate a lumen, a wall-less, 3-mm radius tube of 
scatterers running parallel to the transducer face (i.e. in the lateral direction) was defined above the FC 
(which was positioned at 20 mm in the Field phantom). The lumen scatterers were translated at 100 cm/s 
with a parabolic flow profile to simulate carotid blood flow, and were assigned amplitudes 10 times less (-
20 dB) than scatterers in the FC and NC. A percentage of scatterers in the lumen (10%) were kept 
stationary with full backscatter amplitude to represent clutter that is typically present in vascular 
ultrasound imaging. Overall, 20 unique phantoms with independent speckle realizations were generated. 
Three imaging transducers with varying center frequencies (6 MHz, 9 MHz, and 12 MHz) were 
defined in Field II using xdc_focused_array to investigate the impact of tracking frequency on FC 
thickness measurement. All other relevant transducer parameters are given in Table 7.2. Two-dimensional 
ARFI acquisitions were simulated by translating each scatterer phantom laterally from -2.1 mm to 2.1 mm 
in steps of 0.35 mm. At each lateral position, RF data from each time step in the ARFI ensemble was 
calculated with Field II.  
7.2.3 Processing of Tracked Data 
After generating all the RF data, white Gaussian noise was added to each RF line in the ensemble 
prior to motion tracking using the awgn function in MATLAB to simulate 40 dB electronic signal-to-
noise ratio (SNR). Ensembles were motion tracked with one-dimensional normalized cross-correlation 
with parabolic interpolation using kernel lengths ranging from 0.5λ to 4λ [206]. Two-dimensional peak 
displacement (PD) images were then rendered by taking the maximum displacement at each axial 
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position, resulting in 4,800 images for analysis (3 frequencies × 8 kernel sizes × 20 speckle realizations × 
10 FC thicknesses). 
7.2.4 Fibrous Cap Thickness Measurement 
Due to the large number of images in the data set, a semi-automatic FC thickness measurement 
algorithm was developed that utilized simple k-means clustering (Figure 7.2). First, a 2D ARFI PD image 
was loaded and cropped between axial depths 19 and 24 mm, which approximated the ARFI depth-of-
field for the simulated ultrasonic parameters. Next, the image was saturated to an ideal color scaling based 
on the FEM simulated displacements. Because PD was variable with various thicknesses of FC, a 
different color scaling was chosen for each thickness, and was calculated as a percentage of the distance 
between the FEM-measured PD in the FC and NC using a simple formula, 
 
 
𝑃𝐷𝑚𝑚𝛼 =  𝑃𝐷𝑛 − �𝑃𝐷𝑛 − 𝑃𝐷𝑓�𝛽 (7.2) 
where 𝑃𝐷𝑚𝑚𝛼 is the upper-limit of the PD dynamic range, 𝑃𝐷𝑛 and 𝑃𝐷𝑓 are the FEM-measured peak 
displacements in the NC and FC respectively, and 𝛽 represents a fractional multiplier (0 ≤ 𝛽 < 1). A 𝛽-
value of 0 represents the case where the image is scaled based on the maximum displacement of the NC.  
Table 7.2: Simulation parameters. 
Parameter Value 
Transducer Linear array with elevational lens 
Bandwidth 60% 
Lens focus 20 mm 
Sampling frequency  200 MHz 
Speed of sound 1540 m/s 
ARF excitation center frequency 4.21 MHz 
ARF F/# 1.5 
ARF apodization None 
ARF focus 20 mm 
Tracking center frequency 6, 9, 12 MHz 
Tracking Tx/Rx apodization Hamming 
Tracking Tx F/# 1.5 
Tracking Rx F/#* 1.5 
Tracking Tx focus 20 
*Aperture growth and dynamic Rx focusing enabled 
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𝛽-values greater than 0 represent increasing amounts of color saturation, which ultimately decreases the 
dynamic range of the PD image. The importance of color scaling is discussed in more detail in the 
following sections.  
Next, the saturated image was passed into the kmeans function in MATLAB with the following 
parameters: cluster size of 4, uniform selection of initial cluster centroid positions, and 60 replicates. 
After clustering was complete, the cluster number corresponding to the FC had to be identified. This was 
done by taking the mode of the cluster map of all lateral locations at the axial position corresponding to 
the midpoint of the fibrous cap. With the FC cluster number identified, the largest contiguous cluster in 
this grouping was identified using bwlabel, and average thickness was measured by determining the top 
and bottom pixel of the cluster at each lateral location and calculating the median top/bottom across each 
image. If the largest contiguous cluster did not span the entire lateral extent of the ARFI image, this 
 
Figure 7.2: Block diagram describing the semi-automated FC thickness measurement procedure. FC, 
fibrous cap; PD, peak displacement; FEM, finite element method; NaN, not a number. 
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indicated that the FC was not identified correctly or was otherwise not identifiable under the given 
imaging conditions and was assigned a value of NaN. This process was then repeated for every 2D ARFI 
image in the data set. An example of clustering and FC thickness measurement for a 0.5 mm FC thickness 
imaged at 9 MHz with a 1.5λ-tracking kernel is given in Figure 7.3. 
Finally, a simple outlier rejection algorithm [271] was implemented to remove faulty clustering 
and spurious FC thickness measurements. For each simulated FC thickness, 20 measurements were taken 
representing one measurement from each speckle realization. Outliers were defined as any measurements 
that exceeded 3-times the median absolute deviation (MAD) of the given sample [271]. These data sets 
were rejected from the final analysis. 
7.2.5 Additional Performance Metrics 
In addition to measuring FC thickness, a number of metrics were computed across the simulations 
to characterize FC measurement performance. These metrics included contrast (C) and contrast-to-noise 
ratio (CNR) of the FC and NC, and were calculated using the following equations [131]: 
 𝐶 = 20𝑙𝑜𝑜10 �𝜇𝑛𝜇𝑓� (7.3) 
 𝐶𝑆𝑆 =  �𝜇𝑛 −  𝜇𝑓�
�𝜎𝑛2 + 𝜎𝑓2 (7.4) 
where µf and µn are the mean PD in the FC and NC, respectively, and σf  and σn are the standard 
deviations of PD in the FC and NC, respectively.  
7.2.6 Comparison with In Vivo Data 
To validate simulation results, data were compared against two in vivo examples of carotid plaque 
with histologically verified fibrous caps from Chapter 6. As was done in the simulation study, in vivo data 
were motion tracked with eight kernel sizes whose length was determined with respect to the center 
frequency of the tracking pulses (6.15 MHz). To analyze the impact of color scaling, in vivo images were 
scaled using an adaptive algorithm that was previously described in Chapter 5. Plaque outlines were first  
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segmented by hand, and then the upper bound of the dynamic range of the ARFI image was set to the 
median + 2*MAD peak displacement calculated from the plaque outline. For additional test cases, images 
were scaled to median + 4*MAD, and also scaled to the maximum PD within the necrotic core 
(representing an “unsaturated” image, similar to the β = 0 case described for the simulations). From these 
data sets, average fibrous cap thickness was measured from images by hand by drawing multiple lines 
using the imdistline tool in MATLAB. Finally, contrast and CNR were calculated between the FC and NC 
by drawing regions of interest around each respective feature and using the equations described above. 
7.3 Results  
To demonstrate the similarity between in silico and in vivo imaging scenarios, individual 
simulated ARFI lines were first compared against a clinical ARFI image of a carotid plaque. Figure 7.4(a)  
 
Figure 7.3: Example of k-means clustering algorithm and FC thickness measurement. Imaging parameters 
for the following data set were 9 MHz tracking pulse and 1.5λ kernel, and the simulated FC was 0.5 mm 
thick. (a) ARFI PD image. (b) Cluster image after performing k-means clustering. (c) Largest cluster 
corresponding to the location of the FC with semi-automatic thickness measurements (white lines) 
overlaid. The measured FC thickness in this example was 0.59 mm. FC, fibrous cap; PD, peak 
displacement; ARFI, acoustic radiation force impulse. 
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shows a plot of PD versus axial depth (oriented such that axial depth is on the Y-axis) taken from the 31st 
lateral location (3.63 mm) of the ARFI image shown in Figure 7.1. Figure 7.4(b) shows a corresponding 
simulation data set for an FC thickness of approximately the same size (~1 mm). Data in the in vivo image 
was tracked with 6.15 MHz and 1.5λ kernel, and is compared against a simulated data set at 6 MHz and 
1.5λ kernel. In the in vivo example, PD in the FC (axial positions 24.5 mm to 25.5 mm) was 
approximately 1 µm while PD in the NC (axial positions 25.7 mm to 27.2 mm) reached as high as 13 µm. 
Similarly, the simulation predicted low displacement in the FC (axial positions 20 mm to 21 mm) of 
approximately 2 µm, and high displacement in the NC (axial positions 21 mm to 22 mm) of 
approximately 10 µm. Ultrasonic tracking of PD in the region of the NC underestimated the true PD by  
 
 
Figure 7.4: Comparison of FEM simulated data to an in vivo example. (a) ARFI peak displacement from 
in vivo example 1 (lateral position 3.63 mm). The fibrous cap appears as an area of low displacement 
from axial positions 24.5 mm to 26 mm while the necrotic core appears as an area of high displacement 
approximately spanning axial positions 25.5 mm to 27.5 mm. The full-width half-max of the fibrous cap 
is denoted by a black arrow. (b) Simulated data from FEM (gray, dashed line) and Field II (black, solid 
line) with fibrous cap thickness of 1 mm. The fibrous cap in the simulated data spans axial positions 20 
mm to 21 mm, while the necrotic core spans positions 21 mm to 22 mm. Ultrasonic tracking of FEM 
displacements shows significant underestimation of displacement in the area of the necrotic core. The 
full-width half-max of the fibrous cap as measured by FEM and ultrasound are shown as gray and black 
arrows, respectively. US, ultrasound; ARFI, acoustic radiation force impulse; FEM, finite element 
method. 
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Figure 7.5: FEM-measured peak displacement results with and without saturation. (a) FEM-measured 
thickness versus true simulated thickness with no saturation. Dashed line indicates the line of 
equivalency. (b) FEM peak displacement profiles for all ten fibrous cap thicknesses with no saturation. 
Dashed line indicates border between lumen and fibrous cap. (c) FEM-measured thickness versus true 
simulated thickness with saturation. (d) FEM peak displacement profiles for all ten fibrous cap 
thicknesses with adaptive saturation. The cap thickness was measured as the full-width half-max between 
the fibrous cap and necrotic core layers, as shown by the black arrows in (b) and (d).  Note that without 
saturation, FEM-measured thickness substantially overestimated the true simulated thickness due to 
mechanical coupling between the fibrous cap and necrotic core. 
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approximately 4 µm. This example suggests there was acceptable agreement between the FEM-
simulations and data taken in vivo in a real carotid artery plaque.  
Figure 7.5 shows the FEM-predicted PD profiles for all ten FC thicknesses simulated in this 
study, as well as a comparison of FEM-derived FC thickness measured as the full-width half-max 
(FWHM) between the FC and NC. The top row of images shows the results with no PD saturation (𝛽 = 
0), while the bottom row of images shows the results with substantial PD saturation (𝛽 = 0.75). These 
simulations demonstrate that PD in the NC decreases as a function of FC thickness, suggesting that 
plaques with thin FCs may appear “softer” in ARFI images. Interestingly though, Figure 7.5(a) and (b) 
suggest that FC thickness measurements made with ARFI may experience a substantial positive bias (0.19 
± 0.01 mm), particularly if the full dynamic range of PD is utilized. This bias arises not from ultrasonic 
imaging parameters, but rather from mechanical coupling between the stiff FC and soft NC. Coupling 
between these regions produces a gradient of PD at the interface between the layers, which changes the 
perceived location of the FC/NC edge. As demonstrated in Figure 7.5(c) and (d), the positive bias can be  
 
Figure 7.6: FEM thickness bias as a function of image 
saturation level. An image saturation level of 0 indicates the 
full dynamic range of peak displacement is used. Saturation 
levels greater than zero indicate reduction of dynamic range 
as depicted in Figure 7.5. 
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reduced substantially to 0.06 (± 0.016) mm if PD saturation is employed to reduce the dynamic range; 
however, no amount of saturation can remove it completely. This is depicted graphically in Figure 7.6, 
which shows the reduction of bias as a function of image saturation level. 
Figure 7.7 and Figure 7.8 show examples of simulated ARFI images for all ten FC thicknesses 
taken at 6 MHz and 12 MHz, respectively, with adaptive color scaling. The absolute motion tracking 
kernel length was kept constant (0.257 mm) for both tracking frequencies, using a 1λ kernel at 6 MHz and 
 
Figure 7.7: Examples of simulated 2D ARFI peak displacement images for the ten fibrous cap thicknesses 
taken with tracking pulses centered at 6 MHz and using a 1λ kernel (0.257 mm). The fibrous cap appears 
as a yellow-green band starting at axial position 20 mm. ARFI, acoustic radiation force impulse. 
 
Figure 7.8: Examples of simulated 2D ARFI peak displacement images  for the ten fibrous cap 
thicknesses taken with tracking pulses centered at 12 MHz and using a 2λ (0.257 mm) kernel. The fibrous 
cap appears as a yellow-green band starting at axial position 20 mm. Note that edge definition and 
contrast are qualitatively better compared to the lower tracking frequency shown in Figure 7.7. ARFI, 
acoustic radiation force impulse. 
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2λ kernel at 12 MHz. In these images, the FC is denoted as a region of relatively low displacement 
(located between axial positions 20 mm and 21 mm), with the NC appearing as a region of high 
displacement directly below the FC regions. As expected based on the motion tracking kernel size, the 
stiff FC layer is difficult to resolve when is it 0.1 - 0.2 mm thick; however, at 0.3 mm it becomes readily 
identifiable, particularly at the 12 MHz frequency. Qualitatively, the images at 6 MHz appear notably 
worse (layer edges are less distinct, contrast is poorer, etc.) than at 12 MHz, despite having identical 
motion tracking kernel lengths, suggesting that higher frequency tracking is critical to FC thickness 
measurement performance.  
These qualitative observations are confirmed in Figure 7.9 and Figure 7.10, which compare the 
ARFI-derived FC thickness to the true simulated thickness. Figure 7.9 depicts the results with respect to 
relative wavelength-based kernel sizes, while Figure 7.10 depicts the results with respect to absolute 
kernel sizes. In each of these graphs, the dotted line represents the line of equivalency. Cases where the 
algorithm failed to measure a FC thickness (i.e. values assigned as NaN) are not depicted and serve as a 
 
Figure 7.9: Simulated ARFI-measured fibrous cap thickness compared to true thickness grouped by 
relative kernel size (given as a fraction of wavelength, λ). Dashed line indicates the line of equivalency. 
ARFI, acoustic radiation force impulse. 
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lower limit for FC resolution for a given frequency and kernel size. A number of observations can be 
made from these results: 1) no combination of imaging parameters were able to resolve FC thicknesses of 
0.1 mm, 2) the smallest resolvable FC with 6 MHz was 0.3 mm, while the smallest with 9 and 12 MHz 
was 0.2 mm, 3) positive bias and variance of FC measurement are inversely proportional to tracking  
frequency and directly proportional to kernel size. Interestingly, the positive bias decreased with 
increasing frequency even when kernel length was set to an absolute size (Figure 7.10). Finally, Figure 
7.11 summarizes the results of FC detection accuracy by depicting bias as a function of kernel size and 
frequency. The lowest mean bias was achieved by a 0.064 mm (0.5λ) kernel at 12 MHz, however the 
variance on the estimates was higher compared to the next best performing kernel (0.128 mm, or 1λ, at 12 
MHz). 
 
Figure 7.10: Simulated ARFI-measured fibrous cap thickness compared to true thickness grouped by 
absolute kernel length. The plot representing the 0.257 mm kernel sizes includes data for 1λ (6 MHz), 
1.5λ (9 MHz), and 2λ (12 MHz). The plot representing the 0.513 mm kernel sizes includes data for 2λ (6 
MHz), 3λ (9 MHz), and 4λ (12 MHz). Dashed line indicates the line of equivalency. ARFI, acoustic 
radiation force impulse. 
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Figure 7.12 shows the contrast between the FC and NC as a function of FC thickness using an 
absolute kernel length of 0.257 mm. Three levels of PD saturation are depicted (β = 0.0, β = 0.5, and β = 
0.75). The dotted line indicates the inherent contrast calculated from FEM results directly. This figure 
demonstrates that PD contrast between the FC and NC increases nonlinearly with increasing FC 
thickness. Additionally, center frequency is demonstrated to be important in regards to contrast; higher 
center frequencies were able to capture more of the underlying contrast compared to the lower 
frequencies. The mean improvement in contrast between 6 MHz and 12 MHz was 1.8 (± 0.14) dB, 
however 12 MHz still underestimated the true tissue contrast by 2.1 (± 0.39) dB, which can be explained 
by displacement underestimation due to shearing [230], [272]. As PD saturation level increased, the 
inherent contrast in PD between the FC and NC was reduced proportionally, and the reduction in contrast 
due to displacement underestimation was mitigated. At significant levels of saturation (β = 0.75), the 
contrast achieved by 9 MHz and 12 MHz tracking was nearly identical. The effect of kernel size on 
contrast is depicted in Figure 7.13, which shows contrast as a function of kernel size for three FC 
thicknesses (0.2 mm, 0.5 mm, and 1 mm) and two dynamic ranges (β = 0.0 and β = 0.75). These figures  
 
Figure 7.11: Simulated ARFI-measured thickness bias a 
function of absolute kernel size. ARFI, acoustic radiation 
force impulse. 
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Figure 7.12: ARFI-measured contrast between the simulated fibrous cap and necrotic core layers as a 
function of fibrous cap thickness for three different saturation levels (β = 0.0, β = 0.5, and β = 0.75). 
Kernel size held constant at an absolute length of 0.257 mm. Dashed line indicates FEM-measured 
contrast. ARFI, acoustic radiation force impulse. 
 
 
Figure 7.13: ARFI-measured contrast between the simulated fibrous cap and necrotic core layers as a 
function of absolute kernel size for three different fibrous cap thicknesses (0.2 mm, 0.5 mm, and 1.0 mm). 
The top row shows results for unsaturated images (β = 0), while the bottom row shows results for 
saturated images (β = 0.75). Note that saturation reduces contrast in some cases. Dashed line indicates 
FEM-measured contrast. ARFI, acoustic radiation force impulse; FC, fibrous cap. 
 
135 
show that both very small and very large kernel sizes tend to have poorer contrast, compared to 
intermediate kernel sizes. Specifically, in the 9 MHz and 12 MHz cases, there is a clear inflection point 
that occurs around the 1λ kernel size, where the contrast is maximized. Furthermore, image saturation 
effectively reduced contrast for all kernel sizes as shown in Figure 7.12. Interestingly, at high levels of 
image saturation, the difference in contrast between small and large kernels was not as pronounced as in 
Figure 7.13. 
Figure 7.14 shows the CNR between the FC and NC as a function of FC thickness using an 
absolute kernel length of 0.257 mm. As was the case with contrast, this figure demonstrates that CNR 
also increases nonlinearly with increasing FC thickness. The mean improvement in CNR between 6 MHz 
and 12 MHz was 0.36 (± 0.05) with no color saturation, and increased to 0.66 (± 0.20) with the highest 
level of saturation (β = 0.75). The effect of kernel size on CNR is depicted in Figure 7.15 for two dynamic 
ranges (β = 0.0, and β = 0.75). Unlike contrast, which was typically maximized with small kernel sizes 
(i.e. 1λ) regardless of FC thickness, the kernel size that maximized CNR actually changed as a function of 
FC thickness. For thicker FCs, larger kernel sizes yielded higher mean CNR values, however higher 
variance of CNR was also observed. CNR versus kernel size plots for higher levels of saturation showed a 
similar trend, only with higher CNR values as was seen in Figure 7.14. 
Figure 7.16, shows FC thicknesses measured from two carotid ARFI images taken in vivo 
(Chapter 6). Panels A and B (example 1) show the PD image and histology (combined Masson elastin 
stain; collagen in green) for a Type Va plaque in the common carotid of a symptomatic 57-year-old male. 
Panels C and D (example 2) show the PD image and histology (Lillie’s-modified Masson’s trichrome 
stain; collagen in blue) for a Type Va plaque in the internal carotid artery of a 53-year-old symptomatic 
female. In example 1, mean ARFI-derived FC thickness was 1.31 (± 0.07) mm and histology-derived 
mean thickness was 1.18 (± 0.30) mm, representing an 11.0% overestimation by ARFI. In example 2, 
mean ARFI-derived FC thickness was 0.92 (± 0.13) mm and histology-derived mean thickness was 0.88 
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Figure 7.14: ARFI-measured CNR between the simulated fibrous cap and necrotic core layers as a 
function of fibrous cap thickness for three different saturation levels (β = 0.0, β = 0.5, and β = 0.75). 
Kernel size held constant at an absolute length of 0.257 mm. CNR, contrast to noise ratio; ARFI, acoustic 
radiation force impulse. 
 
 
Figure 7.15: ARFI-measured CNR between the simulated fibrous cap and necrotic core layers as a 
function of absolute kernel size for three different fibrous cap thicknesses (0.2 mm, 0.5 mm, and 1.0 mm). 
The top row shows results for unsaturated images (β = 0), while the bottom row shows results for 
saturated images (β = 0.75). Note that saturation increases CNR in some cases. CNR, contrast to noise 
ratio; ARFI, acoustic radiation force impulse; FC, fibrous cap. 
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 (± 0.26) mm, representing a 4.6% overestimation by ARFI. Both images were captured with a tracking 
frequency of 6.15 MHz and processed with a 0.25 mm (1λ) kernel. 
 Figure 7.17 depicts the impact of kernel size and dynamic range on the two in vivo examples. 
ARFI images from example 1 are shown with four different kernel sizes (0.5λ, 1.5λ, 2.5λ, and 3.5λ) and 
two different dynamic ranges (maximum PD values set to 2.7 µm corresponding to median + 2*MAD and 
4.2 µm corresponding to median + 4*MAD). FC measurements are illustrated on the ARFI images as 
white lines, and average FC thickness for all eight kernel sizes and two dynamic range settings are 
quantified in the plot on the right. As predicted from the simulation results, higher kernel sizes 
 
Figure 7.16: FC thicknesses measured from ARFI images taken in vivo and compared against histology. 
(a) ARFI PD image of a Type Va carotid plaque showing the FC measurement lines in white. (b) 
Combined Masson’s elastin stain showing the FC thickness measurement for plaque example 1. (c) ARFI 
PD image of another Type Va carotid plaque. (d) Lillie’s-modified Masson’s trichrome stain for plaque in 
example 2. The table reports mean (± standard deviation) FC thicknesses measured from ARFI and 
histology as well as ARFI percent error. The tracking pulse frequency in these examples was 6.15 MHz, 
and a motion tracking kernel size of 1λ was utilized. Data to create this figure were adapted from Chapter 
6. 
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introduced higher positive bias into the FC measurements. The magnitude of bias from kernel size in the 
in vivo examples (~0.4 mm with a 4λ kernel) was moderately larger than predicted by simulation (~0.25 
mm). Additionally, larger dynamic range (akin to lower β values) also resulted in higher positive bias, 
again mirroring the simulations results.  
Finally, in vivo results for contrast and CNR are shown in Figure 7.18. In this figure, data from 
the dynamic range with the lowest positive bias (i.e. median + 2*MAD) is graphed alongside data from an 
“unsaturated” dynamic range (i.e. the maximum PD in the necrotic core). As predicted from the 
simulations (Figure 7.13(c) and (f) and Figure 7.15(c) and (f)), saturation decreased contrast but increased 
CNR. The magnitude of decrease and increase varied between examples, with example 1 demonstrating 
the largest decrease in contrast (~6 dB) and increase in CNR (~0.5) with saturation. Interestingly, the  
 
Figure 7.17: The impact of kernel size and dynamic range (DR) color scaling on mean ARFI-measured 
fibrous cap thickness for two in vivo examples. ARFI images, motion tracked with various kernel sizes 
from Figure 7.16 (example 1), are shown in two columns. The first column shows images scaled using the 
median + 2*MAD color scaling (for a dynamic range of 2.7 µm), while the second column shows images 
scaled using median + 4*MAD color scaling (for a dynamic range of 4.2 µm). Four motion tracking 
kernels for each color scaling are shown (0.5λ, 1.5λ, 2.5λ, and 3.5λ) and fibrous cap measurement lines 
are displayed as white lines. Mean fibrous cap thickness for all kernel sizes and both in vivo examples is 
shown in the plot on the right. Note that both larger kernel size and higher dynamic range increases 
measurement bias. ARFI, acoustic radiation force impulse; MAD, median absolute deviation. 
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overall magnitude of CNR in the in vivo examples was moderately lower than in simulation. For example, 
in simulations with 1.0 mm FCs and utilizing color saturation, the CNR values exceeded 1.5, however in 
vivo the color-saturated CNRs were closer to 1.0. 
7.4 Discussion 
In this study, a simulation framework for testing the capability of ARFI imaging to quantify the 
thickness of thin, mechanically stiff layers, representing atherosclerotic fibrous caps, was presented. As 
mentioned previously, to be clinically relevant for vulnerable carotid plaque characterization, an ARFI 
system should be capable of accurately detecting plaques with an average FC thickness of <0.5 mm 
and/or a minimum thickness of <0.2 mm. The results of this study suggest that 0.2 mm is actually the 
lower limit of ARFI’s detection potential even with optimal imaging parameters, so while measuring caps 
less than 0.2 mm may be challenging, measuring caps around 0.5 mm should be feasible. 
 
Figure 7.18: ARFI-measured contrast and CNR between the necrotic core and fibrous cap for two in vivo 
examples from Figure 7.16. In each plot, two dynamic ranges are shown; one scaled using the median + 
2*MAD (solid lines), and the other scaled to the maximum displacement within the necrotic core, i.e. an 
unsaturated image (dashed lines). Note that the saturated and unsaturated cases loosely reflect the 
simulated β = 0.75 and β = 0 saturation levels, respectively, as depicted in Figure 7.13 and Figure 7.15. 
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Three specific imaging parameters were explored in this study in detail – center frequency, kernel 
size, and image saturation level. It is well known that increasing center frequency improves the resolution 
of ultrasonic imaging, and, specifically in the context of ARFI imaging, has the added benefits of 
reducing motion tracking jitter [223] and increasing contrast by mitigating displacement underestimation 
from shearing [230]. Although the results shown in Figure 7.9 suggest that both the 9 MHz and 12 MHz 
tracking pulses performed similarly in terms of the smallest detectable FC (0.2 mm), the 12 MHz tracking 
pulses attained the lowest amount of positive bias (Figure 7.11), the highest contrast values (Figure 7.12), 
and the highest CNR values (Figure 7.14). This was mostly likely due to the shortened pulse length at 
higher frequencies (fractional bandwidth for each simulated transducer was held constant at 60%). 
To date, ARFI plaque characterization in clinical studies has been implemented with 6 MHz 
[268] and 9 MHz [213] tracking pulses, but 12 MHz sequences have yet to be tested in vivo. At such high 
frequencies, depth of penetration may be an issue, however 12 MHz B-mode is currently the upper limit 
that is utilized in the clinic for carotid imaging [273], suggesting this frequency may be relevant in an 
ARFI setting as well. Another practical challenge for implementing ARFI with a 12 MHz tracking pulse 
is the requirement of increased transducer bandwidth in order to maintain a low center frequency for the 
ARFI pushing pulses. In this simulation study, the pushing pulse was kept constant at 4 MHz, which has 
typically been used in carotid ARFI studies done in vivo. Therefore, a transducer that can push at 4 MHz 
and track at 12 MHz would require a center frequency of 8 MHz and a minimum fractional bandwidth of 
100% (or alternatively, a transducer centered at 12 MHz with fractional bandwidth of 67%). While this 
bandwidth requirement is high, advancements in transducer materials and design have demonstrated the 
capability of operating at greater than 100% bandwidth [274] suggesting this hurdle may be overcome as 
well.  
In regards to kernel size, smaller kernel sizes were necessary to achieve more accurate 
measurement of the FC. For each center frequency that was tested, the smallest kernel size (0.5λ) resulted 
in the lowest positive bias (Figure 7.11). However, these kernel sizes also yielded lower CNR values 
(Figure 7.15) when compared to larger kernel sizes (e.g. 1λ or 1.5λ), indicating higher variance (i.e. jitter) 
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in motion tracking. These results are consistent with previous studies [206] that reported a tradeoff 
between bias and jitter when utilizing small, sub-wavelength kernel sizes. When kernel sizes become too 
small, corruptive jitter dominates the measurements and obviates the marginal improvement in bias. 
Notably, using large kernel sizes (e.g. 3λ or 4λ) also resulted in poor FC thickness measurement 
performance, as seen by the increased positive bias (Figure 7.11 and Figure 7.17), reduced contrast 
(Figure 7.13 and Figure 7.18), and even a reduction of CNR in some cases (Figure 7.15 and Figure 7.18). 
The benefits of using a large kernel are mainly related to the reduction in jitter; however, due to the thin 
size of the feature being measured, large kernel sizes quickly exceed the size of the FC and cause 
undesirable averaging and smoothing to occur, making their implementation impractical in this 
application of ARFI. Therefore, based on the simulations and preliminary in vivo results, a kernel size of 
1λ or 1.5λ is recommended for clinical implementation of FC thickness measurement.  
Lastly, image color saturation was determined to be highly important for accurate measurement 
of the FC, largely due to the mechanical coupling between the FC and NC. As seen in Figure 7.5 and 
Figure 7.6, the ideal saturation level occurs when the maximum PD in the image is capped to a certain 
percentage above the PD in the FC. By saturating the image, the inherent contrast in PD between the FC 
and NC is reduced (Figure 7.12) in order to improve the bias. Interestingly, high levels of saturation can 
obviate the impact of displacement underestimation, which substantially reduces the PD measured in the 
soft NC and ultimately reduces contrast from the FC. This effect can be observed in Figure 7.12(c) where 
the ARFI-measured contrast nearly matches the FEM-measured contrast after saturation. Further, 
saturation improves the CNR metric, as seen in Figure 7.14(c), due to the reduction in PD variance in the 
NC.  
 In the simulations, the image saturation level was chosen adaptively based on the known FEM 
displacements in the regions of FC and NC. In practice, these PD values are not known a priori, making 
adaptive color saturation one of the most significant challenges for ARFI in this application. In order for 
ARFI to be able to consistently quantify FC thickness, a standardized color-scaling algorithm will need to 
be developed. It was previously proposed to set the color scaling based on the median PD measured 
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across the entire plaque (Chapter 5), and this same scheme was utilized for the two clinical examples 
presented in Figure 7.16. In both cases, the chosen color scaling demonstrated good contrast between the 
NC and the FC, and the positive bias in the ARFI-derived thickness measurements (0.13 mm and 0.04 
mm) agreed with the predicted bias of 0.13 (± 0.05) for the corresponding frequency and kernel size 
(Figure 7.11) suggesting appropriate color scaling was used. However, due to the limited number of in 
vivo cases, further studies are necessary to determine if this color-scaling algorithm is relevant for wide-
scale application to carotid ARFI images.  
There were a number of potential limitations in this study. First, all simulated FCs were highly 
idealized, oriented perfectly orthogonal to the axial direction of the transducer, and were of homogeneous 
thickness across the lateral dimension. In reality, as seen in Figure 7.16, plaques may have curvature, may 
be imaged at non-90° angles relative to the transducer due to patient anatomy, and may have variable 
thickness across the lateral field of view. The lateral resolution of an ARFI system is expected to be worse 
than the axial resolution, and displacements may experience more averaging bias due to side lobes of the 
tracking point spread function, which may explain the increased kernel bias observed in the in vivo data 
set as compared to the simulation (Figure 7.17). Therefore, it is predicted that utilizing the highest 
tracking frequency may be even more beneficial to making FC thickness measurements in vivo than 
shown in this manuscript. A second limitation to this study was in the modeling of the layer interfaces, 
specifically the lumen/FC interface and the FC/NC interface. The lumen/FC interface was not simulated 
with FEM, meaning that the mechanical interaction between lumen and the FC was not evaluated in this 
study. It is possible that the forces exerted on the FC by flowing blood may impact displacements 
measured with ARFI, however the similarity observed between simulation and in vivo data sets suggests 
that this impact should be minimal (note that in vivo data sets were gated to diastole, where blood flow is 
expected to be at its slowest). Regarding the FC/NC interface, as shown in Figure 7.5, mechanical 
coupling between the FC and NC layers significantly impacted bias in layer thickness measurement. It is 
unclear whether this coupling accurately modelled the mechanical interaction between the two features in 
vivo. Indeed, NCs have sometimes been described as “semi-solid” [275], and previous studies have shown 
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that atheroma lipids can exist in any of three states; liquid, liquid crystalline, or crystalline [251], 
suggesting the mechanical coupling between the FC and NC may be more complicated, e.g. as a fluid-
solid interaction. Anecdotal evidence from our two in vivo examples suggests sharper transitions between 
the FC and NC, which could indicate a weaker mechanical coupling than was modelled in this study; 
however, more data need to be collected before this observation can be confirmed. 
7.5 Conclusion 
Overall, these simulation studies have demonstrated the feasibility of quantifying the thickness of 
thin, stiff layers with transcutaneous ARFI imaging and provide insight into the factors impacting ARFI’s 
ability to quantify fibrous cap thickness in carotid plaques. The FEM results revealed that mechanical 
coupling between the stiff and soft layer may introduce substantial positive bias into the ARFI 
measurements. To counteract this positive bias, image contrast saturation can be utilized to reduce the 
dynamic range of the ARFI image and improve the thickness measurement. Regarding ultrasonic tracking 
parameters, the results suggest that utilizing high center frequency tracking pulses (12 MHz) achieve the 
best thickness measurements as seen by the lower bias, higher contrast, and higher CNR. The results also 
demonstrated that motion-tracking kernel size can have a large impact in thickness measurements 
performance; setting the kernel too small will cause large amount of jitter and decrease CNR, while 
setting the kernel too high will introduce large amounts of positive bias. In each case, using a kernel size 
of approximately one wavelength gave the optimal balance between bias, contrast, and CNR. In two in 
vivo clinical examples, one with a 0.88 mm cap and the other with a 1.18 mm cap, ARFI was able to 
measure average FC thickness to within 11% error of the histologically verified thickness. Given 
appropriate imaging parameters, these simulations suggest that transcutaneous ARFI may be capable of 
measuring average carotid fibrous cap thickness of 0.2 – 0.3 mm, which could aid in the stratification of 
plaque vulnerability for rupture and future ischemic event. 
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CHAPTER 8 
 ARFI-Derived Carotid Plaque Stiffness Measurements Compared with Histology II: In 
Vivo Assessment of Fibrous Cap Thickness and Rupture 
 
8.1 Introduction 
In this chapter, we continue our analysis of ARFI images taken in patients undergoing CEA and 
present a comprehensive case-by-case analysis of all plaques that were imaged during the course of our 
clinical study. In our preliminary analysis of data collected early in the study (Chapter 6 and Chapter 7), 
we gained a considerable appreciation for the challenges involved with comparing ultrasound images to 
histological CEA samples. In particular, two of the greatest difficulties that we encountered were 
maintaining plaque alignment between ultrasound and histology and processing heavily calcified samples.  
In the literature, the most common approach to processing heavily calcified samples is to simply 
decalcify them prior to embedding. This approach can pose problems for an imaging validation study 
such as this one where quantifying performance for detecting calcium is a main goal [276]. Indeed, in 
Chapter 6 we avoided decalcification of our samples in order to prevent missing important features. This 
decision turned out to be moderately beneficial in the two Type Va plaques (small calcifications could 
easily be identified on VK staining and even used to aid in specimen alignment) but was detrimental in 
the two Type Vb plaques, causing histological slices to be torn during sectioning. A solution to this was 
found in the CT literature [76], in which the authors utilized ex vivo µCT of CEA samples prior to 
   
© 2015 IEEE. Portions reprinted, with permission, from T. J. Czernuszewicz, J. W. Homeister, M. C. Caughey, M. 
A. Farber, J. J. Fulton, P. F. Ford, W. A. Marston, R. Vallabhaneni, T. C. Nichols, and C. M. Gallippi, “In vivo 
carotid plaque stiffness measurements with ARFI ultrasound in endarterectomy patients,” in Proc. IEEE Ultrason. 
Symp., Taipei, Taiwan, 2015. 
 
 
145 
decalcification to serve as the gold standard for calcium deposition. This study showed that CT had 
perfect sensitivity and specificity for calcifications and that µCT could yield isotropic resolution down to 
30 µm. Therefore, we decided that the optimal processing approach for our CEA specimens going 
forward would be to scan samples ex vivo with µCT followed by decalcified histology.  
As will be described in this chapter, this approach not only made processing and spatial alignment 
of calcified samples possible, but also improved our selection of the histological cutting plane.  
8.2 Methods 
The in vivo imaging methods implemented in this chapter utilize many of those described in 
Chapters 6. They are reiterated here briefly, but the reader is referred to the previous chapters for more 
detail. 
8.2.1 Patients 
Data sets were obtained from an additional seventeen patients undergoing clinically indicated 
CEA at UNC Hospitals (bringing the total enrollment to N = 25). Inclusion criteria remained the same; 
individuals with either symptomatic carotid artery disease with a stenosis in the carotid artery thought to 
be the source of emboli or asymptomatic carotid artery disease with >60% stenosis that were 
unresponsive to medical management were enrolled. Institutional review board (IRB) approval was 
obtained and informed consent was given from each study participant. 
8.2.2 Ultrasonic Imaging 
ARFI imaging was performed using the same ultrasound system and imaging parameters 
described in Chapter 6. The imaging protocol was modified slightly to include the capture of additional 
transverse B-modes of the carotid bifurcation (by rotating the transducer 90° from the longitudinal 
imaging plane). Both static B-modes and CINE loops of the sonographer sweeping the transducer up from 
the common carotid were captured to aid in specimen alignment. 
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Signal processing of raw RF data was done as described in Chapter 6 using normalized cross 
correlation and linear motion filtering to measure ARFI displacements. PD images were rendered and the 
dynamic range was set using the adaptive color saturation approach described in Chapter 7. This process 
involved outlining the plaque manually, and then setting the maximum of the dynamic range to the 
median PD plus two median absolute deviations (MAD).  
8.2.3 Ex Vivo Specimen Imaging 
Extracted CEA specimens were immediately photographed and transferred to 10% neutral-
buffered formalin for a minimum of 48 hours. After fixation, ex vivo µCT imaging was performed on the 
samples with a Scanco µCT 40 (Scanco Medical AG, Bassersdorf, Switzerland) at 20-µm isotropic voxel 
resolution. To mount the specimen for µCT imaging, a Styrofoam packing peanut was placed at the 
bottom of the µCT cassette to serve as a radiolucent spacer. To prevent sample dehydration, a small 
amount of formalin was poured into the µCT cassette, and the cassette was sealed by stretching Parafilm 
across the top opening. Scan times varied depending on the length of the specimens, but on average, were 
approximately 30 minutes long. 
Post-processing of the µCT data involved a number of steps. First, the raw DICOM files were 
imported into Fiji (http://fiji.sc), an open source image processing toolkit based on NIH ImageJ, in order 
to downsample the µCT volume and crop the outline of the µCT cassette. Downsampling was done to 
reduce computational overhead when volume rendering and was achieved using the Import -> Image 
Sequence option in Fiji to isotropically reduce the data by a factor of 2 (increasing voxel size to 40 µm). 
Next, a single image frame in the sequence that only displayed the outline of the µCT tube was identified, 
and the inner ring of the tube was segmented using the Magic Wand tool and Thresholding. All pixels 
outside of the inner ring were cleared using the Edit -> “Clear Outside” option, and the setting was 
applied to all image frames in the volume. The edited volume was then exported to a Stacked TIFF file. 
Stacked TIFF volumes were imported into 3D Slicer 4.3.1 (http://www.slicer.org), a freely 
available medical image processing and volume-rendering software. First, the volume was segmented 
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into two tissue types – calcifications and soft tissue – by defining two label maps in Slicer. Segmentation 
was achieved by using empirically determined thresholds on pixel intensity values (which were 16-bit 
integers ranging in value from 0 to 216). Calcification was identified as any pixel exceeding a value of 
38,000, while soft tissue was identified as pixels ranging between 33,500 and 37,000. Spurious pixels 
were removed using the Remove Island Effect (with Morphology Method) option in Slicer. After 
segmenting the volume, the axial (red) slice was adjusted to match the vessel morphology, such that it 
yielded a true axial view of the specimen (i.e. a transverse slice of the carotid). With the axial panel 
aligned, the carotid bifurcation was identified, and the slice was rotated to match the ICA/ECA 
orientation from in vivo transverse B-modes captured at the time of ARFI imaging. Finally, the sagittal 
(yellow) slice was displayed and adjusted to represent the orthogonal view that would be achieved by 
rotating the transducer 90° and compared to the longitudinal B-mode images. In this way, the 
approximate location of the ultrasound-imaging plane could be located, and used to guide histological 
sectioning. 
8.2.4 Histology 
After ex vivo imaging, samples were decalcified for at least 24 hours with Immunocal decalcifier 
(StatLab Medical, McKinney, TX). Next, specimens were cut longitudinally into two halves following the 
ultrasound plane predicted from µCT and B-mode, and marked with tissue marking dye (Polysciences 
Inc., Warrington, PA) to indicate sample orientation. Once the tissue was marked, gross microscopic 
images of the luminal surface (6.3× magnification) were taken with a dissecting microscope (MZ9.5, 
Leica Microsystems GmbH, Wetzlar, Germany) for reference, and the tissue was embedded in paraffin. In 
most cases, the cutting plane was oriented with the surgeon’s anterior/longitudinal incision, however, 
when it did not, samples were embedded whole to prevent fragmentation (in which case, no dissecting-
microscope images were captured). Samples were then sectioned with a microtome at 5-µm slice 
thickness and stained with hematoxylin and eosin (H&E) and a combined Masson’s elastin (CME) stain 
for collagen and elastin.  
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Histological slides were digitized with a Scanscope slide scanner (Aperio Technologies Inc., 
Vista, CA) at 20× magnification. A pathologist examined and manually segmented the digitized slides 
using ImageScope (Aperio Technologies Inc., Vista, CA), a freely-available slide viewing/annotation 
software package, and indicated areas of necrotic core, fibrous cap, calcification (with help from the µCT 
images), fibrosis, and hemorrhage. Fibrous cap thickness was manually measured from pathologist 
annotations by drawing lines with the imdistline tool in MATLAB. After annotation, plaques were 
assigned grades based on the American Heart Association (AHA) plaque classification system [16]. 
8.3  Results  
Carotid plaques were successfully imaged without adverse event from an additional 11 males and 
6 females. Of these samples, 3 were noted to be badly damaged/fractured after surgery and were difficult 
Table 8.1: Patient characteristics. 
 Total (N = 25) 
Male (number)  16 (64%) 
Age (years) 62.4 ± 10.52 
Doppler-indicated  
systolic velocity (cm/s) 404.68 ± 131.18 
Doppler-indicated  
diastolic velocity (cm/s) 150.91 ± 63.89 
Symptomatic  18 (72%) 
   Amaurosis fugax 5 
   TIA 8 
   Completed stroke 6 
ARFI focal depth (cm) 2.2 ± 0.42 
Peripheral vascular disease 9 (36%) 
Diabetes mellitus 6 (24%) 
Hyperlipidemia 22 (88%) 
Hypertension 22 (88%) 
Smoking history 21 (84%) 
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to align, and 14 underwent µCT imaging. Patient characteristics for the full data set including patients 
from Chapter 6 are given in Table 8.1 (N = 25 patients). 
Figure 8.1 and Figure 8.2 show an example of how specimens were aligned using µCT. This 
particular sample was extracted from a symptomatic (TIA) 71 year-old male with a past medical history 
of coronary artery disease, myocardial infarction, and previous contralateral CEA. Figure 8.1 shows the 
gross specimen photograph next to a 3D µCT rendering in a coronal perspective. The bifurcation is 
clearly identified at the bottom of the specimen in both photograph and 3D rendering, and is confirmed by 
the surgeon’s suture which marks the cephalad portion of the ICA. The axial and sagittal slices (oriented 
dynamically with Slicer) are depicted with red and yellow dashed lines. From the µCT data, a small 
calcification is identified almost precisely at the location of the bifurcation (white arrow). In vivo B-mode 
imaging of the bifurcation shows that the ICA and ECA in this patient were oriented next to each other 
 
Figure 8.1: Comparison of gross CEA specimen and µCT 3D rendering. (a) Gross 
photograph of CEA specimen. (b) 3D rendering of µCT volume. Green pixels represent 
soft tissue while yellow pixels represent calcium. Only one small calcification was seen 
in this plaque, located directly at the bifurcation (white arrow). The dashed lines 
represent positions of the axial (red) and sagittal (yellow) slices that correspond with the 
transverse and longitudinal ultrasound images. 
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(Figure 8.2a), and that there was substantial stenosis in the proximal ICA (Figure 8.2b). Aligning the µCT 
volume to the transverse B-mode (Figure 8.2c), and taking the corresponding sagittal slice yielded a µCT 
image that matched nearly perfectly with the longitudinal B-mode (Figure 8.2d). Note that B-modes 
shown in Figure 8.2 were taken from the patient’s medical record and not captured simultaneously with 
ARFI imaging. Finally, the matching histological plane and corresponding ARFI image are shown in 
Figure 8.3. Histology demonstrated that this was a complicated Type VI plaque with a large necrotic core 
and ruptured fibrous cap at the point of maximal stenosis identified previously by B-mode. ARFI-
 
Figure 8.2: Example of plaque alignment using ex vivo µCT imaging. (a) Transverse B-mode image 
showing the carotid bifurcation. The small calcification appears as a bright spot in the B-mode. (b) 
Longitudinal B-mode of the ICA showing a focal stenosis just past the bifurcation. (c) Axial slice through 
µCT volume positioned such that the ICA and ECA orientation match the in vivo B-mode. (d) Sagittal 
slice through µCT volume showing nice agreement with longitudinal B-mode. The orientation determined 
in panels (c) and (d) guided how the sample was embedded for sectioning. The 3D rendering of the µCT 
volume is shown in Figure 3.2. 
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measured displacements in the region of the hemorrhagic necrotic core were high, 6.6 ± 6.7 µm compared 
to the rest of the plaque (2.15 ± 0.79 µm). Average fibrous cap thickness measured from histology was 
0.24 ± 0.09 mm, the thinnest cap observed in this study. Although difficult to see in ARFI imaging, a 
small band of lower displacing pixels was observed at the location of the fibrous cap. This band of lower-
displacing pixels was measured to be 0.51 ± 0.15 mm thick, substantially overestimating the FC thickness 
measured from histology. However, the band appeared to be discontinuous from the rest of the low-
displacing pixels suggesting that plaque rupture may be inferred by the lack of low-displacing pixels 
separating the high-displacing plaque region from the lumen. 
Figure 8.4 shows the imaging results from the right internal carotid artery (ICA) of a symptomatic 
45-year-old female. B-mode imaging shows a generally echolucent plaque, with an area of bright 
echogenicity toward the right side of the distal wall plaque. ARFI imaging, focused at a depth of 16 mm, 
 
Figure 8.3: Carotid ARFI image with matched histology and ex vivo µCT imaging from a symptomatic 
71-year-old male. (a) Hybrid ARFI/B-mode peak displacement image showing a focal stenosis with high 
peak displacement (yellow outline) and a bright echogenic region embedded in a region of low 
displacement (magenta outline). (b) µCT image showing minor calcification (magenta outline) proximal 
to the focal stenosis. (c) CME stain shows a complicated Type VI plaque with large necrotic core and 
hemorrhage at the main stenosis, co-aligned with the region of high displacement on ARFI imaging. 
Smaller necrotic cores present in the proximal wall do not appear in the ARFI image. A very thin fibrous 
cap is measured in the distal wall (0.24 ± 0.09 mm) 
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shows a focal stenosis with plaque in both proximal and distal walls. Plaque in the proximal wall appears 
to displace far (10.8 ± 11.7 µm) and is covered by a low-displacing region (2.8 ± 0.9 µm disp., 0.93 ± 0.4 
mm thick) suggesting necrotic core and fibrous cap. Plaque in the bottom wall appears to have a focal 
region of relatively higher displacement (3.0 ± 1.6 µm) also covered by a stiffer region (1.5 ± 0.5 µm 
disp., 0.56 ± 0.1 mm thick). Histology confirms the presence of AHA Type Va plaques in both proximal 
and distal walls, with necrotic core and fibrous caps with thicknesses of 0.91 ± 0.1 mm, and 0.60 ± 0.1 
mm, respectively). Although not depicted in the ARFI field of view, the echogenic region in the right part 
of the distal wall plaque spatially aligned with a region of calcification as seen on µCT. 
 
Figure 8.4: Carotid ARFI image with matched histology and ex vivo µCT imaging from a 45-year-old 
symptomatic female. (a) ARFI peak displacement image. Significant stenosis is visible due to plaque in 
both the proximal and distal wall. In the proximal wall, an area of large displacement (yellow outline) is 
observed, covered by a lower displacing cap. Relatively larger displacements are also seen in the distal 
wall, but with smaller absolute magnitude. (b) µCT image showing minor calcification in the distal wall 
(magenta outline), that matches with a bright spot on B-mode (magenta). (c) H&E stain and (d) CME 
stain show a Type Va plaque with necrotic core in both the proximal and distal walls (yellow outline). 
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Figure 8.5 shows a series of ARFI PD images from three asymptomatic patients and three 
symptomatic patients. Regions of high displacement are indicated with yellow arrows, and areas where 
the lumen appears to communicate with a region of high displacement (which may indicate rupture) are 
shown with white arrows. Figure 8.5a shows a Type Va plaque (large necrotic core covered by a fibrous 
cap) from an asymptomatic patient. The corresponding ARFI image shows a plaque with a large low-
displacing region (1.34 ± 0.5 µm disp.) coincident to an area of dense collagen on histology to the left of a 
region of high displacement (3.39 ± 0.9 µm disp.). The low-displacing region separating the high-
displacing region from the lumen was measured to be 0.65 ± 0.13 mm thick, which overestimates the 
fibrous cap thickness measured from histology (0.34 ± 0.11 mm thick). 
 
Figure 8.5: Series of ARFI peak displacement images taken from six endarterectomy patients. (a) Type 
Va plaque from asymptomatic 65 y/o male. Histology showed substantial collagen deposition next to a 
necrotic core covered by a thin fibrous cap (0.34 ± 0.11 mm). (b) Type Vb plaque from asymptomatic 64 
y/o male. Histology showed substantial calcification of the fibrous cap. (c) Type VI plaque from 
asymptomatic 65 y/o female. Histology showed hemorrhage interspersed with significant calcification. 
(d) Type VI plaque from symptomatic 46 y/o female. Histology revealed hemorrhaged necrotic core at the 
focal stenosis point.  (e) Type VI plaque from symptomatic 75 y/o male. Histology revealed ulcerated 
plaque with mild calcification and hemorrhage. (f) Type VI plaque from symptomatic 71 y/o male. 
Histology showed plaque with large hemorrhaged necrotic core and mild calcification. Yellow arrows 
depict regions of increased ARFI displacement that correlate to underlying necrotic/hemorrhagic regions 
on histology. White arrows depict regions where lumen communicates with region of high-displacement 
suggesting plaque rupture/hemorrhage. 
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Figure 8.5b shows a Type Vb plaque (plaque with substantial calcification) from an 
asymptomatic patient. In the ARFI image, the plaque appears to be generally low-displacing (1.49 ± 0.6 
µm) with exception of a small, slightly higher-displacing region (2.12 ± 0.7 µm) located in the center 
(yellow arrow). Histology demonstrates a plaque with calcified fibrous cap overlaying a region of 
necrosis. The low-displacing region separating the high-displacing region from the lumen in the ARFI 
image was measured to be 1.05 ± 0.28 mm thick, which does not agree well with the fibrous cap 
measured from histology (0.38 ± 0.12 mm). However, if calcification (which is expected to give a stiff 
response) is included in the cap thickness measurement, the thickness measured from histology increases 
to 1.16 ± 0.44 mm. This example demonstrates that ARFI-based plaque characterization may be 
influenced by concomitant features with similar material stiffnesses. 
Figure 8.5c shows a Type VI plaque (complicated plaque with hemorrhage) with substantial 
calcification from an asymptomatic patient. Despite the presence of hemorrhage, the ARFI image shows a 
homogeneously low-displacing plaque (1.39 ± 0.6 µm disp.). Like the previous example, this plaque 
demonstrates that ARFI plaque characterization may be hampered by concomitant calcium, which in this 
case causes a complicated Type VI plaque to appear stiff. Interestingly though, in both Figure 8.5b and 
Figure 8.5c, the patients were asymptomatic. Further prospective studies must be performed to determine 
whether ARFI can predict which of these plaques would be likely to develop symptoms or cause future 
stroke. 
Figure 8.5d-f show three examples of Type VI plaques from symptomatic patients. In each of 
these examples, plaque rupture/ulceration appears to be evident as a communication between the lumen 
and a region of high displacement (white arrows). The ARFI images all show areas of very large peak 
displacements (yellow arrows), suggesting very soft plaques, that spatially align with areas of 
hemorrhage/necrotic core. Peak displacements in these regions were measured to be 2.52 ± 0.7 µm, 3.63 
± 0.8 µm, and 6.66 ± 9.7 µm, for panels d, e, and f, respectively. Interestingly, average fibrous cap 
thicknesses from each of these examples were measured to be quite thick at 0.83 ± 0.28 mm, 0.82 ± 0.4 
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mm, and 0.895 ± 0.16 mm from histology, and 0.72 ± 0.19 mm, 1.06 ± 0.3 mm, and 0.95 ± 0.29 mm from 
ARFI.  
 Finally, Figure 8.6 shows a quantitative comparison of ARFI-derived fibrous cap thickness 
compared against histology utilizing Bland-Altman (BA) analysis. Note that one example was excluded 
(shown as a red circle) due to excessive calcification of the fibrous cap, which made it appear thicker than 
indicated on histology (the plaque shown in Figure 8.5b). BA analysis showed that ARFI had a small but 
statistically significant positive bias (0.12 ± 0.16 mm, p = 0.014) for estimating fibrous cap thickness. 
This bias matched very closely to that predicted by FEM for the corresponding imaging parameters (0.13 
± 0.05 mm), although with slightly higher standard deviation. When fibrous caps below the expected 
ARFI imaging resolution of 0.4 mm were excluded from analysis, the positive bias fell slightly to 0.08 ± 
0.16 mm and was not statistically significant (p = 0.1).  
 
Figure 8.6: Linear regression and Bland-Altman analysis on ARFI-measured fibrous cap thickness versus 
histology-measured fibrous cap thickness for an unblinded reader. One sample (shown in red) was 
excluded from analysis due to the coinciding calcification in the fibrous cap that made it appear much 
thicker on ARFI imaging.  
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8.4 Discussion  
The results presented in this chapter further demonstrate the applicability of ARFI imaging for 
atherosclerotic plaque characterization. ARFI peak displacements were shown to compare favorably with 
underlying histology, with areas of lipid/necrotic core tending to displace farther than areas of collagen or 
calcium. Additionally, ARFI images of ruptured/hemorrhaged plaques were captured for the first time. As 
hypothesized, these regions had higher displacements than areas of collagen; however, the upper limit of 
displacements was similar to that of necrotic core making it difficult to discriminate hemorrhage 
uniquely. Nevertheless, as shown in Figure 8.5, it may be possible to infer hemorrhage by identifying 
regions where high-displacing plaque communicates with the lumen. One aspect of hemorrhage that could 
not be tested thoroughly in this study was the impact of old versus new hemorrhage. It may be expected 
that old hemorrhage that has sufficiently clotted may actually increase the plaque stiffness as compared to 
a non-ruptured necrotic core. However, larger clinical studies must be performed to determine if this is 
the case. 
In addition to confirming expected stiffness responses of various plaque features, this study also 
demonstrated the capability of ARFI to measure fibrous cap thickness in an in vivo setting. BA and 
regression analysis showed that ARFI-measured thickness was correlated to histological thickness and 
tended to have a positive bias compared to the true fibrous cap thickness. Encouragingly, the magnitude 
of the experimentally measured bias matched very closely with that predicted from FEM in Chapter 7. 
Unfortunately, due to the lack of fibrous cap examples with average thickness below 0.5 mm and the 
resolution limitation of 0.4 mm of the imaging system, it was not possible to rigorously test the 
performance of ARFI for detecting “critical” fibrous caps. Nonetheless, the agreement of in vivo results 
with FEM suggests that improvements in frequency and bandwidth of ARFI systems may allow for 
detection of these thin caps in future studies. 
One limitation of ARFI observed in this study was the dependence on focal depth. In a number of 
examples, the diameter of the carotid artery exceeded the depth of field of the ARFI pushing pulse, and 
the plaque in the wall outside of the focus would incorrectly represent the underlying histology. Even 
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when plaques in both proximal and distal wall fell within the ARFI focus, choosing only one dynamic 
range setting tended to affect interpretation of the deeper wall. For example, in the plaque shown in 
Figure 8.4, the chosen dynamic range favored detection of the necrotic core in the proximal wall because 
displacements in this wall drove the dynamic range up. PDs in the necrotic core of the proximal wall were 
over 3 times higher than PDs in the necrotic core of the distal wall, despite the fact that the distal wall had 
a thinner cap (which should increase the PD of the necrotic core as seen in Chapter 7). In the future, 
utilizing advanced imaging techniques, such as rapid multi-focal-zone ARFI [240], may help mitigate 
some of the focusing and uneven force distribution problems observed in this study. 
Calcification posed another challenge in a number of ARFI images in this study, particularly 
calcification in the proximal wall. Calcification is well known to be a strong ultrasound absorber/reflector, 
and thus very difficult to image around. In ARFI imaging, calcification can make features behind it 
appear stiffer than they should by reducing the overall ARF delivered to that tissue. Additionally, 
calcification was observed to introduce reverberation clutter, which also created low-displacement 
streaking artifacts behind the calcification and obscuring displacements in the distal wall. This type of 
artifact can be seen in Figure 8.3, where the otherwise red-colored lumen appears blue/yellow in the 
region directly below the small calcification. Although the penetration problem through calcium can only 
be mitigated by either increasing the acoustic intensity of the ARFI pulse or using more sensitive 
displacement estimators (to measure displacements smaller than the CRLB), the problems of the 
reverberation artifact may be improved by utilizing clutter suppression techniques such as harmonic 
imaging [237]. 
8.5 Conclusion  
Overall, this study supports the hypothesis that ARFI stiffness measurements reflect underlying 
plaque composition. As demonstrated previously on smaller scales, it was confirmed that relatively higher 
ARFI displacements tend to correspond to areas of lipid/necrotic core, while lower displacements 
corresponded to areas of collagen or calcium. Furthermore, it was shown for the first time that 
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ruptured/hemorrhaged plaques also exhibit a “soft” response to ARFI, although the displacement ranges 
were similar to those measured in intact necrotic core suggesting that it may be difficult to identify 
hemorrhage uniquely via PD measurements alone. However, based on a number of examples of ruptured 
plaques seen in this chapter, it is hypothesized that hemorrhage may be inferred by identifying regions of 
high-displacement in the plaque that communicate with the lumen and are not separated by a band of low-
displacing pixels that indicate fibrous cap. Finally, the capability of ARFI to measure fibrous cap 
thickness directly was demonstrated for a greater number of plaques than done previously. In the 
following chapter, these data sets will be presented to blinded image readers to confirm whether plaque 
features are identifiable when the underlying histology is unknown. 
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CHAPTER 9 
 Blinded-Reader Performance of ARFI Plaque Characterization 
 
9.1 Introduction  
Previous chapters have shown the feasibility of ARFI for delineating carotid plaque features such 
as soft lipid/necrotic core (NC) and fibrous cap (FC). However, up to this point, all analysis was 
performed by a single image reader who was not blinded to the histology. To truly demonstrate ARFI’s 
clinical potential, these results must be reproducible by unbiased image readers who are blinded to the 
true answers.  
In this chapter, we continue our analysis of the ARFI images taken in CEA patients by rigorously 
testing performance in a blinded reader study involving trained medical professionals. Similar to Chapter 
5, ARFI images are scored for various plaque compositional elements, and the detectability is determined 
by receiver operating characteristic (ROC) curve analysis. Additionally, a qualitative plaque stiffness 
scale (similar to the Gray-Weale echogenicity scale [110]) is developed for ARFI ultrasound and 
correlated to underlying plaque features. Finally, the blinded reader’s capability of measuring FC 
thickness is assessed, as was done with an unblinded reader in Chapter 8. 
9.2 Methods 
The methods implemented in this chapter utilize the same ARFI images taken from patients 
undergoing CEA that were presented in Chapters 6 through 8.  The reader is referred to these chapters for 
details on imaging methods and patient clinical characteristics (Table 8.1). 
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9.2.1  Reader Evaluation Study 
Six readers were recruited to evaluate ARFI images. The readers included three attending 
radiologists from UNC Hospital (two from neuroradiology and one from abdominal radiology), one 
sonographer, one interventional cardiologist, and one pathologist who served as a reader in the ex vivo 
study presented in Chapter 5. Most readers had no previous experience with ARFI imaging and were 
trained for approximately 2 hours prior to commencing ARFI image evaluation. The training regimen 
involved introducing the readers to the fundamentals of ARFI imaging, reviewing examples from 
preclinical and outside clinical studies [210], [267], and instructing readers on the annotation software 
(which is described in greater detail below).  The six readers were kept blinded to the histological results 
of the CEA specimens and patient clinical presentation during the course of ARFI image assessment. 
To facilitate reader evaluation, a custom graphical user interface (GUI) was developed in 
MATLAB to show image sets in a random order and save responses to the reader’s hard drive (Figure 
9.1). As was done in Chapter 5, the GUI consisted of two parts, an “overall” rating and segmentation 
portion, and a “subsection” rating portion. However, in contrast to the previous study that only utilized 
ARFI images, in this study, the B-mode and ARFI/B-mode overlay were shown side-by-side to better 
represent how ARFI would be used clinically. The reader was also given additional options to aid their 
interpretation of the image. A button was added that allowed the reader to look at the B-mode from the 
patient’s medical record leading up to surgery.  
Typically, this B-mode was higher quality (i.e. captured with harmonic imaging for reduced 
clutter, and frequencies around 9 MHz) than the B-modes captured in conjunction with ARFI sequences 
and more similar to the images that are seen in routine clinical practice. The high quality B-mode was 
stripped of any identifying information as well as any sonographer notes. Readers were also given an 
option to turn on image smoothing to reduce noise in the ARFI peak displacement image. The smoothing 
algorithm consisted of an interpolation step in the lateral dimension (3× spline interpolation) followed by 
2D wiener filtering (1 × 1 mm kernel size) using the wiener2 function in MATLAB. The smoothed  
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images appeared similarly to elastograms produced by commercial ARF-elastography products such as 
Siemens’ Virtual TouchTM Imaging (Siemens Medical Solutions USA Inc., Ultrasound Division). 
For the overall rating portion, the reader was first asked to give the image set a quality rating 
using a five-point scale: 1-Very bad; 2-Bad; 3-OK; 4-Good; 5-Very good. Next the reader scored the 
plaque echogenicity using the modified Gray-Weale scale [110]: 1-Uniformly echolucent; 2-
Predominantly echolucent; 3-Predominantly echogenic; 4-Uniformly echogenic; 5-Cannot be classified 
due to shadowing. A corollary plaque stiffness scale was developed for ARFI imaging and rated next: 1-
Uniformly soft; 2-Predominantly soft; 3-Predominantly stiff; 4-Uniformly stiff; 5-Cannot be classified 
due to shadowing. Finally, the reader was asked to segment various features including: plaque outline; 
collagen/fibrosis; calcium; lipid/necrotic core; fibrous cap; and intraplaque hemorrhage (IPH). 
Segmentation was performed interactively using the impoly tool in MATLAB. 
After segmenting the plaque and rating the overall plaque appearance, the readers moved on to 
 
Figure 9.1: GUI used by readers to grade and segment ARFI images. Note that in this screenshot the 
plaque is outlined in white (i.e. “guided” analysis). Readers also evaluated images when no outline was 
shown (i.e. “unguided” analysis). Segmentation colors are as follows (collagen – red, necrotic core – 
yellow, fibrous cap – magenta). 
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the subsection analysis, which was implemented similarly to Chapter 5. The GUI drew a black box on top 
of the ARFI and B-mode images, and the reader was instructed to independently rate the plaque features 
that were present inside the box. Four of the five plaque features that were segmented above (collagen, 
calcium, NC, and IPH) were rated on ordinal scales based on percent area of the feature. The rating scale 
was as follows: 1-Absent (0%); 2-Slight (1-25%); 3-Moderate (26-50%); 4-Extensive (51-75%); 5-Severe 
(76-100%). Fibrous cap was rated on a slightly different scale: 1-Absent; 2-Thin (~0.5 mm); 3-Moderate 
(~1 mm); 4-Thick (~1.5 mm). And finally, the reader was asked to judge if the plaque was ruptured (1-
No, 2-Yes) and also to grade the plaque type based on the modified-AHA plaque rating scale [76]. The 
readers were instructed to judge plaque rupture and IPH if they saw an area of lumen communicating with 
a soft region in the plaque. Ratings were performed for six subsections for every ARFI image (three on 
the proximal wall and three on the distal wall). 
After rating all ARFI images, the readers were asked to repeat their analyses, but now with ARFI 
images indicating the true plaque outline as determined by an unblinded reader (i.e. the author of this 
dissertation). Using this knowledge of the plaque outline, the readers were allowed to change their 
answers for feature segmentations and subsection ratings if desired. Both the unguided and guided 
readings of the data set were saved for analysis.  
9.2.2 Histology 
As was done in previous chapters, histology was rated by an expert pathologist who was blinded 
to the ARFI results. The pathologist’s rating was facilitated with another custom GUI developed in 
MATLAB (Figure 9.2). The histology GUI was similar to the ARFI GUI but only displayed histology 
slides instead of ARFI images, and had a few different options. First, the ultrasound-specific ratings were 
removed (e.g. image quality, echogenicity, plaque stiffness). Second, an additional ordinal rating option 
was added to the AHA pull-down and was labelled “N/A” that was used by the pathologist to indicate that 
a given subsection did not have enough tissue to be rated. Lastly, an additional plaque component 
category, termed “Loose Matrix”, was introduced to indicate areas of plaque that did not fall within the  
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classification of dense fibrosis (dark collagen stain, highly organized structure) or NC (light collagen 
stain, cholesterol clefts, cellular debris, amorphous structure). The loose matrix category followed the 
same ordinal scale as other the plaque features: 1-Absent (0%); 2-Slight (1-25%); 3-Moderate (26-50%); 
4-Extensive (51-75%); 5-Severe (76-100%).  
9.2.3 Statistical Analysis 
ARFI performance for identifying plaque features was quantified using a number of statistical 
approaches. To test performance for plaque components, parametric ROC curve analysis (bi-gamma) was 
performed on a subsection basis, similar to Chapter 5. Histological dichotomization was applied to create 
“true negative” and “true positive” distributions, and every dichotomization threshold was tested (results 
are only shown for the best threshold). Performance for a given plaque feature was determined by 
evaluating the area under the ROC curve (AUC), and by choosing an operating point that maximized 
sensitivity and specificity (with the constraint that sensitivity be greater than specificity) [277].  
 
Figure 9.2: GUI used by pathologist to grade and segment histology. Segmentation colors are as follows 
(plaque outline – blue, necrotic core – yellow, fibrous cap – magenta, calcium – green). 
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In addition to testing each plaque component separately, combined plaque component categories 
were created that merged plaque features with similar expected ARFI responses, i.e. collagen and calcium 
(which are expected to both be stiff) and NC and IPH (which are expected to both be soft). Merging 
categories was done by taking the highest ordinal response from the two categories, and comparing it to 
the equivalently combined histological response.  
To test the accuracy of AHA ratings, unweighted Cohen’s kappa (κ), a coefficient that describes 
level of agreement (on a scale of 0 to1, where 0 – no agreement, 1 – perfect agreement), was computed. 
The κ values were computed for the strictest case where no categories were combined (i.e. a 6×6 
contingency table for AHA ratings), and also for less-strict, collapsed cases (i.e. 2×2 tables), as done in 
Wintermark et al. [76]. Additionally, Spearman correlation coefficients (ρ) were calculated between 
plaque stiffness ordinal responses and histological plaque feature grades. 
Finally, contrast between the FC and NC in readers’ segmentations was calculated for ARFI and 
B-mode images following equation (7.3). To normalize contrast measurements between the two imaging 
modes, contrast was computed directly from pixel values of the displayed images (scaled between 0-255), 
and the ARFI color map was changed to an inverted grayscale (high displacement = low pixel value, low 
displacement = high pixel value) to match with the expected B-mode response (echolucent = low pixel 
value, echogenic = high pixel value). 
9.2.4 Image Inclusion Criteria 
Due to the challenges of spatially aligning CEA samples with six subsections in the ARFI image, 
detailed inclusion criteria were developed to only include well-matched data. First, subsections from any 
plaque specimen that were not whole after CEA were automatically rejected from statistical analysis. 
While histological processing was usually possible on fractured samples, these samples lacked notable 
landmarks, such as the carotid bifurcation, that were needed to spatially align them to the corresponding 
ARFI images. Next, any subsections that were rated as N/A by the pathologist (indicating that no tissue 
was present in histology) were excluded because there was no gold standard for these subsections. After 
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these histological exclusions, two ARFI exclusions were also implemented. First, any plaque with a mean 
image quality rating of less than 2 (“Bad”) was automatically excluded. Second, if either the proximal or 
the distal wall was outside of the ARFI focus, then all three subsections from that wall were excluded. 
The ARFI focus was expected to span approximately 5 mm; therefore, if the distance from the medial 
edges of the plaques in proximal and distal wall exceeded this, then only the wall that was within the 
focus was chosen for analysis.  
9.3 Results  
During the course of this clinical study, 26 plaques were harvested from 25 CEA patients (Table 
8.1) representing a total of 156 possible subsections (26 plaques × 6 subsection per plaque) and 52 walls 
(26 plaques × 2 walls per plaque). Six plaques were badly damaged, lost, or fractured during CEA, 
preventing spatial alignment, and one plaque was excluded due to image quality being less than two.  
Finally, an additional 14 subsections were removed due to pathologist rating of N/A, and 42 subsections 
(14 walls) were removed due to being outside the focus. The final data set included 58 subsections 
spanning 22 walls from 17 plaques extracted from 16 patients. Figure 9.3 shows a flowchart detailing the 
exclusion procedure. Figure 9.4 shows histograms of the final counts of plaque types that were included 
for analysis as well as the plaque types that were excluded after discounting those outside the ARFI focus. 
From the included plaque samples, the pathologist was able to measure 16 with fibrous caps (from 15 
plaques), which reduced to 14 after ARFI image quality exclusion.   
Boxplots of AUC values achieved by the readers (with plaque outline guides) are shown in Figure 
9.5 for each of the four plaque components evaluated in this study (collagen, calcium, NC, IPH), as well 
as the combined categories (collagen/calcium and NC/IPH). For these results, the histological category 
“collagen” was merged with the “loose matrix” category by taking the maximum ordinal response 
between the two for a given subsection, and a histological dichotomization threshold of >2 was used (i.e. 
ratings of “Absent” and “Slight” were counted as true negatives while ratings of “Moderate”, 
“Extensive”, and “Severe” were counted as true positives). 
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Figure 9.5a depicts the results for all six readers, and Figure 9.5b shows the results for the 
radiologists alone. When all readers were considered (Figure 9.5a), the median AUCs for each feature 
(ordered from highest to lowest) were as follows: NC, 0.762; dense collagen, 0.647; IPH, 0.636; calcium, 
0.566. The median AUC for the combined categories were higher than both taken separately, with the 
collagen/calcium category reaching a median AUC of 0.755 and the NC/IPH category reaching a median 
AUC of 0.877. Not surprisingly, the radiologists (readers 1, 2, and 3) outperformed the non-radiologists, 
 
Figure 9.3: Flowchart for specimen inclusion in blinded reader study. 
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having the three highest AUCs in the collagen/calcium category and three out of the top four in the 
NC/IPH category.  
When only the AUCs from the radiologists were considered (Figure 9.5b), the median AUCs for 
each feature were as follows: NC, 0.809; dense collagen, 0.696; IPH, 0.639; calcium, 0.612. The median 
AUC for the combined metrics when only considering radiologists were 0.859 for collagen/calcium and 
0.887 for NC/IPH. The radiologists’ ROC curves for the combined categories are shown in Figure 9.6, 
and the corresponding sensitivities and specificities for an operating point that maximizes their sum is 
given in Table 9.1. 
Figure 9.7 shows the change in median AUC when readers utilized the plaque outlines and were 
given the chance to change their answer. A positive change indicates that AUC increased with the 
outlines, while a negative change indicates the AUC decreased with the outlines. In nearly all cases the 
AUC increased as a result of giving the readers the plaque outlines. When considering all readers, the 
AUCs for the combined metrics improved by almost 8 percentage points equally between the stiff and 
soft groups. When only including the radiologists, the collagen/calcium combined metric improved 
 
Figure 9.4: Histograms showing counts of excluded and included subsections broken down by AHA 
plaque types. 
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substantially more than the NC/IPH category (16 percentage points compared to 5 percentage points, 
respectively) after the inclusion of the plaque outlines.  
Figure 9.8 shows the Spearman correlation coefficient between the qualitative ARFI stiffness 
score (from the three radiologists) and the pathologist’s rating for a given plaque compositional element. 
The nature of the stiffness scale is such that high values on the scale indicate stiff plaque and should be 
positively correlated with stiff features, while low values indicate soft plaque and should be inversely 
correlated to soft histological features. As expected, the results demonstrate that qualitative ARFI 
stiffness ratings were positively correlated with collagen (median: 0.329, p = 0.012) and inversely 
correlated with NC (median: -0.515, p < 0.001) and IPH (median: -0.274, p = 0.037). Surprisingly, 
calcium only showed a weak positive correlation (median: 0.165, p = 0.217); however, it was not 
statistically significant. The combined categories yielded slightly higher median correlation coefficients 
than their individual members; the collagen/calcium category was positively correlated (median: 0.379, p 
= 0.003) while the NC/IPH category was negatively correlated (-0.531, p < 0.001).  
 
 
                                    (a)                             (b) 
Figure 9.5: Boxplots of reader AUC for various plaque composition elements. Results for all readers are 
shown in (a), while results for just the radiologists are shown in (b). Dashed vertical line separates the 
individual plaque categories from the combined categories. COL, collagen; CAL, calcium; NC, 
lipid/necrotic core; IPH, wide intraplaque hemorrhage; C/C, combined collagen/calcium; N/I, combined 
necrotic core and intraplaque hemorrhage.  
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Figure 9.6: ROC curves for radiologists for detecting combined stiff features (collagen and calcium) and 
combined soft features (necrotic core and intraplaque hemorrhage). Boxplots showing AUC for the two 
categories are reprinted from Figure 9.5 for comparison. 
 
 
Table 9.1: Sensitivity and specificity for combined plaque categories. 
 Collagen/Calcium Necrotic Core/Hemorrhage 
Reader Sensitivity Specificity Sensitivity Specificity 
1  0.832 0.602 0.805 0.804 
2 0.795 0.76 0.853 0.835 
3 0.854 0.853 0.789 0.788 
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 Cohen’s kappa analysis for AHA plaque rating (Figure 9.9) reflected the performances observed 
in the ROC analysis. When evaluating each plaque type individually (i.e. a 6 × 6 frequency table), the 
ARFI-determined AHA plaque ratings did not agree strongly with the gold standard (median κ = 0.215, p 
= 0.02), although it was statistically significant. However, when the frequency table was collapsed and 
merged (i.e. 2 × 2 tables) to evaluate agreement between combined categories (Type Va or Type VI) and 
(Type Vb or Vc), concordance between ARFI and histology ratings increased substantially. When plaques 
with large NC (Type Va) and plaques with IPH (Type VI) were combined, the median kappa coefficient 
was 0.515 (p < 0.001), and when plaques with large calcifications (Type Vb) and plaques with dense 
collagen (Type Vc) were combined, the median kappa coefficient was 0.468 (p = 0.003).  
Performance for measuring FC thickness is demonstrated in Figure 9.10 and Figure 9.11. Figure 
9.10 shows a comparison of ARFI-measured FC thickness to histologically measured FC thickness for all 
readers as well as just the radiologists. The dashed line represents the line of equivalency. Average FC 
thickness as measured by histology ranged from 0.24 mm up to 1.26 mm. When considering all readers  
 
Figure 9.7: Barplots showing the difference in median AUC when readers were given the plaque outline 
versus when they were not. Positive change indicates that median AUC increased after showing plaque 
outlines, negative change indicates that median AUC decreased after showing plaque outlines. COL, 
collagen; CAL, calcium; LPL, lipid/necrotic core; IPH, wide intraplaque hemorrhage; C/C, combined 
collagen/calcium; L/I, combined lipid and intraplaque hemorrhage. 
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(Figure 9.10a), performance for accurately measuring FC thickness was poor; reader 5 in particular 
struggled to identify any of the FCs and had substantial error in their measurements. Agreement between 
ARFI-measured thicknesses improved dramatically when only considering results from the three 
radiologists (Figure 9.10b). Regression and Bland-Altman (BA) analysis on each individual radiologist 
(Figure 9.11) demonstrated that readers 1 and 2 (i.e. the neuroradiologists) had the highest agreement for 
measuring FC thickness with coefficients of determination (R2) values of 0.64 and 0.89, respectively. BA 
analysis showed that reader 1 had a slightly wider spread of measurement error, however, with a non-
significant negative bias (-0.048 ± 0.18 mm, p = 0.41), while reader 2 had a tighter spread but with a 
significant positive bias (0.13 ± 0.09 mm, p = 0.007).  When results from all three radiologists were 
combined, a statistically significant positive bias was also measured (0.12 ± 0.30 mm, p = 0.037). Of 
note, the mean positive bias across all three radiologists matched nearly identically to the mean positive  
 
Figure 9.8: Spearman correlation coefficient between reader-assigned qualitative stiffness score and 
plaque components. Data shown for radiologists only. Vertical line indicates separation between 
individual categories and combined categories. COL, collagen; CAL, calcium; LPL, lipid/necrotic core; 
IPH, wide intraplaque hemorrhage; C/C, combined collagen/calcium; N/I, combined necrotic core and 
intraplaque hemorrhage. 
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bias predicted by FEM in Chapter 7 (0.13 ± 0.05 mm) for the equivalent imaging parameters (6 MHz and 
1.5λ tracking kernel). Given the considerably larger standard deviation on the radiologist’s measurements 
as compared to FEM (±0.3 mm vs. ±0.05 mm), it is possible that this result was coincidental, 
nevertheless, the level of agreement between FEM and in vivo measurements was highly encouraging.  
Lastly, Figure 9.12 shows a comparison of the contrast between the FC and the NC in both B-mode 
and ARFI PD images, as segmented by the radiologists. In each case, contrast from ARFI statistically 
significantly exceeded that of B-mode. Median ARFI contrast for each reader ranged from 4.4 dB to 8.9 
dB, while median B-mode contrast ranged from -0.29 dB to 0.35 dB. These results suggest that without 
ARFI, the radiologists would not be able to contrast the FC from NC/IPH using the provided B-modes 
alone. 
 
Figure 9.9: Cohen’s kappa for AHA plaque type ratings. Data shown for the full 
contingency table (6×6), and two collapsed tables (2×2) where type Va and VI 
plaques (i.e. soft plaques) were combined and type Vb and Vc (i.e. stiff plaques) were 
combined. 
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9.4 Discussion  
This study represents the first quantitative in vivo validation of ARFI carotid plaque 
characterization done in humans. Six blinded readers spanning a wide range of medical professionals 
evaluated ARFI images and were able to distinguish soft lipid-rich or hemorrhagic plaques from stiff 
fibrotic or calcified plaques with varying levels of success. In general, readers were able to better 
characterize features when the borders of the plaque were identified for them, and readers with greater 
levels of experience evaluating medical images, i.e. the radiologists, tended to outperform their non-
radiologist counterparts. Neuroradiologists, specifically, achieved the highest agreement for measuring 
FC thickness, suggesting that reader familiarity with carotid ultrasound improved reader performance.  
Examining the AUC values presented in Figure 9.5, it is clear that ARFI struggled to distinguish 
regions of collagen, calcium, and hemorrhage when each category was taken separately. In each case, 
median AUCs never exceeded a value of 0.7, even when only considering the performance of 
radiologists. Of the individual categories, NC had the highest detection rate with a median AUC of 0.809,  
 
                                (a)                                (b) 
Figure 9.10: ARFI-measured fibrous cap thickness measurements by blinded readers compared against 
histological thickness. (a) Results for all readers. (b) Results for radiologists only. Reader ID number is 
given in the legend. 
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Figure 9.11: Regression and Bland-Altman analysis of ARFI-measured fibrous cap 
thickness versus histology from three blinded radiologists. R2, coefficient of 
determination; rho, Spearman correlation; RPC, reproducibility coefficient; CV, 
coefficient of variation; SD, standard deviation.  
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albeit with a wide range (0.690 – 0.888). As predicted in prior chapters, ARFI performance was 
substantially improved when features with like stiffness were grouped into combined categories, namely 
collagen and calcium, and NC and IPH. AUCs for the combined metrics had median values of 0.859 and 
0.887, respectively, with upper ranges reaching as high as 0.92. These results are reinforced by the 
analysis of Spearman correlation for the plaque stiffness scale (Figure 9.8) and Cohen’s κ (Figure 9.9) 
which show similar trends. Clinically, these data are encouraging because plaques with either NC or 
hemorrhage have both been shown to be relevant to predicting future ischemic events, with mean hazard 
ratios of 3.00 and 4.59, respectively [102].  
Although discrimination of IPH from NC and calcium from collagen was not realized in this 
study, it is expected that these features may be differentiable with improved reader training and 
enhancements to the ARFI imaging system. As mentioned previously, readers were largely untrained 
prior to enrolling in the study due to the limited number of training examples available to them. Because 
of this, no training was done on samples harvested from enrolled CEA patients in order to have the 
highest sample size possible for statistical analysis. Therefore, readers were limited to training mainly on 
porcine plaque examples taken from our prior studies and a small number of previously published in vivo 
human examples. This likely impacted IPH detection the most because none of these prior studies 
 
       (a)      (b)      (c) 
Figure 9.12: Comparison of B-mode and ARFI contrast between fibrous cap and necrotic core. For all 
readers, ARFI gave statistically significantly higher contrast than B-mode. 
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included examples of complicated Type VI plaques. With further training, it is possible that readers may 
be able to better identify disruptions in FCs as shown in Chapter 8.  
In terms of calcium and collagen discrimination, it is likely that simply incorporating modern B-
mode imaging techniques (such as harmonic imaging and spatial compounding) will greatly improve 
detection of these features independent of each other. B-mode sensitivity to calcium has been shown to be 
quite high in other studies (88.2%) [278], whereas in this study it was low, suggesting either that our B-
modes were inferior or that ARFI data confounded the reader interpretation of calcium causing them to 
alter their answers. The former is more likely to be the case considering that B-mode images captured 
with the Siemens URI tool only included fundamental-frequency images with no additional processing 
and, anecdotally, readers expressed concerns that B-modes were difficult to interpret during training 
sessions. However, the second hypothesis may also be valid because ARFI displacements in regions of 
calcification tended to be noisier than in collagen alone (most likely due to poor displacement tracking). 
Although beyond the scope of this study, a thorough evaluation comparing ARFI/B-mode to B-mode 
alone for plaque characterization should be conducted and will be a topic of future experiments.   
  In addition to improving the B-mode images, it is expected that utilizing higher-energy ARFI 
excitations (or improved motion tracking techniques [279]) may aid in discrimination of these features as 
well. As seen in Chapters 6 and 8, displacements in fibrotic/calcified plaques were relatively low (~1-2 
µm) and approached the fundamental noise floor of the cross-correlation tracking algorithm. If 
displacements in these features could be increased (via higher energy ARFI pulses), or the noise floor 
itself could be reduced (via improved tracking algorithms), it may be possible for ARFI to discriminate 
the two features.  
This study also demonstrated the capability for utilizing ARFI to make FC thickness 
measurements (Figure 9.11). Two of the three radiologists, specifically the two neuroradiologists, were 
able to achieve high R2 values (0.64 and 0.89), and good agreement on Bland-Altman analysis. However, 
due to the small number of FCs with a true average thickness of <0.5 mm, the capability of ARFI for 
detecting “critical” caps could not be assessed rigorously. There were only three examples in the data set 
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of FCs that were less than 0.5 mm thick. The thinnest cap (0.24 mm) was completely missed by all three 
radiologists, the second thinnest cap (0.34 mm) was caught by two radiologists but incorrectly classified 
by both as having a thickness of >0.5 mm, and the third cap (0.49 mm) was caught by two radiologists 
and correctly classified by both as having a thickness of <0.5 mm. Not surprisingly, this third cap in the 
series was the only one that was thicker than the expected axial resolution limit of the system (0.4 µm at 
6.15 MHz and 1.5λ tracking kernel). Although more data should be collected to determine whether ARFI 
is sensitive to <0.5 mm caps, the results depicted in Figure 9.11 suggest that ARFI should be able to 
determine whether a cap is “non-critical” (i.e. >0.5 mm) with relatively high accuracy. This performance 
is also expected to increase by utilizing higher frequency ARFI configurations as seen in Chapter 7. 
There were a number of limitations to this study. First, a large number of plaque subsections (N = 
42, out of 100) had to be excluded because a given wall fell outside of the ARFI focus. This represents 
one of the main drawbacks of ARFI; namely, that if the focus is not set precisely, complete plaque 
characterization may be hindered. This problem may be alleviated in the future using rapid multi-focal-
zone ARFI techniques to extend the depth of field of an ARFI image [240]. Second, as described 
previously, perfect alignment between ultrasound and histology was challenging. Histological samples 
were occasionally warped or poorly adhered to the slide (particularly NC tissue), which sometimes made 
rating samples difficult. Great care was taken to ensure that each histological slice was aligned to the 
corresponding ARFI image prior to being given to the pathologist for rating; however, it is expected that 
there remained some amount of disagreement between histology and ARFI imaging planes (particularly 
for images that were acquired prior to the development of the µCT alignment techniques described in 
Chapter 8). Finally, as was done in Chapter 5, each subsection was considered to be an independent 
sample for statistical analysis. This assumption is valid for most cases, but not valid for adjacent 
subsections from the same plaque wall. Due to the challenges with describing a correlation function for a 
given reader between adjacent subsections, this assumption was accepted, as was done in Chapter 5, 
under the justification that our parametric estimations of reader response distributions should still be 
statistically consistent even without knowing the correlation structure.  
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9.5 Conclusion  
This study has demonstrated the potential for blinded readers to use ARFI for discriminating soft 
from stiff plaque components under guided conditions (i.e. when the plaque border is outlined). Although 
the readers achieved relatively low AUC for distinguishing individual plaque components, performance 
improved for combined stiff collagen and calcium (median AUC: 0.859) and soft lipid-rich necrotic core 
and hemorrhage (median AUC: 0.887) categories. Additionally, ARFI was capable of measuring fibrous 
cap thickness as thin as approximately 0.49 mm and showed good agreement with histologically 
measured thickness. Lastly, the performance of ARFI for plaque characterization was shown to be highly 
dependent on reader specialization (with radiologists performing better than non-radiologists). Given 
these encouraging preliminary results, the next step to translating ARFI to the clinic will be to perform 
prospective clinical trials to determine whether ARFI features can be used to predict plaque vulnerability 
and future ischemic events.  
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CHAPTER 10 
 Towards Intravascular ARFI (IV-ARFI) Imaging 
 
The following chapter describes a novel, dual-frequency ultrasound transducer designed for 
catheter-based ARFI imaging with application in coronary plaque characterization. Two designs are 
presented; an initial prototype transducer with a 5 MHz pushing element and a 40 MHz tracking element, 
and a second-generation design with 6.5 MHz pushing element and 26 MHz tracking element. Feasibility 
of ARF generation is shown first using optical tracking techniques, followed by full ARFI ensemble 
acquisition in a tissue-mimicking phantom. Additionally, acoustic characterization is performed for both 
transducers. The results of this study show that ARFI imaging is feasible on a small-aperture transducer 
fit for IVUS implementation. 
10.1 Introduction  
The methods presented thus far for ARFI-based plaque characterization have focused on imaging 
plaque specifically in the peripheral arteries, such as the carotid arteries. Peripheral arteries are typically 
superficial and have relatively large diameter making them ideal imaging targets for ARFI. Coronary 
arteries, on the other hand, are small, deep, and obstructed by ribs. Transthoracic ultrasound can be used 
to image all three of the major coronary arteries (left anterior descending, circumflex, and right coronary 
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X. Jiang, “Acoustic radiation force (ARF) generation with a novel dual-frequency intravascular transducer,” in Proc. 
IEEE Ultrason. Symp., Chicago, IL, USA, 2014. 
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artery) [280]; however, the frequencies (3-5 MHz) and small aperture sizes (≤1 cm) required for this type 
of imaging are far too low to image vulnerable plaque features such as thin fibrous caps (<0.65 mm). 
Therefore, ultrasonic coronary plaque imaging is typically performed with minimally-invasive 
intravascular ultrasound (IVUS) [281]. In IVUS, an ultrasound transducer (single element or an array) is 
placed at the end of a catheter and guided to the coronary vasculature through a femoral access site. 
A significant challenge with implementing ARFI on an IVUS system is that IVUS transducers 
and arrays typically operate at very high frequencies (20-45 MHz) and are not designed to sustain the 
high-voltage, long-duration pulses required for ARFI imaging. Additionally, when high frequencies are 
used for the ARF pulse, the magnitude of the displacements may be reduced due to the significant 
attenuation of acoustic intensity at higher frequencies. Indeed, in a preliminary study that implemented 
ARFI on two modified Volcano IVUS arrays [282], higher peak displacements were observed using 9 
MHz ARF pulses compared to 20 MHz, suggesting a tradeoff between spatial resolution and ARFI 
signal-to-noise ratio (SNR) when using single-frequency transducers. Therefore, an optimal IV-ARFI 
implementation for high-resolution coronary plaque characterization will most likely require a dual-
frequency approach similar to that proposed for corneal imaging [283].  
In this chapter, ARFI is first implemented on a small-aperture, dual-frequency IVUS transducer 
previously designed for microbubble contrast imaging [284]. The transducer’s capability to generate 
displacement with ARF is evaluated using previously described optical tracking methods [272]. Then, a 
second-generation transducer is designed to improve the performance of the IV-ARFI transducer and full 
acoustic tracking along with ARF-generation is demonstrated in a graphite phantom. 
10.2 Methods 
10.2.1 Transducer Design (1st Generation) 
The first generation transducer used in this study is described in detail in Ma et al. [284]. Briefly, 
the transducer was designed as a dual-element layered structure. The low-frequency “pushing” element 
(0.6 × 3.0 × 0.3 mm) comprised the lower layer of the transducer with the high-frequency “tracking”  
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element (0.6 × 0.5 × 0.065 mm) resting on top. Matching layers of Al2O3/epoxy and Parylene were casted 
and coated on top of the low-frequency and high-frequency elements, respectively, to improve acoustic 
output and sensitivity. A frequency-selective isolation layer was placed between the two elements to serve 
as a backing for the high-frequency element, and the entire structure was mounted on the tip of a 20-
gauge hypodermic needle. The active piezoelectric material used for both low and high frequency 
elements was lead magnesium niobate-lead titanate (PMN-PT). A photograph of the transducer is shown 
in Figure 10.1. 
10.2.2 Optical Phantom Construction 
A translucent, gelatin-based, tissue-mimicking phantom was constructed based on the formulation 
described in Appendix A. The phantom recipe consisted of the following ingredients (with percent 
 
Figure 10.1: Photograph of the front face of the first-
generation dual-frequency IVUS probe mounted on the end of 
a 20-gauge needle tip.   
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composition by mass in parentheses): 300 bloom type-A gelatin (4%; Sigma-Aldrich Corp., St. Louis, 
MO), agar (0.5%; Fisher Scientific, Fair Lawn, NJ), <15-µm graphite (0.36%), n-propanol (1%), corn 
syrup (15.5%) and de-ionized water (78.64%). The agar powder was left unmelted and served as the main 
acoustic scatterer, while the graphite particles served as markers for optical tracking. Corn syrup was 
added to increase the acoustic attenuation while maintaining translucency. Attenuation in the phantom 
was measured to be 0.3 dB/cm/MHz. 
Phantom stiffness was measured using ultrasonically-based shear wave speed measurement 
implemented on a Siemens Acuson Antares (Siemens Medical Solutions USA Inc., Ultrasound Division) 
scanner. Shear wave group velocity was measured using lateral time to peak methods described 
previously [189]. 
10.2.3 Optical Tracking of ARF Displacement 
ARF-induced displacements were measured in the translucent phantom with a custom high-speed 
camera setup described in Appendix A. The setup consisted of an acrylic water tank mounted on an 
Olympus IX71 inverted microscope (Olympus America Inc., Melville, NY) fitted with a 10× objective 
and opposing, coaxial, 100-W halogen illumination source. Optical data from the microscope were 
digitized with a Fastcam SA1 high-speed camera (Photron USA Inc., San Diego, California, USA) 
configured to acquire frames at 150 kHz across a 128 x 128 pixel field of view (FOV). Prior to data 
collection, the optical and acoustic foci were aligned using a needle hydrophone (HNC-0400, Onda Corp. 
Sunnyvale, CA) mounted on a manual micro-positioning stage. Figure 10.2 shows an illustration of the 
optical setup. 
With the acoustic and optical foci aligned, the needle hydrophone was replaced with an optical 
phantom held in an acrylic holder. Using the manual positioning stage, the phantom was translated until a 
graphite particle was visualized in the microscopes FOV. Once positioned, the manual and digital motion 
stages were locked for a stable data collection.  
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To generate ARF, sinusoidal bursts with varying pulse length (300, 600, 900, and 1200 cycles) at 
5 MHz were generated with an arbitrary function generator (AFG3102, Tektronix Inc., Portland, OR) and 
amplified by 50 dB with a radiofrequency amplifier (3200L, Electronic Navigation Industries Inc. 
Rochester, NY). The amplitude of the pre-amplified burst was set to 600 mVpp (190V after amplification). 
To synchronize data capture, the function generator was set to manual trigger mode, and the trigger output 
was connected to the TTL trigger of the high-speed camera. Five repeated acquisitions were captured at 
each of the pulse durations, and saved to disk for processing.  
Optical motion tracking was performed using 2D normalized cross correlation (NCC). Two-stage 
interpolation was utilized to measure subsample displacements; first, optical movie frames were 
upsampled by a factor of 4 using spline interpolation prior to running NCC, and then correlation curves 
 
Figure 10.2: Illustration of IV-ARFI optical tracking setup. 
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were further upsampled by a factor of 4 prior to selecting  the maximum. Finally, displacement profiles 
were filtered with a fourth-order 10 kHz lowpass Butterworth filter to reduce high-frequency noise. 
10.2.4 Acoustic Backscatter Test 
Individual A-lines were captured from the phantom using a custom program developed in 
Labview (National Instruments, Austin, TX). To test the motion-tracking capabilities of the transducer, 
one A-line was captured for reference and the transducer was moved with a manual motion stage ~0.1 
mm away from the phantom face. A-lines were imported into MATLAB, filtered with a fourth-order 
Butterworth bandpass (30-55 MHz), and motion tracked using one-dimensional normalized cross-
correlation. Specific parameters of the cross-correlation algorithm included upsampling the RF data with 
4× spline interpolation, and motion-tracking kernel sizes of 5λ, 6λ and 7λ. 
The pulse/echo capability of the high frequency element was tested using a standard non-
translucent graphite gelatin phantom. The phantom recipe consisted of the following ingredients: 300 
bloom type-A gelatin (5%), graphite (5%), n-propanol (1%), and de-ionized water (89%). The phantom 
was congealed in a plastic container and a cylindrical hole (~5 mm diameter) was cut into the phantom 
from the top so the IVUS probe could be inserted. To generate acoustic pulses, the high-frequency 
element was driven with a pulser/receiver (5900PR, Panametrics Inc., Waltham, MA) using 1 µJ output 
energy. The receive settings on the pulser included a 10-50 MHz analog bandpass filter and 48 dB gain. 
 
Figure 10.3: Structure of the second-generation IV-ARFI transducer. Single-crystal PMN-PT served as 
the active material for both the high (coaxial 1) and low (coaxial 2) frequency elements. PI film was used 
as a frequency-selective isolation layer. Epo-tek epoxy and Al2O3 was used for the matching layers. 
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The received voltage signal from the pulser was sampled with an A/D card (PDA16; Signatec Inc., 
Newport Beach, CA) at 160 MHz.  
10.2.5 Transducer Design (2nd Generation) 
The second-generation dual-frequency IVUS transducer similarly consisted of a PMN-PT single 
crystal low-frequency pushing element (6.5 MHz) and a PMN-PT single crystal high-frequency tracking 
element (26 MHz). The dimensions of the low-frequency pushing and high-frequency tracking elements 
were 5.0 mm × 0.6 mm × 0.3 mm and 0.5 mm × 0.6 mm × 0.07 mm, respectively (Figure 10.3). Similar 
to the first generation transducer, an acoustic isolation layer was placed between the two piezoelectric 
layers. However, a substantial change in this transducer was the addition of a second ground wire to help 
isolate the low and high frequency elements.  
A polyimide (PI) film was chosen to be used as the isolation layer of the high-frequency element 
and the thermal barrier because of its low acoustic impedance and low thermal conductivity. This thermal 
Table 10.1: Parameters of 2nd-generation IV-ARFI design. 
Parameter Pushing layer Tracking layer 
Center Frequency 6.5 MHz 26 MHz 
Active material PMN-PT PMN-PT 
Active material  impedance (MRayl) 32 32 
Active material width (mm) 0.6 0.6 
Active material length (mm) 5 0.6 
Active material thickness (μm) 300 70 
Matching Al2O3/epoxy Al2O3/epoxy 
and Parylene C 
Matching impedance (MRayl) 5.5 5.5 and 2.6 
Matching thickness (μm) 110 20 and 12 
Isolation material - Polyimide 
Isolation impedance (MRayl) - 3.5 
Isolation layer thickness (μm) - 12.5  
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barrier layer protects the high-frequency tracking element when a high voltage, long-duration pulse is 
applied to the low-frequency pushing element. 
The isolation layer thickness and the pulse-echo responses of high-frequency element were 
designed using the KLM model [285]. For the high-frequency element, a dual-matching-layer structure 
was designed to increase the bandwidth and the sensitivity. Primary design parameters are listed in Table 
10.1. 
A flow diagram of the fabrication strategy is shown in Figure 10.4. A PMN-PT single-crystal 
plate (5 mm × 5 mm × 0.3 mm) with Cr/Au as electrodes on both 5 mm x 5 mm surfaces was prepared 
first. A 12-µm PI film (Kapton HN, DuPont, Wilmington, DE) was metalized with Ti/Au on the top 
surface by using e-beam deposition as a connection with the bottom electrode of the high-frequency 
element. The PI film was bonded on top of the low-frequency element by using Epo-tek 301 (Epoxy 
Technology Inc., Billerica, MA). A small PMN-PT chip (5.0 mm × 0.6 mm × 0.3 mm) was then bonded 
on top of the PI film. An Al2O3/epoxy layer was poured to surround the high-frequency element and 
lapped to the designed thickness (0.07 mm). The top electrode (100Å Ti, 1000Å Au) of the high-
frequency element was deposited by e-beam deposition. Afterwards, the matching layer of the high-
frequency element (Al2O3/epoxy) was poured on the high-frequency element and lapped to 20 µm. Then 
 
Figure 10.4: Fabrication process of a dual-frequency IVUS transducer. 
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the whole package was bonded to a 20-gauge needle by using silver epoxy (8331-14G, M.G. Chemicals, 
Surrey, B.C., Canada). Two coaxial cables (MCX 40232, Hitachi Cable America Inc., Purchase, NY) 
were bonded to the high-frequency element and low-frequency element of the transducer, separately, 
using silver epoxy. Finally, a passivation layer and the second matching layer of the high-frequency 
element, Parylene C, with a thickness of 12 µm was coated by using the SCS Labcoter® 2 vacuum 
deposition system (PDS 2010, Specialty Coating Systems, Inc., Indianapolis, IN). Transducer design and 
fabrication was performed by collaborators at North Carolina State University (Zhuochen Wang, and Dr. 
Xiaoning Jiang). 
10.2.6 Transducer Characterization 
The second-generation dual-frequency IVUS transducer was characterized by measuring the 
complex electrical impedance, pulse-echo responses of the high-frequency element, and acoustic pressure 
transmission generated by the low-frequency element. Electrical impedance and phase were measured 
with an impedance analyzer (Agilent 4294A, Agilent Technologies Inc., Santa Clara, CA).  
The center frequency and fractional bandwidth of the high-frequency element were obtained from 
the pulse-echo measurement in a water tank using a pulser/receiver (5900 PR, Olympus Corp, Waltham, 
MA) and an oscilloscope (Agilent DSO7014B, Agilent Technologies Inc., Santa Clara, CA). The energy 
of the applied pulse was set to 1 μJ during pulse-echo test. A point target was placed in front of the high 
frequency element as the reflection target at a distance of 3 mm away from the aperture.  
The acoustic pressure measurement of the low frequency element was conducted by using a 
hydrophone (HNA-0400, ONDA Co, Sunnyvale, CA) positioned at 5 mm axially away from the 
transducer surface. A 5 V, 10-cycle sinusoidal burst at 6.5 MHz was generated by an arbitrary function 
generator (AFG3101, Tektronix Inc., Beaverton, OR). Pressure output was recorded using an oscilloscope 
(Agilent DSO7014B, Agilent Technologies Inc., Santa Clara, CA). 
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10.2.7 ARFI Testing 
A standard non-translucent graphite gelatin phantom with 10 kPa elastic moduli was prepared. 
The phantom recipe consisted of the following ingredients: 300 bloom type-A gelatin (5%), graphite 
(5%), n-propanol (1%), and de-ionized water (89%). The phantom was congealed in a plastic container 
and a cylindrical hole (~5 mm diameter) was cut into the phantom from the top so the IVUS probe could 
be inserted (Figure 10.5a). Phantom stiffness was measured using ultrasonically-based shear wave speed 
measurement implemented on a Siemens Acuson Antares (Siemens Medical Solutions USA Inc., 
Ultrasound Division) scanner. 
A custom program developed in Labview (National Instruments, Austin, TX) was used to control 
the low frequency pushing and high frequency tracking during the ARFI test (Figure 10.5b). The ARFI 
test was performed by pushing the phantom with 600, 900, and 1200-cycle sinusoidal bursts (92.3, 138.5, 
and 184.6 µs, respectively) using the low-frequency pushing element. The excitation bursts were 
generated with an arbitrary function generator (AFG3102, Tektronix Inc., Beaverton, OR) and amplified 
to 160 Vpp with a radiofrequency amplifier (3200L, Electronic Navigation Industries Inc., Rochester, 
NY). In order to track the displacement of the phantom, the high frequency element was driven with a 
pulser/receiver (5900PR, Olympus Corp, Waltham, MA) using 2 μJ output energy. The pulse/echo 
settings on the pulser included a 10-50 MHz analog bandpass filter and 48 dB gain. The received voltage 
signal from the pulser was sampled with an A/D card (PDA16; Signatec Inc., Newport Beach, CA) at 160 
MHz. The ARFI transmission and pulse/echo tracking were synchronized by the arbitrary function 
generator – channel 1 was programmed to output the ARF burst after a time delay of 0.2 ms, while 
channel 2 was programmed to output a trigger signal to drive the pulser/receiver at the tracking PRF.  
The ARFI pulse sequence was designed as 1) two reference A-lines followed by 2) a pushing 
pulse at the same location, and 3) 58 tracking pulses to monitor phantom displacement. A pulse repetition 
frequency (PRF) of 10 kHz was used for the pulse sequence. All raw RF data were saved to disk for 
offline processing. Prior to motion tracking the data were filtered with a 5-tap Butterworth bandpass (10-
40 MHz) and up-sampled by a factor of 4 using spline interpolation. Displacement was calculated using  
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normalized cross-correlation between the up-sampled reference and tracking lines [206]. Peak-hops, due 
to subtle inconsistencies with the pulser PRF, were observed and removed using a custom approach. This 
was implemented by motion tracking a known stationary echo (i.e. the transmit ring-down present in the 
nearfield), and subtracting the motion of the stationary echo from the displacement profile at the depth of 
interest (located ~2-5 mm away from the transducer). 
10.3 Results/Discussion 
10.3.1 First-Generation Transducer 
Figure 10.6a shows the results of the optical tracking experiments for the first generation 
transducer in an 8.1 (± 0.8) kPa phantom using ARF bursts of 300 (60 µs), 600 (120 µs), 900 (180 µs), 
and 1200 cycles (240 µs) at 5 MHz. Each graph represents the median of 5 repeated acquisitions. As 
expected, longer pulse durations increased the magnitude of ARF displacement up to ~1.5 µm for the 
longest pulse. At approximately 4 ms, a shear wave reflection is seen from the front face of the phantom 
(arrow) altering the exponential recovery of the displacement curve. Figure 10.6b shows boxplots of peak 
displacement versus ARF pulse duration for the repeated acquisitions (whiskers represent 1.5 times the 
 
Figure 10.5: Experimental setup for ARFI test in the phantom. a) The IVUS-ARFI transducer was 
put in the cylindrical hole and merged in the deionized water. b) The block diagram of ARFI test. 
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inter-quartile range). Median (IQR) peak displacement for 300, 600, 900, and 1200 cycles were 0.33 (0.27 
– 0.39) µm, 0.72 (0.62 – 0.87) µm, 1.1 (1.0 – 1.3) µm, and 1.6 (1.43 – 1.75) µm, respectively.  
Figure 10.7 shows an A-line captured with the 40 MHz element of the first generation IV-ARFI 
transducer in an opaque graphite phantom. The edge of the phantom is clearly seen at ~3 mm axial depth, 
and identifiable backscatter extends ~2 mm into the phantom (indicated by the gray fill in the image) 
before attenuating to the noise floor. Maximum signal amplitude (measured in the region between 3-5 
mm) was 16.7 dB higher than the maximum amplitude of the electronic noise (measured in the region 
between 5 and 7 mm). Figure 10.8 shows two A-lines taken with the 40 MHz element, one prior to 
movement (shown previously in Figure 10.7) and the other after ~100 µm of bulk motion from a manual 
motion stage. Median (median absolute deviation) displacements measured with NCC from the range of 
3-5 mm were 111.6 (± 39.9) µm, 111.7 (± 8.0) µm, and 111.7 (± 1.9) µm using kernel lengths of 5λ, 6λ 
and 7λ, respectively. As expected, larger kernel sizes decreased error on the displacement measurements.  
 
Figure 10.6: Displacements measured optically from first generation IV-ARFI transducer. (a) Median 
displacement vs. time curves tracked optically (legend indicated the duration of the ARF-burst in 
number of cycles). As the number of cycles in the ARF burst is increased, peak displacement 
increases. A shear wave reflection from the front face of the phantom is seen at ~4 ms (arrow).  (b) 
Boxplots showing peak displacement versus ARF pulse duration measured from the 5 repeated 
acquisitions. Whiskers represent 1.5 times the IQR. Mean plotted as a diamond on top of each box. 
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While the preliminary results from the first generation IV-ARFI transducer were promising, a 
number of challenges arose. First, a full ARFI acquisition with acoustic tracking was not realizable due to 
electrical cross-talk between the low and high-frequency elements. Second, the signal-to-noise ratio (16.7 
dB maximum) of the high-frequency element was low compared to conventional ARFI implementations 
 
Figure 10.7: Two A-lines taken with the high-frequency 
element, one prior to movement, and the other after ~0.1 mm 
of bulk motion with a manual motion stage. The two A-lines 
are out of phase (double-sided arrow) suggesting that motion 
can be tracked with the high-frequency element. 
 
 
Figure 10.8: A-line acquired by the high-frequency element of first generation IV-ARFI transducer in a 
graphite phantom to illustrate the capability for pulse/echo imaging. The phantom edge occurs at ~3 mm 
from the transducer face, and measurable backscatter extends ~2 mm into the phantom (indicated by the 
gray fill) before attenuating below the noise floor. Maximum signal amplitude is 16.7 dB higher than the 
noise floor. 
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(~40 dB), requiring much larger tracking kernel sizes in order to reduce the effects of jitter. Lower SNR 
may be expected in IVUS applications because acoustic pulses are unfocused, however the higher 
frequencies utilized in IVUS would be expected to reduce jitter. Lastly, ARFI displacements measured 
optically only reached ~1.5 µm in an 8.1 kPa phantom. While this level of ARF generation may be 
enough to differentiate a soft necrotic core from the rest of the plaque, stiffer plaque components may not 
be differentiable without increasing the magnitude of the applied ARF. A number of these challenges 
were addressed with the second-generation transducer, which is detailed in the following section. 
10.3.2 Second-Generation Transducer 
The transducer characterization results are shown in Figure 10.9 and Figure 10.10, which depict 
the electical-impedance/phase spectra and fractional bandwidth, respectively. The electrical impedance 
for both active layers was approximately 50 Ohms, with resonances at 26 MHz and 6.5 MHz for the high- 
and low-frequency elements, repectively.  The -6 dB fractional bandwidth of the high frequency 
pulse/echo element was measured to be 47%, covering a frequency span of 20 to 32.7 MHz (Figure 
10.10a). The peak-to-peak pressure generated by the low-frequency pushing element with the 5 V, 10-
cycle burst excitation was measured to be 233 kPa at 5 mm axially from the transducer surface (Figure 
10.10b).  
 
Figure 10.9: Electrical impedance and phase spectrum of 2nd-generation transducer. a) High frequency 
element and b) low frequency element. 
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Figure 10.11 shows the results of ARFI testing utilizing a 1200 cycle burst and acoustic tracking. 
Interestingly, the PD vs. axial position graph (Figure 10.11a) shows a soft region located approxiamtely 3 
mm away from the phantom surface that displaced more than two times further than the phantom closer to 
the transducer (~12 µm vs. ~5 µm, respectively). Displacement vs. time curves for the stiff and soft 
regions are shown in Figure 10.11b and c.  
Figure 10.12 shows PD vs. axial position for a number of ARF burst lengths taken at a different 
location in the phantom. As expected, the average displacement in the phantom increases as a function of 
burst duration, and the phantom appears to be much more homogenous throughout the ARFI depth of 
field (2-5 mm) as compared to the imaging location depicted in Figure 10.11. In both cases, acoustic 
tracking becomes unpredictable and highly variable at depths greater than 5 mm. This is due to the poor 
depth penetration and SNR of the tracking pulses, which leads to a substantial increase in jitter. 
Additionally, the phantom material near to the transducer (less than 2 mm) appears to not displace much. 
This portion resides in the near field of the low-frequency element, so the low displacement observed in 
these regions could be due to poor ARF-generation at such shallow depths. Alternatively, it was noted 
that these transducers suffer from substantial ringdown from the transmited pulses due to the lack of a 
 
Figure 10.10: Pulse/echo and hydrophone characterization of 2nd-generation transducer. a) Pulse-echo 
response of high frequency element. b) Hydrophone measurement of low frequency element using a 5 V 
10-cycle burst excitation. 
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true backing layer, which could write stationary clutter into the near-field regions and be measured as 
little to no motion. 
Indeed, the ringdown was utilized as a stationary source to mitigate the effect of peak-hopping that 
resulted from the instability of the pulser PRF. Although it is expected that the arterial wall will be 
located around 1-2 mm from the IVUS probe face, future designs will probably require improved backing 
and ringdown suppression to ensure that measurements of displacement are not biased by stationary 
echoes. 
 
Figure 10.11: Acoustically tracked displacements with 2nd-generation transducer. (a) Peak displacement 
vs. axial depth showing a soft region in the phantom. (b) Displacement vs. time curve in the stiffer 
phantom region (2.5 mm axial depth). (c) Displacement vs. time curve in the softer phantom region (3.1 
mm axial depth).  
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10.4 Conclusion 
In this chapter, a novel prototype IVUS transducer capable of performing intravascular ARFI 
imaging was developed and tested. Using a 2nd-generation design, ARFI displacements of up to 12 µm 
were measured in a tissue-mimicking phantom with average stiffness of 10 kPa. As expected, ARF 
displacement was proportional to the pulse duration of the ARF burst, with the longest bursts (~200 µs) 
resulting in the most displacement. In the future, this transducer will need to be mounted on a rotational 
motor to generate 2D IV-ARFI images, and tested on actual atherosclerotic plaques to determine whether 
it can differentiate vulnerable plaque features.  
This chapter represents the final piece of research that was completed as part of this dissertation. 
In the following chapter, a summary of important conclusions derived from this work is given, and some 
future directions for improving ARFI plaque characterization are presented.  
 
Figure 10.12: Acoustically measured peak displacement vs. 
time for three different ARF-burst durations. Note this data 
was acquired at a different phantom location than data in 
previous figure. 
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CHAPTER 11 
 Conclusions and Future Directions 
 
11.1 Conclusions  
The results presented in this dissertation support the hypothesis that ARFI ultrasound is capable 
of noninvasively characterizing atherosclerotic plaque composition in humans by interrogating 
mechanical stiffness. In general, it was demonstrated that areas of elevated peak displacement correlate 
with the presence of necrotic core or intraplaque hemorrhage, while areas of decreased peak displacement 
correlate with the presence of fibrosis or calcification. Not only was it shown that ARFI stiffness can 
reveal underlying plaque composition, but that largely untrained readers can identify these regions while 
blinded to the histological result, so long as the readers are guided to the location of the plaque border. In 
the best cases, some radiologists were able to achieve AUCs exceeding 0.9 for the combined 
lipid/hemorrhage and collagen/calcium rating categories. This result is a key accomplishment of this 
dissertation and suggests that ARFI is not only an effective technique, but also a facile one that can be 
learned quickly. It is expected that as ARFI-based elastography methods continue to penetrate into clinics 
and hospitals, radiologists will become more familiar with them and performance should improve beyond 
that demonstrated in these preliminary studies. 
In addition to measuring performance, ARFI was shown to be relevant to quantifying fibrous cap 
thickness with both FEM simulation and in vivo validation. In the FEM studies, it was shown that ARFI 
has the potential to visualize fibrous caps down to 0.2 mm when using the highest possible tracking 
frequency (12 MHz) and best signal processing parameters (1λ tracking kernel, and optimal dynamic 
range scaling). An important result from FEM analysis was that coupling between the stiff fibrous cap 
and the necrotic core introduces a positive bias into ARFI measurements that is largely independent of 
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imaging parameters. The bias was shown to be consistent across a wide range of fibrous cap thicknesses 
(0.1 – 1 mm) with an average magnitude of approximately 0.13 mm. Due to the consistency of the bias, it 
is possible that a simple correction factor could be developed to remove it if fibrous cap measurement is 
implemented clinically. However, the simulations also revealed that the bias is highly sensitive to image 
dynamic range. Improved methods of automatically scaling ARFI images will be critical for the success 
of fibrous cap thickness measurement with ARFI. 
Finally, this work was the first to demonstrate ARFI in ruptured plaques with hemorrhage, a 
feature that has otherwise never been imaged before with ARFI. As predicted, ARFI displacements were 
elevated in regions of hemorrhage, with similar magnitude to that seen in necrotic core. Although blinded 
readers were not able to uniquely identify hemorrhage from necrotic core, careful unblinded analysis of 
ARFI images showed that rupture may be directly visualized by identifying locations where high-
displacing plaque regions communicate with the lumen.  
11.2 Future Directions  
There were a number of challenges encountered during the course of this work that serve as 
starting points for future directions of ARFI plaque characterization. First was the inability of ARFI to 
uniquely describe intraplaque hemorrhage from necrotic core. Prospective MRI studies have shown that 
the presence of intraplaque hemorrhage and thinning/ruptured fibrous cap carry slightly higher hazard 
ratios for future ischemic events compared to intact necrotic core (4.59 and 5.93 compared to 3.00) [102]. 
Therefore, improving ARFI’s sensitivity to rupture and hemorrhage should be a priority going forward. 
This could be achieved by utilizing higher resolution ARFI systems, and potentially implementing 
advanced clutter suppression techniques such as harmonic ARFI imaging to enhance image quality. A 
lower priority, but no less important, would be the improvement of ARFI for distinguishing between 
collagen and calcium. The literature on the dangers of calcification is mixed, with some studies showing 
that it helps stabilize plaque and others that show it destabilizes [286]. For ARFI to reach its full potential 
as a plaque characterization technique, it will need to uniquely discriminate calcium in order to determine 
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the cases where it increases vulnerability. Some of these features may be better discriminated by 
considering more than peak displacement alone and, instead, evaluating the full motion dynamics in 
response to an ARFI excitation. Methods that utilize robust principal component analysis (PCA) to reduce 
and cluster ARFI data sets [287] or fit biomechanical models to the measured tissue displacements to 
evaluate viscoelastic parameters [207] may be relevant in this regard. 
Second, readers, in general, had lower AUC performance when the plaque border was not 
identified for them. This could have been attributed to the unsophisticated B-mode imaging that was used 
in these studies, or to the lack of definition of the lumen in some ARFI images, or both. These 
conclusions are based on the experience of the unblinded reader, who ultimately determined the true 
plaque outlines. Even with knowledge of the histology, the unblinded reader sometimes had difficulty 
perceiving the plaque outline in some hybrid B-mode/ARFI images. The plaque borders were truly made 
clear when the higher-resolution B-mode images from the patient’s medical record and power Doppler 
representations of the lumen were also seen. Therefore, it is expected that the “unguided” blinded readers’ 
AUCs would have matched more closely with the “guided” AUCs because the plaque outlines would 
have been detected more accurately. Implementing high resolution B-mode and Doppler methods should 
be possible in second generation ARFI plaque characterization systems because combined ARFI/Doppler 
pulse sequences have since been developed [256]. 
Third, due to the small number of patients enrolled in this study, it was difficult to assess the 
differences between plaques from symptomatic and asymptomatic patients. In general, it appeared that the 
asymptomatic patients had more heavily calcified plaques and had less distinct “soft features” on ARFI 
images. More patients need to be imaged to determine whether these trends hold true. Improving the 
sensitivity of noninvasive imaging to dangerous asymptomatic atherosclerosis is regarded as one of the 
top priorities in the medical community due to new evidence suggesting CEA may no longer be the best 
intervention strategy for asymptomatic disease [63]. Therefore, future ARFI studies should specifically 
target asymptomatic patients to determine what additional information can be provided by this modality. 
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Finally, the next step to bringing ARFI closer to the clinic will likely be the conduction of larger 
prospective clinical trials that correlate ARFI plaque signatures to future ischemic events. While it was 
necessary to utilize CEA patients in this dissertation to validate ARFI’s capability of detecting plaque 
features, these patients represent a sort of “best case” scenario for imaging because plaques in these 
patients are usually highly advanced and features are large. It is expected that lower grade plaques may be 
more challenging to image as features get smaller. For ARFI to make a significant impact on standard of 
care, it has to exceed the performance of Duplex ultrasound for predicting which plaques are likely to 
cause a stroke. This means that it must be effective in asymptomatic patients and patients with much 
lower stenosis levels than were imaged in this CEA study. Prospective studies will be critical to getting 
ARFI accepted as a relevant carotid imaging technique. 
While there is still much work to be done, the research presented in this dissertation suggests that 
ARFI is very capable of detecting vulnerable plaque features and has the potential of greatly improving 
diagnosis of atherosclerosis in peripheral arteries. Future studies should build on the work presented 
herein and utilize the data sets provided to improve the next generation of ARFI plaque imaging systems.   
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APPENDIX A 
 Experimental Validation of Displacement Underestimation in ARFI Ultrasound 
 
In this appendix, optical tracking was utilized to experimentally measure the displacement 
underestimation achieved by acoustic tracking using a clinical ultrasound system. Three optically 
translucent phantoms of varying stiffness were created, embedded with sub-wavelength diameter 
microspheres, and ARFI excitation pulses with F/1.5 or F/3 lateral focal configurations were transmitted 
from a standard linear array to induce phantom motion. Displacements were tracked using confocal 
optical and acoustic methods. As predicted by earlier FEM studies, significant acoustic displacement 
underestimation was observed for both excitation focal configurations; the maximum underestimation 
error was 35% of the optically measured displacement for the F/1.5 excitation pulse in the softest 
phantom. Using higher F/#, less tightly focused beams in the lateral dimension improved accuracy of 
displacements by approximately 10 percentage points. This work experimentally demonstrates limitations 
of ARFI implemented on a clinical scanner using a standard linear array and sets up a framework for 
future displacement tracking validation studies. 
A.1 Introduction 
Acoustic radiation force impulse (ARFI) ultrasound is a non-invasive imaging technique that is 
used to investigate the mechanical properties of internal tissues [205]. Fundamentally, ARFI works by 
employing a long duration ultrasonic pulse that, through transfer of momentum, generates a force in the 
   
© 2013 SAGE Publications. Portions reprinted, with permission, from T. J. Czernuszewicz, J. E. Streeter, P. A. 
Dayton, and C. M. Gallippi, “Experimental validation of displacement underestimation in ARFI ultrasound”, 
Ultrason. Imaging, vol. 35, no. 3, pp. 196–213, Jul. 2013. 
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propagating medium. This force displaces the underlying tissue in a highly localized manner serving as a 
precise, virtualized form of palpation.  
The physics behind acoustic radiation force (ARF) have been extensively studied, and in an 
absorbing media, under simplified plane wave assumptions, the force has been shown to be proportional 
to the intensity of the acoustic pulse (see Section 4.2). When applied impulsively, this force creates a μm-
order, uniaxial deformation in the direction of wave propagation that can be tracked using various 
ultrasound-based time delay estimators (TDEs). In practice, the same transducer can be used to generate 
both the ARF pulse and the tracking pulses. This ensures that the tracking pulses are co-located with the 
induced motion, thereby increasing the accuracy of displacement estimation by largely eliminating 
decorrelation from off-axis motion. Decorrelation has been shown to be a key source of variance in 
ultrasound-based motion tracking as predicted by the Cramér-Rao lower bound [223].  
Using the same transducer for both pushing and tracking is elegant in design, but not without side 
effect. Namely, the displacement estimates are susceptible to another form of decorrelation called 
shearing artifact. Shearing artifact is the result of non-uniform, on-axis scatterer displacement within the 
tracking point spread function (PSF) that is caused by the gradient of force induced by the pushing pulse. 
Because some scatterers are not moving as far as others under the tracking PSF, averaging occurs and the 
final displacement estimates do not depict the full extent of tissue motion (see Section 4.4.4). An analytic 
expression for the magnitude of this type of decorrelation was derived by McAleavey et al. [228], which 
mitigated this effect by modifying the focal configuration, or F/# (defined as the ratio of aperture width, z, 
to focal depth, d), of the pushing and tracking pulses appropriately. It was concluded that a broad 
defocused pushing pulse combined with a narrow focused tracking pulse will yield both the highest 
correlations and the highest ARFI displacement estimates. Furthermore, it was predicted that in a 
common imaging scenario (1D linear array) where control over F/# can only be exerted in the lateral 
dimension, ARFI-measured displacement could, at most, be only 1/√2 of the true peak displacement. 
 A number of studies have since been published that have investigated the impact of shearing 
decorrelation using finite element method (FEM) modeling [229], [230]. In Palmeri et al. [230], ultrasonic 
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tracking of an ARFI induced deformation with a 1D linear array was simulated in homogenous media 
with various elastic constants. It was shown that underestimation due to shearing was not constant over 
time (i.e. underestimation was worst in the early time points, as low as ~50% of the true induced motion) 
and the accuracy of estimation improved more rapidly with stiffer material. The reason ARFI 
displacement estimation improves over time is that shear waves radiate out from the region of excitation 
(ROE) and the distortive shear wave front is no longer within the tracking PSF. The stiffer the material, 
the faster the shear waves are able to traverse the resolution cell, and the accuracy of the estimation is 
improved at a correspondingly higher rate. In Dhanaliwala et al. [229], an expression for signal-to-noise 
ratio (SNR) in an ARFI image was derived by extending the original McAleavey derivation for shearing 
decorrelation, and FEM experiments were performed with a 1.5D linear array. The authors show that 
using a smaller elevational aperture for the pushing pulse results in ARFI images with higher SNR due to 
the improvements in the shearing decorrelation.  
 While shearing artifact has been comprehensively studied in the literature with FEM, there is a 
notable lack of experimental measurements of the phenomenon. The only published data in this regard is 
from [228] in which the TDE correlation values taken in a single phantom were shown to change as a 
function of the ratio of pushing to tracking elements. The fact that experimental measurements are sparse 
is not entirely surprising due to the inherent complexity of developing an apparatus that can truly measure 
ARF-induced dynamics; displacements are usually very small (μm-order), the motion fast (msec-order 
recovery times), and ROEs located deep (cm-order) within tissue. A number of groups have approached 
this problem using optically-based techniques [288]–[291], the most recent of which includes tracking 
ARF-induced motion with a high-speed camera [292], [293]. Initially, Bouchard et al. [292] used two 
opposing piston transducers (one to push and one to track) that were confocally aligned on a metal wire 
embedded near the surface of a phantom, and  tracked the motion induced by the pushing piston with a 
high-speed camera. These methods were further refined by Bouchard et al. [293], where instead of a 
metallic marker, small sub-wavelength size (10-μm diameter) polystyrene beads were embedded in a 
translucent phantom to provide a more realistic ARFI imaging scenario. ARFI displacements, again 
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induced by a single element piston transducer, were motion tracked optically to investigate the dynamics 
of an ARFI excitation at depth within a phantom but were not simultaneously tracked acoustically as done 
previously. 
In the following appendix, the high-speed camera framework proposed by Bouchard et al. is 
extended and utilized to experimentally validate ARFI displacement estimates taken with a clinical 
imaging system. A conventional linear array transducer is confocally aligned with a high-speed camera to 
simultaneously capture ARFI displacements measured acoustically and optically in translucent phantoms. 
The acoustically tracked displacements are then validated using the optical gold standard to 
experimentally measure the displacement underestimation previously demonstrated with FEM 
simulations. In addition, experiments are performed on phantoms with varying material stiffness using 
different excitation focal configurations to investigate the impact of these parameters on acoustic 
displacement tracking. 
A.2 Methods 
A.2.1 Optical Phantom Construction 
Three custom, translucent, gelatin-based, tissue-mimicking phantoms were constructed adapting 
the formulation of Bouchard et al [293]. The phantom recipes consisted of the following ingredients: 
type-A gelatin (Acros Organics, Geel, Belgium), agar (Fisher Scientific, Fair Lawn, NJ, USA), black 
polystyrene microspheres (10-μm, Polysciences Inc., Warrington, PA, USA), n-propanol, and de-ionized 
water (concentrations are given in Table A.1). The agar powder was added to each phantom for acoustic 
scattering while the polystyrene beads served as markers for optical tracking. The diameter of the agar 
particles was not published by the manufacturer and was measured experimentally with an Accusizer 
780A (Particle Sizing Systems, Santa Barbara, CA, USA) system to be 28.4 ± 33.5 µm. The estimated 
concentration for the polystyrene bead suspension given by the manufacturer was 4.55 × 107 particles/mL.  
To evaluate the scattering of the two different particles (agar versus polystyrene), the estimated 
differential scattering cross-section (σd) was computed for each using the following formula [294]: 
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 (A.1) 
where ω is the angular acoustic center frequency, a is the radius of the scatterer, co and cv are the speeds 
of sound in the background and scatterer respectively, ρo and ρv are the densities of the background and 
scatterer respectively, and θ is the angle of the scatterer with respect to the center of the transducer 
(assumed to be 180°). The density (ρv) and speed of sound (cv) values for agar and polystyrene were 
assumed to be 1.04 g/cm3 and 1500 m/s, and 1.05 g/cm3 and 2350 m/s, respectively. The values for ρo and 
co were assumed to be 0.98 g/cm3 and 1540 m/s respectively for the gelatin background. Using these 
parameters, the differential scattering cross-section was estimated to be higher for the agar (2.98 × 10-9 
cm2 sr -1) compared to the polystyrene (8.39 × 10-13 cm2 sr -1). The backscatter coefficient (ηBS) was also 
calculated with the following equation: 
 𝜂𝐵𝐵 = 𝑛𝜎𝑑   (A.2) 
Table A.1: Phantom Recipes and Material Parameters 
Ingredient Phantom 1 Phantom 2 Phantom 3 
Type-A gelatin (g) 12.9 22 34 
n-propanol (mL) 10 10 10 
Water (mL) 190 190 190 
Agar (g) 1 1 1 
Polystyrene microspheres (drops) 10 10 10 
    
Parameter Phantom 1 Phantom 2 Phantom 3 
Speed of sound (m/s) 1521.9 ± 0.26 1533.7 ± 0.44 1555.9 ± 0.32 
Attenuation (dB/cm @ 3.5 MHz) 0.25 ± 0.05 0.51 ± 0.05 0.44 ± 0.04 
Young’s Modulus (kPa) 6.6 ± 0.49 19.8 ± 0.93  30.2 ± 1.48 
Speckle SNR 1.89 ± 0.11 1.82 ± 0.08 1.84 ± 0.07 
*Young’s modulus values were measured using shear wave velocimetry. Values for speed of 
sound, attenuation, and Young’s modulus are reported as mean ± one standard deviation. 
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where n is the number density of the scatterers. The number density of agar was measured by the 
Accusizer to be 3.50 × 105 particles/mL, while the number density of polystyrene beads was estimated to 
be 1.14 × 105 particles/mL based on the manufacturer’s reported concentration. Therefore, the backscatter 
coefficient was calculated as 1.04 × 10-3 cm-1 sr -1 for agar, and 9.54 × 10-8 cm-1 sr -1 for polystyrene. 
Three phantoms were heated to 40°C and congealed in a rectangular acrylic cast (inner 
dimensions: 86 × 86 × 25.4 mm); their elasticity was varied by adjusting the amount of gelatin powder. A 
cylindrical acrylic piece with a diameter of 12.5 mm was cut in half and glued to the top and bottom of 
the acrylic cast to create a groove in each phantom that improved light transmission and ensured uniform 
sound transmission elevationally. Approximately 28 mm of phantom was cut with a wire in order to 
situate the groove ~20 mm (the desired axial focal depth) from one edge of the phantom. Figure 
A.1depicts the phantom design, showing close-up schematics of the phantom, transducer, and microscope 
objective.  
 
Figure A.1: Schematics of phantom design and confocal alignment of optical and acoustic foci showing 
the axial/elevational view and the axial/lateral view. Although only one microbead is shown in these 
schematics, many microbeads (~2.28 × 107 beads) were dispersed throughout the whole volume of the 
phantom. 
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A.2.2 Experimental Setup 
The general experimental setup is shown in Figure A.2(a) and (b). Ultrasonic imaging was 
performed with a Siemens Acuson Antares™ imaging system (Siemens Medical Solutions USA, 
Ultrasound Division), equipped with the Axius Direct Ultrasound Research Interface (URI) that allowed 
customizable beam sequencing and access to the raw radiofrequency (RF) data, and a VF7-3 linear array 
transducer. The transducer was secured in a holder connected to a digital three-axis motion controller 
mounted on an optical air table (Newport Corp., Irvine, CA, USA). A custom acrylic water tank was 
constructed and mounted on an Olympus IX71 microscope (Olympus America Inc., Melville, NY, USA) 
fitted with a 10× objective and opposing, coaxial, 100-W halogen illumination source (U-LH100L-3, 
Olympus America Inc., Melville, NY, USA). A Fastcam SA1 high-speed camera (Photron USA Inc., San 
Diego, CA, USA) was coupled to the microscope for digital frame capture.  
Alignment of the optical and acoustic foci was achieved following methods similar to Bouchard 
et al. [293]. First, an Onda HNC-0400 needle hydrophone (Onda Corp., Sunnyvale, CA, USA) was 
mounted on a manual micro-positioning stage, and the tip was aligned to the optical focus of the 
microscope. Next, the needle hydrophone was connected to a Signatec PDA14A analog-to-digital (A/D) 
convertor (Signatec Inc., Newport Beach, CA, USA), and, using a custom program developed in 
LabVIEW (National Instruments, Austin, TX, USA), the transducer was swept across the hydrophone in 
the lateral/elevational dimensions while transmitting a single A-line to generate a 2D map of the acoustic 
point spread function (PSF). Using the 2D PSF map as a guide, the transducer was then positioned such 
that the peak amplitude was centered on the hydrophone. This process of mapping the PSF and 
positioning the transducer was repeated iteratively with smaller ranges and finer step resolutions to 
achieve precise lateral/elevational alignment of the transducer.  
Due to the difference in the speed of sound (SOS) in water and the phantoms, axial alignment was 
not performed by measuring acoustic intensity with the hydrophone, but rather by positioning the 
transducer a known distance away from the optical focus (in this case, 20 mm). This positioning was 
achieved ultrasonically, using the pulse-echo RF data of a single A-line captured by the ultrasound 
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Figure A.2: Schematic and photograph of optical experimental setup. 
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scanner; the tip of the needle hydrophone (i.e. the optical focus) served as a strong reflector, and the 
transducer was positioned accordingly after measuring the SOS in water. 
With the acoustic and optical foci aligned, the needle hydrophone was removed and replaced with 
a phantom held in an acrylic holder. At the back of the holder, a piece of strong attenuating rubber was 
placed to minimize sound reflections. Finally, the phantom was translated laterally and elevationally, 
using the manual positioning stage, until a polystyrene bead was centered in the microscope’s FOV, after 
which data collection began.  
A.2.3 Data Collection 
ARFI ensembles consisted of two reference pulses, one acoustic radiation force (ARF) excitation 
pulse, and 500 tracking lines with an 11 kHz pulse repetition frequency (PRF). ARFI excitations were 
300 cycles at 4.21 MHz, and both tracking and reference lines were two cycles at 6.15 MHz. Two 
different focal configurations (F/#) were used for the excitation pulse (F/1.5 or F/3), while the 
reference/tracking pulses always used an F/1.5 configuration on transmit and dynamic focusing and 
aperture growth (F/0.75) on receive. The focus in elevation, set by a cylindrical lens, was 3.8 cm. For 
each acquisition, a single ensemble was captured, spatially corresponding to the line that was used when 
mapping the PSF. Prior to each ARFI ensemble, a matched B-mode was also acquired (220 RF lines 
spaced 0.18 mm apart). 
The high-speed camera was configured to acquire frames at a 150 kHz frame rate, across a 128 x 
128 pixel FOV. To synchronize the ultrasound system and the camera, the electrocardiogram (ECG) 
triggering features on the Antares were utilized. An ECG simulator was connected via a standard three 
wire ECG cable to the Antares ECG input port, and the camera’s “trigger in” port was connected to the 
Antares’ auxiliary ECG output port. When the ECG simulator was switched on, the Antares 
simultaneously triggered ARFI acquisition and output a trigger pulse that synchronized the camera. In this 
manner, optical and acoustic data was captured for 10 different beads in each phantom, with 3 matched 
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acquisitions per bead for a total of 180 data sets (3 phantoms × 2 F/#’s × 10 beads × 3 repeated 
acquisitions). 
In order to control for displacement magnitude decorrelation, the output power of the Antares was 
empirically calibrated such that the maximum displacement magnitude was normalized across all 
phantom stiffnesses and focal configurations. Starting with the stiffest phantom and F/3 pushing pulse, 
the scanner was arbitrarily set to a high output power (90%), and the displacement of the bead was 
tracked optically, yielding a peak displacement of ~18 μm (see “Data Processing” for description of 
optical tracking methods). The output power for all other phantoms and focal configurations was then 
scaled down appropriately by iteratively searching for a setting that resulted in an optically tracked peak 
displacement matching ~18 μm. Table A.2 shows the empirically determined power settings used for 
every phantom and focal configuration combination.  
Elasticity of each phantom was measured using ultrasonically based shear wave velocimetry 
[186], [189]. The beam sequence used to perform these measurements consisted of 40 ARFI ensembles 
(300 cycle, F/1.5 pushing pulse) spaced 0.53 mm apart laterally with a stationary region of excitation 
(ROE) positioned at the center of the lateral FOV. Shear wave group velocity was computed from this 
data using lateral time to peak (TTP) methods, and subsequently related to Young’s modulus following 
previously derived equations [189]. 
Table A.2: Empirically determined power settings for the Antares for each phantom and pushing 
pulse focal configuration (F/#) to yield equivalent displacement. 
 Output Power Setting 
F/# Phantom 1 (%) Phantom 2 (%) Phantom 3 (%) 
F/1.5 28.3 38.0 47.0 
F/3 43.6 70.0 90.0 
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A.2.4 Data Processing 
Acoustic motion tracking was performed by one-dimensional normalized cross correlation (kernel 
length = 4.5λ ≈ 1.1 mm, where λ is the wavelength of the tracking pulses) applied to the raw RF data. As 
demonstrated by Palmeri et al.[230], a kernel size of up to 5λ reduces noise from jitter without 
significantly changing mean displacement estimates, which was desirable for this study due to the 
relatively small sample size of beads per phantom. Optical motion tracking was performed by two-
dimensional normalized cross correlation. Two-stage interpolation was used in both the acoustic and 
optical data to track sub-sample displacements; the first stage included upsampling the raw RF data (or 
raw grayscale pixel data) by a factor of 4 with spline interpolation, while the second included fitting a 
parabola to the maximum of the correlation function in the case of the acoustic data, and upsampling the 
correlation curve by a factor of 4 in the optical case [206], [293]. Finally, acoustically tracked 
displacements were scaled by the measured SOSs in the phantoms (see “Speed of Sound and Attenuation 
Measurements” for SOS measurement methods) to convert time delays to distance measurements. 
To validate acoustic displacement measurements and compute displacement underestimation a 
number of steps were performed to align the acoustic and optical data. First, to reduce experimental noise, 
the median displacement curve was computed from the three matched acquisitions taken from each bead 
(this was done for the three acoustic acquisitions as well as the three optical acquisitions). Next, a time 
correction factor was computed for the optical data to correct for a small delay that occurred between the 
trigger and the start of the ARFI acquisition (the delay was caused by dummy frames that had to be added 
to the beam sequence to allow proper ECG synchronization). This was done by identifying the frame in 
which the camera first saw motion (axial displacement ≥ 1 μm), and setting the time of this frame equal to 
the time of ARF pulse plus the time-of-flight (TOF) to the bead. The time correction (∆𝑡) was calculated 
using the following equation: 
 
∆𝑡 =  𝑖0
𝐹𝑃𝑆
− (𝑡𝐴𝐴𝐴 + 𝑡𝑇𝑇𝐴) 
 
(A.3) 
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 𝑡𝑇𝑇𝐴 = 𝑧𝑐𝑝 (A.4) 
where i0 is the index of the camera frame where motion is first observed, FPS is the frame rate of the 
camera acquisition, tARF is the time the ARF pulse is fired and tTOF is the time of flight of the ARF pulse to 
the microbead (defined as the distance to the bead from the transducer, z, divided by the measured SOS in 
the phantom, cp). With the optical and acoustic data aligned in time, linear interpolation was used on the 
optical displacement curves to get the true displacement at each acoustic time point. This interpolation 
was necessary because the PRF of the ultrasonic scanner was not an integer multiple of the camera 
framerate, and therefore the clocks were not synchronized perfectly sample for sample. Finally, with the 
optical and acoustic data aligned, two-sample Wilcoxon rank sum tests (α = 0.01) were performed at each 
time step to test for statistical difference between the optical and acoustic displacement measurement. A 
flow chart of the data collection and data processing steps is given in Figure A.3. 
To ensure the phantoms exhibited fully developed speckle, speckle signal-to-noise ratio (SNR) 
was computed over a 4 × 4 mm region of interest (ROI) centered at the location of each bead on the 
envelope detected B-mode data (calculated as the absolute value of the Hilbert transformed RF data). The 
measured speckle SNR values are reported in Table A.1. 
A.2.5 Speed of Sound and Attenuation Measurements 
The SOS for each phantom was measured with a 0.5” (1.27 cm) diameter element, 2” (5.08 cm) 
spherically focused Panametrics-NDT 3.5 MHz piston transducer (Olympus, Waltham, MA, USA) in a 
custom-built water tank. First, an aluminum plate reflector was positioned approximately 5 cm from the 
transducer face. Using a Panametrics-NDT Pulser/Receiver (Olympus, Waltham, MA, USA) in pulse-
echo mode (negative impulse), two different A-lines were obtained at precisely 10 mm apart using a 
Newport motion-stage with micron resolution (Newport Corp., Irvine, CA, USA). The SOS in water, cw, 
was calculated using the following equation: 
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Figure A.3: Flow chart describing data collection and data processing steps of optical experiments. 
ECG = electrocardiogram; ARFI = acoustic radiation force impulse; RF = radiofrequency; 1D = one 
dimension; 2D = two dimension. 
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𝑐𝑤 = 2(𝛥𝛥)|𝑡1 − 𝑡2| (A.5) 
where Δd is the distance the transducer was moved between A-lines, t1 is the time of peak negative 
pressure of the first A-line and t2 is the time of peak negative pressure of the second A-line. The measured 
SOS (1496.8 m/s) was subsequently verified using a Fluke 51 II Thermometer (Fluke Corp., Everett, 
Washington, USA) to determine the water bath temperature (24.6°C) and compared to published data 
[295].  
Using the empirically determined SOS in water, the piston transducer was positioned precisely 
5.08 cm from the plate reflector by aligning the peak negative pressure to the time (67.9 μsec) associated 
with a distance of 5.08 cm. Ten different A-lines were acquired with each phantom positioned between 
the transducer and the plate reflector. Since the phantom width was constructed to be 2.54 cm, each A-
line would travel through 5.08 cm of phantom and 5.08 cm of water in one round-trip path. Thus, the SOS 
measurements in each phantom, cp, were calculated using the following equations: 
 
𝑐𝑝 = 2�𝛥𝑝 �
�𝑡𝑝+𝑤 − 𝑡𝑤�
 (A.6) 
 
𝑡𝑤 =  2(𝛥𝑤)𝑐𝑤  (A.7) 
Where dp is distance the sound traveled in the phantom, tp+w is the time associated with the peak negative 
pressure of each acquired A-line, tw is the calculated round-trip time that it takes the sound wave to travel 
through water, dw is distance the sound traveled in water. 
Attenuation, α, was measured directly after measuring SOS using the same pulse-echo 
experimental set up and was calculated using the following formula: 
 
𝛼 = 20𝑙𝑜𝑜10 � 𝑉𝑤𝑉𝑝+𝑤�2(𝛥𝑝)  (A.8) 
where Vw and Vp+w are the peak negative echo voltage amplitudes from water only and phantom and 
water, respectively. 
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A.3 Results 
Figure A.4 shows an example of the raw data taken from the 30.2 kPa phantom with an F/1.5 
pushing pulse focal configuration. Panel (a) shows the optically and acoustically tracked data, in their 
native sample rates, plotted on top of each other. Two artifacts can be seen in this plot: first, a broad, low 
displacement peak appears in both the optical and acoustic traces at ~1.5 msec, and second, a sharp, 
negative displacement peak (suggesting significant motion towards the transducer) appears in the optical 
trace at 0.19 msec. The broad, low-displacement artifact was observed previously by Bouchard et al. 
[293] and is the result of a shear wave reflection off of the proximal (w.r.t. the camera) edge of the 
phantom. The sharp negative displacement, on the other hand, is due to the high frequency compressional 
motion that the microbead experiences as the ARF pulse passes through it. The reason this motion is 
misregistered as a bulk negative motion is that the high frequency (4.21 MHz) compressional 
displacement is severely undersampled by the camera (150 kHz) and aliasing occurs. This phenomenon is 
shown more clearly in panels (b), (c), and (d), which show zoomed in versions of displacement, 
correlation coefficient (ρ), and filmstrip of the raw camera data, respectively. Looking at panel (d) first, 
the bead appears blurry for 11 frames (73.3 μsec) at the beginning of displacement, which corresponds to 
the duration of a 300 cycle ARF pulse oscillating at 4.21 MHz (71.3 μsec). During this time, the edges of 
the bead appear smeared over the axial extent of compressional vibration, and the correlation coefficient 
(panel (c)) drops significantly (ρ ≈ 0.8). Callé et al. [290] reported similar findings using an optical 
interferometric technique, which was not limited by frame rate and could fully sample the compressional 
motion of an ARF pulse as it passed through a Mylar sheet embedded in a phantom. In the context of this 
study, the negative tracking artifact was disregarded because no acoustic tracking data was taken at time 
points coinciding with the compressional motion. 
Figure A.5 shows how the displacement estimate varies as a function of time using both optical 
and acoustic tracking methods, which are matched sample for sample for all experiments. The top row 
corresponds to displacements tracked in the 6.6 kPa phantom, while the center and bottom rows 
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Figure A.4: Example of displacement profiles tracked optically and acoustically. (a) Displacement 
profiles in the 30.2 kPa phantom with an F/1.5 ARF pulse focal configuration. Note two anomalous 
displacements: a broad, low displacement occurring at ~1.5 msec corresponding to a shear wave 
reflection off the proximal phantom boundary, and a sharp, negative displacement occurring before 
the first acoustically tracked point at ~0.19 msec corresponding to aliased compressional motion 
from the high frequency 300-cycle ARF pulse. (b) Zoomed in version of the optical displacement 
vs. time trace. (c) Zoomed in time scale showing the maximum correlation coefficients calculated 
for each optical time point. Vertical lines in both (b) and (c) depict timing of acoustic pulses: 
thicker black line indicates the ARF pulse, while thinner black lines indicate tracking pulses. (d) 
Filmstrip showing the camera frames over time. Note that the bead appears blurry while the ARF 
pulse oscillates the bead at the carrier frequency (4.21 MHz) in frames 3-13. During this time, the 
correlation coefficient of optical tracking drops significantly (c), and a negative displacement 
artifact appears in the optical trace (b). 
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Figure A.5: Displacement through time measured both acoustically and optically for the 6.6, 19.8, 
and 30.2 kPa phantoms with F/1.5 and F/3 excitation pulse focal configurations. The tracking 
transmit pulse focal configuration was F/1.5 for all cases. Error bars indicate one standard deviation. 
Statistical significance (p < 0.01) is indicated by a black asterisk or cross for higher optical or 
acoustic values, respectively. Note that as the phantom gets stiffer or F/# increases, the time over 
which the acoustic and optical measurements are statistically different decreases. 
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correspond to the 19.8 kPa and 30.2 kPa phantoms, respectively. The left column shows the results using 
an F/1.5 focal configuration for the ARF pulse, with the right showing F/3. Each data point represents the 
mean displacement measured across 10 beads with error bars showing one standard deviation. Statistical 
differences (p < 0.01) between mean optical and acoustic displacements are indicated with an asterisk 
when the optical mean is higher and a cross when the acoustic mean is higher. Note that as the stiffness of 
the phantom or F/# increases, the mean displacements measured acoustically match the optical 
displacements at earlier time points (listed in Table A.3).  
Figure A.6 shows the mean acoustic displacement as a percentage of the mean optical gold 
standard over time for the 6.6 kPa (a), 19.8 kPa (b), and 30.2 kPa (c) phantoms. Note that the 
underestimation is worst in the first time step, and the accuracy improves with time until ultimately 
reaching 100% of the optical measurement.  
Finally, Figure A.7 shows the mean optical displacement traces for each phantom, with different 
F/# excitations plotted on top of each other. This data is re-plotted in order to illustrate the effect of F/# on 
the recovery profile of the phantom; namely, as the F/# is increased, the recovery time (RT) and time-to-
peak (TTP) is observed to elongate. Table A.4 lists the measured values of peak displacement, recovery 
time, and TTP across F/# and phantom stiffness for comparison.  
Table A.3: Time points at which mean acoustic and optical displacements become non-
significantly different in Figure A.5. 
 Excitation F/# 
Stiffness (kPa) F/1.5 (ms) F/3 (ms) 
6.6  0.96 0.87 
19.8  0.87 0.61 
30.2  0.78 0.52 
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A.4 Discussion 
Previous analytical and FEM studies have shown that ultrasonic motion tracking of ARF-induced 
displacements is subject to underestimation due to scatterer shearing in the lateral and elevational 
dimension [228], [230]. This underestimation is dependent on the underlying material stiffness and can be 
mitigated by beamforming the excitation PSF to encompass the tracking PSF  
 
Figure A.6: Percentage of optical displacement tracked acoustically in phantoms of 6.6 kPa, 19.8 kPa, and 
30.2 kPa with two different excitation pulse focal configurations (F/1.5 and F/3). The tracking transmit 
pulse focal configuration was F/1.5 for all cases. Note that the F/1.5 excitation results in a larger 
displacement underestimation at the early time points. Percentage values were calculated from the mean 
displacement values at each time point in Figure A.5. 
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(i.e. defocus the pushing beam laterally/elevationally and/or lower its center frequency). Material stiffness 
impacts underestimation because it affects the speed at which shear waves propagate away from the ROE. 
The faster the shear wave, the more quickly the displacement field broadens over time in the lateral and 
elevational dimensions, making the scatterer motion under the tracking PSF more uniform and reducing 
the underestimation error. In the same respect, defocusing the excitation beam also reduces displacement 
 
Figure A.7: Mean optically traced displacements with F/1.5 and F/3 ARF pulse focal configurations 
plotted on top of each other to show the effect of pushing F/# on phantom recovery time. In each 
phantom, time to 67% recovery of maximum displacement and time to peak is elongated when a less 
focused pushing pulse is utilized. 
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underestimation by increasing the cross-sectional area over which force is initially deposited and 
broadening the extent of the displacement field relative to the tracking PSF.  
Figure A.5 and Figure A.6 confirm the FEM predicted phenomena, showing improvement in the 
accuracy of acoustically derived displacements as either the stiffness of the phantom or the excitation F/# 
is increased. Figure A.6 shows that the first acoustic time point, which coincides with the highest optical 
displacement in almost all cases, has the greatest underestimation. This underestimation then resolves 
with time at a rate governed by the stiffness of the phantom, which is depicted numerically in Table A.3. 
As expected, the stiffest phantom matches the optical displacement at the earliest time point. Figure A.6 
and Table A.3 also show that doubling the F/# of the excitation pulse in the lateral dimension results in 
improved displacement estimation accuracy and shorter times to non-significant difference from optically 
measured displacements. The acoustic estimates with F/3 excitations were on average 7.7, 10.4, and 7.7% 
closer to the optical measurements for the 6.6, 19.8, and 30.2 kPa phantoms, respectively (over the time 
period that it takes F/1.5 to reach non-significant difference). Finally, the variance (i.e. jitter) of the 
acoustic displacement estimates was observed to be worst in the earliest time points, consistent with 
previously simulated data. 
Figure A.6 also shows that the F/1.5 excitation resulted in a small amount (~10 to 20%) of 
acoustic overestimation of the measured displacement in all three phantoms (at ~0.9 msec and later), 
Table A.4: Mean peak displacement, time to 67% recovery, and time to peak measured optically across 
10 beads (± 1 standard deviation). 
  Phantom 
Parameter F/# 6.6 kPa 19.8 kPa 30.2 kPa 
Peak (μm) 
 
F1.5 17.7 ± 1.6 18.5 ± 1.3 19.8 ± 1.7 
F3 17.6 ± 0.8 18.5 ± 0.8 18.2 ± 0.9 
Recovery (ms) 
 
F1.5 0.46 ± 0.04 0.35 ± 0.03 0.3 ± 0.03 
F3 0.87 ± 0.05 0.69 ± 0.05 0.56 ± 0.04 
TTP (ms) F1.5 0.14 ± 0.012 0.11 ± 0.014 0.10 ± 0.007 
F3 0.22 ± 0.013 0.16 ± 0.005 0.14 ± 0.005 
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which was generally not observed with the F/3 excitation. This overestimation, like the underestimation at 
the earlier time points, could occur if the scatterers at the edge of the PSF are displacing more than the 
scatterers in the center of the PSF. Due to the large -6 dB elevational beamwidth (~2.4 mm) at an axial 
focus of 20 mm, this could conceivably occur if either the shear wave front has not entirely left the PSF at 
the time the center scatterers begin to recover, or if the shear wave reflection artifact has returned into the 
PSF. Figure A.7 suggests that the shear wave reflection does not coincide with the time of overestimation 
in the 6.6 and 19.8 kPa phantoms, but could coincide in the 30.2 kPa phantom. A more in-depth 
investigation that is not confounded by shear wave reflections is needed to conclusively determine the 
mechanisms underlying displacement overestimation. 
Figure A.7 and Table A.4 show an interesting phenomenon associated with increasing the F/# of 
the excitation pulse; the RT and TTP of the phantoms are both elongated. In all three stiffnesses, the 
optically measured RT was increased by a factor of 2, while the TTP was increased by a factor of 1.5 
when the excitation F/# was increased from F/1.5 to F/3. Elongated TTP by F/# was previously reported 
by Palmeri et al. [231] in FEM studies and was attributed to the broader cross-sectional area of the 
pushing beam, but the effect on RT was either not observed or not reported. It would be expected that the 
same inertial (mass) effects described by Palmeri et al. [231] that explain the increase in TTP would 
increase RT as well, but it was outside of the scope of this study to investigate these dynamics in further 
detail. 
There were a number of potential sources of error in this study that could have contributed to 
erroneous measurement of displacement underestimation: focal alignment mismatch between optical and 
acoustic data sets, jitter in optical displacement estimation, and sample-for-sample timing uncertainty. As 
described previously, focal alignment was carried out in water, which had a slightly different SOS than 
the gelatin phantoms. Because of this, the axial focus of the transducer was not precisely positioned on 
the microbead when the experiments were carried out. For the purpose of this study, though, it was not 
critical that the microbead be precisely at the acoustic focus axially, only that the position of the bead 
relative to the transducer be known so that it could be located within the range of the acoustic A-line. 
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Therefore, to discern the axial position of the microbead two empirical SOS measurements had to be 
made, both subject to experimental error; the first was a measurement in water to precisely position the 
transducer 20 mm from the needle hydrophone, and the second was a measurement in each phantom in 
order to calibrate the fast-time dimension of the acoustic RF data. If either of these measurements was 
incorrect, the acoustic data would be slightly misaligned axially and the measured underestimation 
erroneous. The standard deviation on both SOS measurements was generally small though (< 1 m/s) and 
would result in a one or two sample axial shift (~20 to 40 μm) that was not expected to have a significant 
impact on the results of this study.  
Jitter in the optical measurements was another possible source of error. Like acoustic 
displacement estimation, optical displacement estimation was subject to jitter errors arising from limited 
camera pixel resolution and electronic noise from camera components. To quantify the impact of optical 
jitter error, the standard deviation was calculated on the last 100 samples of every optical data set and 
averaged together resulting in an empirical jitter error of 0.11 μm on optical measurements, which is low 
compared to the displacements induced in this study. Finally, timing uncertainty could have impacted the 
sample-per-sample alignment of the optical and acoustic data. One of the consequences of this 
experimental design is that the camera and the ultrasound system run on different clocks, and the Antares 
scanner did not output a trigger with every ultrasonic pulse. Therefore, optical data had to be interpolated 
when the time step of the acoustic pulse did not align precisely with the optical sample. Any error arising 
from this interpolation step, though, was deemed to be insignificant due to the high frame rate of the 
camera acquisition (150 kHz).  
Understanding displacement underestimation is important in the context of imaging mechanically 
heterogeneous tissues because of its potential to impact contrast. The most common 2D parametric 
images created from an ARFI acquisition show peak displacement values measured at each pixel. In this 
type of image, areas of low peak displacement represent stiffer tissues while areas of high displacement 
represent softer tissues.  The underestimation phenomenon, though, works in the opposite direction; the 
stiffer structures have higher shear wave speeds and are less underestimated (i.e. have higher 
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displacement) while the softer structures have slower shear wave speeds and are more underestimated (i.e. 
have lower displacement). Therefore, correcting displacement underestimation, either through excitation 
pulse geometry and transducer design [229] or filtering and motion tracking techniques [232], [233], 
could have major impact on the field of ARFI imaging. This work presents an experimental framework 
for testing and validating these novel approaches to reducing displacement underestimation. 
A.5 Conclusion 
Acoustic displacement underestimation in ARFI, previously predicted by theory and FEM 
modeling, was validated experimentally. A high F/# excitation pulse was seen to reduce the amount of 
displacement underestimation due to lateral shearing. Likewise, a dependence on material stiffness was 
observed, where stiffer phantoms showed less underestimation and faster times to matching the true 
displacements. These experiments set up a framework for future displacement tracking validation studies 
using relevant diagnostic ultrasound hardware. 
 
  
224 
 
APPENDIX B 
 Optimal ARFI Frequency Derivation 
In this appendix, a simple equation is derived to determine the optimal ARFI pushing frequency 
for a given focal depth and tissue attenuation coefficient. The derivation is based on the simple 
formulation that relates acoustic intensity to acoustic radiation force. The results demonstrate an inverse 
exponential relationship between the desired depth of penetration and optimal pushing frequency. 
B.1 Theory 
Under simplified plane wave assumptions, in an absorbing media the force has been shown to be 
proportional to the intensity of the acoustic pulse as follows: 
 
 
𝐹 = 2𝛼𝛼
𝑐
 (B.1) 
where α is the absorption coefficient of the medium, I is the temporal-average beam intensity, and c is the 
speed of the sound through the medium [178], [296]. From equation (B.1), two terms can be described as 
functions of both frequency and propagation depth; the absorption coefficient (α), and the temporal-
average intensity (I). The following will develop an expression for frequency as a function of propagation 
distance, assuming an exponential derating scheme for in-situ pulse intensity.  
Start with the equation (B.1) and add in extra variables for frequency (f) and position (x). Units 
for the equations are as follows: α [ 𝑛𝑑𝑝𝑑𝑛
𝑐𝑚 𝑀𝑀𝑀], f [MHz], c [𝑐𝑚𝑠 ], x [cm], and I [𝑑 𝑐𝑚2𝑠3 ]. 
 
𝐹(𝑥,𝑓) =  2𝛼𝑓
𝑐
𝛼(𝑥,𝑓) (B.2) 
Define derated intensity equation: 
 𝛼(𝑥,𝑓) =  𝛼0𝑒−2𝛼𝑓𝛼 (B.3) 
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Substitute (B.3) into (B.2): 
 
𝐹(𝑥,𝑓) =  2𝛼𝑓
𝑐
 𝛼0𝑒−2𝛼𝑓𝛼 (B.4) 
Take partial derivative of (B.4) with respect to frequency, and set to zero to find maxima (i.e. the 
maximum ARF magnitude): 
 𝜕
𝜕𝑓
𝐹(𝑥,𝑓) =  −2𝛼𝛼0
𝑐
𝑒−2𝛼𝛼𝑓(2𝛼𝑥𝑓 − 1) = 0 (B.5) 
Simplify, and solve for f in terms of x: 
  −4𝛼2𝑥𝑓𝛼0
𝑐
𝑒−2𝛼𝛼𝑓 + 2𝛼𝛼0
𝑐
𝑒−2𝛼𝛼𝑓 = 0 (B.6) 
 
  −4𝛼2𝑥𝑓𝛼0
𝑐
𝑒−2𝛼𝛼𝑓 =  −2𝛼𝛼0
𝑐
𝑒−2𝛼𝛼𝑓 
(B.7) 
 
 4𝛼𝑥𝑓 = 2 (B.8) 
Finally, the optimal ARFI frequency (MHz) can be written as a function of attenuation coefficient 
( 𝑛𝑑𝑝𝑑𝑛
𝑐𝑚 𝑀𝑀𝑀) and depth (cm). 
 
𝑓 =  12𝛼𝑥 (B.9) 
B.2 Methods 
To verify equation (B.9), radiation force magnitude was computed numerically using equation 
(B.1) for a range of attenuation coefficients (0.3, 0.5, and 1.0 dB/cm/MHz), depths (0.1 to 15 cm), and 
frequencies (0.5 to 100 MHz). Using this data, the frequency that maximizes ARF magnitude could be 
determining by taking the maximum at each simulated focal zone. These results are then compared 
against the predicted maxima given by equation (B.9). 
B.3 Results/Discussion 
Figure B.1 shows the results of the numerical analysis of equation (B.1). ARF magnitude is 
plotted as a function of focal depth and frequency, derived numerically by simply inputting values into  
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(B.1). The results show that ARF should be maximized by very high frequencies when the desired focal 
depth is very shallow, and decreases as the focal depth is moved deeper in the tissue.  
Figure B.2 shows the results predicted by equation (B.9), with the frequency of maximum ARF 
magnitude plotted as a function of focal depth. Figure B.2a shows the results for near-field targets (i.e. 
targets less than 1 cm from the transducer face), while Figure B.2b shows the results for farther targets (1 
– 5 cm). As expected, the frequency that maximizes ARF decreases exponentially as the desired focal 
depth is moved farther from the transducer. Finally, Table B.1 shows a range of ideal ARF pushing 
frequencies for a number of imaging targets based on attenuation and depth values reported in literature 
assuming that the attenuation coefficient to reach these depths is a constant 0.5 dB/cm/MHz. 
While these simulations are useful to quickly assess the optimal frequency needed for an ARF 
excitation for a given focal depth, there are a number of limitations. First, the model assumes that 
attenuation increases linearly with frequency, which is an incorrect assumption in some tissue types. 
Second, the model does not take into account the fractional bandwidth of a given transducer, which will 
dictate the amount of intensity that a given transducer can output at a given frequency. In practice, a given 
transducer will output the highest intensity at its resonance frequency, while off-resonance will have 
slightly less intensity. Finally, attenuation varies greatly with tissue types. The current model does not 
support a piece-wise sound attenuation path as would be expected when imaging some of the deeper  
 
Figure B.1: ARF magnitude as a function of frequency and focal depth for three attenuation coefficients. 
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organs. For example, to reach the deepest parts of the liver, the sound much first travel through layers of 
skin, muscle, and fat, and then propagate a significant distance through liver itself, which has distinct 
attenuation characteristics. To improve the model in the future it would be useful to incorporate various 
attenuation paths as well as transducer fractional bandwidth in order to select the ideal pushing frequency 
for a given imaging scenario. 
  
Table B.1: Predicted optimal pushing frequency for various targets.   
Organ Depth (cm) Optimal Pushing Frequency (MHz) 
Carotid Artery 2 – 3 4.3 – 2.9 
Kidney 4 – 10 2.2 – 0.87 
Liver 5 – 13 1.7 – 0.67 
Muscle 1 – 4 8.7 – 2.2 
Thyroid <2 cm >4.3 
 
 
Figure B.2: Frequency of maximum ARF as a function of focal depth, determined by equation (B.9).  (a) 
Shallow focal depths. (b) Mid-range focal depths. Blue, green, and red lines depict different absorption 
coefficients (0.3, 0.5, and 1.0 dB/cm/MHz, respectively).  
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